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ABSTRACT: 
Introduction: 
Struvite stones (magnesium ammonium phosphate) account for 10-15% of renal stones and can 
grow rapidly forming staghorn calculi. With limited medical therapies available and surgery the 
mainstay of treatment, an understanding of the physico-chemical conditions causing struvite 
crystallization allows development of strategies to prevent their formation.  
At present, very little is known about the physico-chemical conditions that result in struvite 
crystallisation. This lack of understanding has two bases: i) the particular ionised concentrations of 
the reactants (e.g. Mg2+,  NH4+, and phosphate) in the urine are unknown; ii) the prevailing 
chemical conditions that would modulate crystallisation are also unclear (e.g. pH, osmolality, other 
urinary constituents).Recent advances in the development of ion-selective electrodes allows 
accurate determination of urinary constituents in small (<1ml) undiluted samples.  
Methods: 
We have furthered developed an NH4+-ion selective electrode and magnesium ion-selective 
electrode to measure the urinary concentrations of each to aid our understanding of struvite 
deposition. [NH4+] and [Mg2+] were measured using plastic dip cast ion-selective electrodes 
dispersed in suitable plasticisers, using nonactin for NH4+ and several different neutral ligands for 
Mg2+.  Data were validated against standardised and developing methodology, including colour 
spectrophotometry and computational algorithms.  Urine samples were also subjected to analysis 
using clinical biochemical techniques. 
Results: 
We characterised an NH4+-ion selective electrode and made the first measurements of [NH4+] in 
undiluted urine samples, in normal subjects and those with stone disease. This technique was 
validated using colour spectrophotometry and then the technique was used to validate a 
computational algorithm. We have developed and characterised the Mg2+-ion-selective electrode 
but Ca2+ caused significant interference.  
Conclusions: 
Direct measurement of the urinary [NH4+] has been achieved for the first time with a value of about 
25mM. This exciting new technique may now provide clinicians with an important point-of-care 
investigative tool in diagnosing and monitoring struvite calculogenesis. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 URINARY TRACT STONES, THE CLINICAL SITUATION  
 
1.1.1 Urinary Tract Stones: 
Urolithiasis is a common disorder with 10% of Caucasian men developing a kidney 
stone by the age of 70. The risk of recurrence without treatment for a calcium oxalate 
stone is 10% at one year and 50% at 10 years (Uribarri et al 1989). Multiple factors 
contribute to urolithiasis.  
 
Up until fairly recently, urinary stones were a major health problem. A large number 
of patients required extensive surgical procedures and a significant minority had their 
kidney removed. Since the advent of extracorporeal methods such as lithotripsy and 
further advances in endoscopic techniques for stone destruction, the management of 
stones has become more efficient and effective, along with decreased morbidity 
relating to stone surgery. 
 
However these advances in technology have allowed medical management of stones 
and research into their prevention to suffer and be left behind. Though surgical 
procedures may well treat stones, they are unable to prevent them and with stone 
recurrence being a major issue, preventative strategies are long overdue for the 
management of stones and certainly for the identifiable group of patients with stone 
recurrence. 
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1.2 EPIDEMIOLOGY: 
 
1.2.1  Intrinsic Factors: 
1.2.1.1 Age / Sex: 
The peak incidence of stones is between age 20 and 40. The male to female ratio is 
3:1 and this is due in part to lower testosterone levels providing protection for women 
and children against developing oxalate stones, since testosterone may increase the 
production of oxalate in the liver (Finlayson 1974). 
 
1.2.1.2 Genetics: 
25% of patients with kidney stones have a family history of stones and in a study (of 
38,000 male health professionals, a family history of stones was more than three times 
higher in men with kidney stones than in non-stone formers (Curhan et al, 1997). 
Renal stones are rare in black-Americans, black-Africans, native-Americans and 
Australian aborigines, but more common in Asians and Caucasians. Familial renal 
tubular acidosis, cystinuria and xanthinuria are hereditary disorders that lead to stone 
formation. 
 
1.2.2 Extrinsic Factors: 
1.2.2.1 Geography: 
High incidence areas include the United States, the British Isles, Scandinavian 
countries, Mediterranean countries and central Europe. Low incidence areas include 
Central and South America, and Africa (Finlayson, 1974). 
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1.2.2.2 Climate/Season: 
Renal stones are common in hot climates and the incidence was thought to be 
increased after the peak temperatures during the hot summer months (Prince et al, 
1960). Baker et al (1993) investigated trends in stone formation in residents in South 
Australia between 1977 and 1991 and found no significant seasonal variation in 
calcium stone formation. There was however an increase in uric acid stone formation 
during summer and autumn and a decrease in infectious stone formation during spring 
and summer.  
 
Hallson et al (1977) showed that crystalluria was greater during summer months in 
patients who formed stones and postulated that increased sweating during high 
temperatures led to concentrated urine and urinary crystal formation.  Uric acid and 
cystine stone-formers are further at risk since concentrated urine tends to be more 
acidic, encouraging these compounds to precipitate. Parry et al (1975) suggested that 
increased vitamin D production during summer, due to increased exposure to sunlight, 
may lead to increased stone formation due to increased calcium excretion in the urine. 
 
1.2.2.3 Diet: 
Increased incidence of renal calculi is associated with a more ‘affluent’ diet (increased 
animal protein, refined sugar and salt). Robertson et al (1978) showed that there was a 
strong relationship between animal protein consumption and stone occurrence. 
Animal protein increases urinary calcium, oxalate and uric acid and generates an 
acidic urine, all contributing to calcium oxalate oversaturation and precipitation. A 
lower prevalence of stone disease has been observed in vegetarians in the UK 
(Robertson et al, 1979) and moderation of animal protein intake was suggested.  
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Interestingly, a higher dietary calcium intake (e.g. 2 glasses milk/day) has been 
strongly associated with a decreased risk of kidney stones. However dietary calcium 
supplementation is not protective.  
 
Sucrose has been shown to increase urinary calcium and oxalate concentrations 
(Thom et al,1981) where sucrose and starch supplements were added to a standard 
diet in normal subjects, resulting in an increased frequency and magnitude of diurnal 
peaks of urinary calcium and oxalate concentration in the higher sucrose diet subjects. 
A lack of dietary fibre is also thought to contribute to stone formation, since fibre 
traps and decreases the rate and extent of absorption of sucrose and animal protein.  
 
1.2.2.4 Water intake: 
Increased water intake causes urinary dilution of the constituents that may otherwise 
crystallise, as well as reduces the average time of residence of free crystal particles in 
the urine (Finlayson, 1974). Current opinion suggests that a low fluid intake 
(<1,200ml/day) predisposes to stone formation.  It is also important to consider the 
trace element content of the water supply of the region.  Sierakowski et al (1978) 
suggested that excessive water hardness (e.g. with calcium and magnesium ions) 
causes a greater incidence of stone disease.  
 
1.2.2.5 Occupation / Stress: 
Sedentary occupations, including professional and managerial groups, have been 
shown to have a higher incidence of urinary calculi as compared to manual workers 
(Lonsdale, 1968). Stress has also been associated with stone disease and a case-
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control study of 400 patients showed that emotional life events were significantly 
associated with stone disease (Najem, 1997). 
 
1.3 STONE TYPE, AETIOLOGY AND INCIDENCE: 
 
There are many different type of stones (see Table 1.1) but the most common type of 
stone consists of a mixture of calcium oxalate and calcium phosphate. 70-80% of 
these stones are said to be idiopathic, where there is no known metabolic cause. 10-
12% are due to metabolic causes (e.g. hyperparathyroidism, renal tubular acidosis, or 
hyperoxaluria). Struvite stones (or infection stones) account for 15-20% of all stones.  
 
It is important to understand the aetiological factors and current treatments for the 
different types of stone formation.  These may then be applied to devise specific 
strategies to manage different types of stone that may develop.  
 
The first part of the Introduction will be concerned with the more common calcium-
containing stones and some less common stone types, as well as general principles of 
stone formation. In section 1.7 and after struvite stones, the main subject of this thesis 
will be discussed in greater detail. 
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Table 1.1: The causes and incidence of stones. 
 
Disorder Stone Type % of all 
stones 
Idiopathic Calcium oxalate / phosphate 70-80 
Hypercalcaemic states: 
(i) Hyperparathyroidism 
(ii) Sarcoidosis 
(iii) Hyperthyroidism 
Calcium oxalate / phosphate 5-7 
Hyperoxaluric states: 
(i) 1o  - enzyme deficiency 
(ii) 2o – enteric hyperoxaluria 
Calcium oxalate 1 
Uric acid lithiasis: 
(i) Diabetes / Metabolic 
Syndrome 
(ii) Gout 
(iii) Myeloproliferative disorders 
Uric acid 8 
Renal tubular acidosis Calcium phosphate 4 
Cystinuria Cystine 1-3 
Xanthinuria Xanthine 0.0001 
Urinary tract infections Magnesium ammonium 
phosphate 
15-20 
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1.4 CALCIUM STONE FORMATION: 
 
Calcium stone formation is really due to a combination of abnormalities. Risk factor 
analysis shows that the following factors (see Fig 1.1), listed in order of decreasing 
importance, are involved in calcium stone formation: 
1. Low urine volume 
2. Mild hyperoxaluria (normal: < 450 μm /day) 
3. Increased urinary pH  
4. Hypercalciuria (normal: < 6.2 (female), < 7.5 (male) mmol / day) 
5. Hypocitraturia 
6. Hyperuricosuria (normal: 1.2 – 4.5 mmol / day) 
7. Hypomagnesiuria 
 
1.4.1  Idiopathic Stone Formation: 
This is the commonest condition and for calcium stones to form, supersaturation of 
the urine with calcium is a prerequisite, i.e. if the urine is undersaturated stone 
formation is impossible. 30%-60% of patients have increased urinary calcium 
excretion in the absence of raised serum calcium levels – idiopathic hypercalciuria. 
Hypercalciuria contributes to stone formation by increasing the relative 
supersaturation of urine. Three types have been described: absorptive hypercalciuria, 
due to increased intestinal calcium absorption; renal hypercalciuria, due to failure of 
reabsorption of filtered calcium by nephrons causing hypercalciuria; resorptive 
hypercalciuria, due to excessive bone resorption of calcium, due to increased 
parathyroid hormone (PTH). 
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1.4.2  Metabolic Causes for Stone Formation: 
1. Hypercalcaemia: of all patients with hypercalcaemia who form stones, almost 
all have primary hyperparathyroidism where PTH increases osteoclast activity, 
calcium reabsorption and vitamin D3 production in the kidney. The mainstay 
of treatment is surgical removal of the adenoma with 90% to 100% 
improvement in stone recurrences. 
Other causes include sarcoidosis, hyperthyroidism and vitamin D toxicity. 
2. Hyperoxaluria: Primary hyperoxaluria is a rare genetic disorder causing 
increased oxalate production in the liver. Pyridoxine decreases oxalate 
production in some patients. Enteric hyperoxaluria due to malabsorption 
(including small bowel resection) increases exposure of the colon to bile salts, 
which causes increased permeability of the colon to oxalate. A combination of 
oral hydration and a low oxalate, low fat diet may be used.  
3. Renal tubular acidosis (R.T.A.): this results from a defect of renal tubular 
secretion of H+, which decreases the ability of the kidney to acidify urine. This 
causes an alkaline urine, which increases calcium phosphate supersaturation, 
leading to calcium phosphate stones. Treatment is directed at correcting 
systemic acidosis with alkali therapy and raising urinary citrate levels. 
4. Hyperuricosuria: seen in 10%-40% of calcium stone formers.  Hyperuricosuria 
promotes calcium oxalate crystallisation. The main cause is excessive dietary 
purine intake. Purine restriction by limiting red meat, poultry and fish helps to 
reduce hyperuricosuria. 
5. Hypocitraturia: seen in 15%-63% of patients with calcium stones. Citrate is 
not only a complexing agent for calcium, creating a more soluble complex 
than calcium oxalate, but also it inhibits calcium oxalate crystal formation and 
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growth. The main cause of decreased citrate excretion in the urine is metabolic 
acidosis.  
6. Hypomagnesuria: studies have shown a low urinary magnesium concentration 
in patients with stones, commonly associated with hypocitraturia. The main 
cause is malabsorption due to inflammatory bowel disease. 
 
 
Fig 1.1:  Risk factors which lead to calcium stone formation. 
 
 
Promoters 
Supersaturation 
↓ Inhibitors 
↑Uric acid 
↑ Ca2+ 
↑ Oxalate 
↑ pH 
↓ Urine Volume 
↓ Citrate 
↓ Mg2+ 
Stone 
Formation 
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1.4.3 Management: 
It is quite difficult to dissolve calcium stones, and therefore an important aspect of 
patient management is the prevention of further calcium stones forming once stone 
clearance has been achieved: Hydration - drink plenty of clear fluids to maintain a 
urinary output >2 l/day; Diet - limit daily meat (protein) intake, increase dietary fibre 
intake and limit oxalate-rich foods; Thiazides - promote calcium resorption in the 
kidney; Orthophosphates - decrease urinary calcium excretion; Sodium cellulose 
phosphate (not extensively used in the UK) - a non-absorbable resin that binds 
calcium and decreases calcium absorption from the intestine; Citrate - potassium 
citrate may be used for treatment of hypocitraturia; Magnesium citrate - to treat 
hypomagnesiuria and hypocitraturia. 
 
1.5 URIC ACID AND CYSTINE STONES: 
 
1.5.1 Uric acid stones 
Purines are metabolised to uric acid, which exists in two forms: ionised urate (soluble) 
and undissociated uric acid (insoluble). The dissociation constant for uric acid is near 
5.35 – at this pH, half of the uric acid is present as the ionised urate form and the 
other half is present as free uric acid.  As the pH decreases, more uric acid precipitates 
out of solution. 
 
Patients with uric acid stones or gout show increased production of uric acid, though 
the cause is not known. Characteristically patients have acidic urine, increased 
hyperuricosuria and reduced volumes of urine. 
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Management:  Medical therapy is successful in dissolving renal uric acid stones, and 
urine alkalinisation (to pH 6.5–7.0) and hydration have been shown to dissolve near 
completely uric acid staghorn calculi. Allopurinol may be used if the patient has 
hyperuricaemia or hyperuricosuria, as it will reduce production of uric acid from 
xanthine.  
 
1.5.2 Cystine stones 
Cystine stones account for 1% of all stones, and only occur in patients with cystinuria. 
Cystinuria, an autosomal recessive disease causing a decreased cystine resorption in 
the proximal tubule of the kidney, affects 1 in 20,000 individuals, and the peak age of 
stone formation is 20-30 years.  
 
The aim of treatment is to reduce cystine concentration in urine and includes: low 
methionine diet – since cystine is a breakdown product of methionine, which is 
present in meat, fish and dairy products; Oral hydration; alkalinise urine to pH >7.5, 
which allows solubilisation of the stone; acetazolamide - augments alkalinisation, by 
inhibiting carbonic anhydrase, thereby increasing urinary bicarbonate excretion; D-
penicillamine or  alpha-mercaptopropionylglycine (MPG) – these bind cystine making 
it soluble in urine; and surgery – to debulk / remove the stone. 
 
1.6 PHYSICO-CHEMICAL PRINCIPLES OF STONE FORMATION: 
 
1.6.1  Supersaturation: 
When a substance is dissolved in water, the solution is said to be ‘saturated’ when the 
concentration of the substance is high enough but crystals have not formed. As the 
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concentration is increased further, crystals precipitate. The point at which saturation is 
reached and crystallisation begins is known as the ‘thermodynamic solubility product’ 
(Ksp). This is a constant under designated conditions of temperature and pH. 
Temperature and pH are always specified, since changes in either factor, may change 
the amount of crystallisation that may occur. It is important to be aware of 
crystallisation studies performed at room temperature rather than at body temperature. 
 
Urine is a more complex solution, since when the concentration of a substance 
reaches the point at which crystallisation would occur in water, crystallisation does 
not occur in urine. This is due to the fact that urine has the capacity to hold more 
solute than water, since urine has a mixture of many electrically active ions 
interacting with each other, affecting their solubility. The presence of organic 
molecules, such as urea, uric acid and citrate also affect the solubility of other 
substances. Urine is therefore described as being ‘metastable’. As the concentration of 
the substance is increased further, a point is reached when the substance eventually 
crystallises and this concentration is known as the ‘formation product’ (KF) of the 
substance. Therefore the metastable range can be described as the range between the 
Ksp and the KF  (Menon et al 2002).  
 
1.6.2  Crystal Formation: 
There are three processes of crystallisation:  
i) Nucleation (the formation of crystals) of which there are two types; 
‘homogeneous nucleation’ which is the formation of the earliest crystal that will not 
dissolve; and ‘heterogeneous nucleation’ which is the formation of crystals on 
surfaces (e.g. cells, debris, urinary casts, and other crystals; Brown et al, 1992). 
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ii) Crystal growth  
iii) Agglomeration (crystals aggregate together to form larger particles).  
 
Furthermore there are two theories (Robertson, 2004) of crystal formation (Fig 1.2).  
i) The ‘free-particle’ theory describes the spontaneous precipitation of crystals in 
supersaturated urine. The crystals grow / aggregate sufficiently during the transit time 
of urine in the kidney. One of the newly formed nuclei grows sufficiently in size that 
they become trapped at a narrow point in the renal tract and form a focus around 
which the stone develops.  
ii) The ‘fixed-particle’ theory proposes that nuclei cannot grow sufficiently 
during the transit time of urine in the kidney, but that once a crystal forms, it adheres 
to the renal epithelium, possibly because of increased stickiness of the epithelium or 
damage to the cell walls (caused by crystals or by viruses and bacteria). 
 
Once formed, the growing crystals then aggregate with each other by a process known 
as agglomeration. This is the stage in crystal formation when crystal growth is most 
rapid. Through further crystal growth and agglomeration the particle becomes a stone. 
 
1.6.3 Modifiers of Crystal Formation: 
Substances that alter or modify crystal formation exist in urine. They have been 
described with respect to calcium-containing stones, but not struvite (magnesium 
ammonium phosphate), cystine or uric acid stones. Types of modifiers include: 
1. Inhibitors: these slow or inhibit the rate of growth / aggregation of crystals or 
reduce the adherence of crystals to the renal epithelium. Examples include 
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magnesium, citrate, pyrophosphate and urinary glycoproteins, such as nephrocalcin 
and non-polymerised Tamm-Horsfall protein (also known as uromodulin). 
2. Promoters: these stimulate crystallisation and examples include matrix 
substance A, and other urinary glycoproteins such as the polymerised form of Tamm-
Horsfall protein (uromucoid). 
 
1.6.4 Crystalluria: 
This is the production of crystals in urine and is an important requirement for stone 
formation. It occurs more frequently in urine from stone-formers than from controls. 
The size of crystals within the urine is associated with the severity of the disorder, as 
defined by stone episode rate. 
 
1.6.5 Stone Matrix: 
Renal stones also contain matrix, which is a non-crystalline material. The matrix 
content of a stone may be between 10%-65% by weight, and tends to be higher when 
there is an associated urinary tract infection. It has been suggested that an alteration in 
the secretion of renal enzymes (decreased urokinase and increased sialidase) may 
increase matrix formation. Certain bacteria, such as Proteus mirabilis and 
Escherichia. coli, alter urokinase/sialidase activity leading to matrix formation, in turn 
causing increased crystal adherence to the renal epithelium.  
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Fig 1.2: a scheme of stone initiation occurring by the ‘free-particle theory’ or the 
‘fixed-particle theory’. 
 
 
1.7 STRUVITE STONES: 
Struvite stones are composed of magnesium ammonium phosphate, are also known as 
‘infection stones’, and account for 15%-20% of all stones. Certain bacteria, such as 
Proteus mirabilis and Ureaplasma urealyticum, secrete the enzyme urease which 
hydrolyses urea to carbon dioxide and ammonium ions. This reaction causes the 
urinary pH to rise. As mentioned previously, E.coli was shown to decrease urokinase 
and increase sialidase activity, causing increased matrix production, thereby leading 
to crystal adherence to the renal epithelium. This explains how non-urease producing 
bacteria may be associated with struvite stones. Struvite calculi also account for the 
majority of staghorn stones.  
Urine crystals flowing 
down renal tubules 
Crystals grow 
and aggregate 
Particle large enough 
to block tubule 
Particle adheres to damaged 
epithelium and crystals aggregate 
on it 
‘Free Particle 
Theory’ 
‘Fixed Particle 
Theory’ 
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1.7.1 Struvite Stones 
Struvite, a crystalline substance composed of magnesium ammonium phosphate, was 
first identified by Ulex, a Swedish geologist, in the 18th century. He created the term 
‘struvite’ in honour of his friend and mentor H.C.G von Struve (1772-1851), a 
Russian diplomat and natural scientist (Griffith, 1987). Brown suggested that bacteria 
split urine and thus caused and facilitated stone formation. He also isolated Proteus 
vulgaris from a stone nucleus and this is known today to secrete urease. However it 
was Hager and Magath, in 1925, who suggested that ‘urease’ was the cause of 
hydrolysis of urine (Griffith, 1978; Bichler KH et al, 2002). 
 
Struvite stones account for 5-20 % of all urinary stones (Griffith, 1978; Sharma et al, 
1989). Data from the 1970s indicated that struvite stones constituted 15% of the all 
stone specimens sent for calculus analysis but Rodman (1998) suggested that this 
figure over-reported the incidence of infection stones, since many small 
spontaneously passed calculi are never caught and do not have their chemical 
composition determined. Bichler et al (2002) suggested that 15-20 % of urinary stones 
were infection stones in industrial countries and their clinic results showed that out of 
4,400 patients with urinary stones, 510 had infection stones (11.6 %).  
 
Struvite stones are also referred to as ‘infection stones’ and ‘triple phosphate stones’. 
The term triple phosphate is derived from the fact that early chemical analyses 
demonstrated calcium, magnesium, ammonium and phosphate (i.e. three cations and 
one anion). More recently struvite stones have been shown to be a mixture of struvite 
and carbonate apatite. 
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For struvite to form, the urine must contain ammonium and trivalent phosphate ions at 
the same time. The renal tubule only makes ammonium when the organism is 
excreting an acid load, however trivalent phosphate is almost not present in acid 
urine. Thus under normal physiological conditions struvite may not precipitate. For 
struvite to form, conditions which are non-physiological are required and these are 
created by urease-secreting bacteria.   
 
Urease splits urea into ammonia and carbonic acid: 
NH2-CO- NH2  H2CO3 + 2 NH3 
 
Ammonia then mixes with water to produce ammonium hydroxide and under these 
alkaline conditions, carbonic acid moves toward bicarbonate and carbonate ions. 
2 NH3 + 2 H2O  2 NH4+ + 2 OH- 
 
Thus, the alkalinisation of urine by the urease reaction causes the formation of NH4+, 
which favours the formation of carbonate ions (CO32-) and trivalent phosphate ions 
(PO43-). This in turn causes struvite and carbonate apatite formation (Rodman, 1999; 
Miano et al, 2007). 
CO32- + 10 Ca2+ + 6 PO43-  Ca10(PO4)6CO3 
6 H2O + Mg2+ + NH4+ + PO43-  MgNH4PO46H2O 
 
However the explanation for mechanism of action is not definite. Rodman (1999) 
suggested that struvite could form in the absence of urea-splitting bacteria, since it has 
been possible to form struvite crystals in vitro in acidic solutions (pH 6) even though 
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the morphology of the resultant crystals is slightly different. In vivo, no non-urease 
mechanism has been demonstrated. 
 
1.7.2 Management: 
Patients may present acutely with loin pain, haematuria, fever, dysuria and frequency. 
Alternatively a large number of patients may present with malaise, weakness and loss 
of appetite. Struvite stones are usually radiopaque on X-ray.  Preventive treatment 
may first be tried.  The main aim of medical treatment is firstly to remove the stone 
completely and then provide medical therapy to prevent recurrent urinary tract 
infection. 
Diet – limiting phosphorus in foods 
phosphate-poor diet; phosphate found in high protein diets.  However, such diets 
are unpalatable to many and are associated with constipation, neurological 
dysfunction, osteopathy and muscle weakness. 
Urease inhibitors 
the compound must have high renal clearance and penetrate bacterial cell walls 
(because most of the urease enzyme is intracellular).  
o Acetohydroxamic acid (AHA) similar in structure to urea and a potent 
irreversible inhibitor of urease. It is effective but severe side-effects limit its 
usage: there may be problems in patients with concomitant deep vein 
thrombosis, pulmonary embolism and haemolytic anaemia and low grade 
intravascular coagulopathies, as well as associated headache and confusion.  It 
must not be used if creatinine clearance is <40ml/min. 
o Hydroxyurea – not as effective as AHA 
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o Flurofamide – about 1000-times more potent, but thus far has failed clinical 
trials 
Stone Clearance 
a combination of percutaneous nephrolithotomy (PCNL) and extracorporeal shock-
wave lithotripsy (ESWL) are commonly used. 
Intermittent bladder catheterisation 
Better nephrostomy care in patients with diverted urinary tracts 
Antibiotics  
once patients are stone and infection free, then suppressive treatment is often 
indicated if the patient is prone to recurrent urine infections.  Sterilise the urine and 
prevent stone recurrences/growth after operative procedures. 
 
1.7.3 Struvite Crystal Formation 
Struvite has been investigated by mineralogists, chemists and physicians. It has been 
found as a mineral in peat beds, in sediments rich in organic remains and in phosphate 
caves. It has been suggested that struvite may have formed from evaporating sea 
water on the primitive earth, and may have been important for prebiotic 
phosphorylation (Abbona et al, 1979).  
 
More recently struvite has become of clinical relevance due to its presence in renal 
stones, staghorn calculi, encrustation of urological devices and vesical calculi. 
However, struvite has also been problematic in wastewater treatment plants where 
struvite deposition has been found in pumps, aerators and pipe bends. Remediation 
methods that have been attempted include jet washing, heat treating, and acid washing 
but not all are successful, and the process for acid washing, which did remove struvite 
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deposits, is complex and time-consuming. Stratful et al (2001) described ‘the most 
productive and cost-effective way to remove struvite build-up is manually with a 
hammer and chisel’. This poignant statement reflects our current still ‘almost 
primitive’ approach to treating renal staghorn stones and it may be time now for a 
more elegant treatment strategy.  Interestingly there are some potential uses for 
struvite, such as a slow-release fertiliser, as a raw material to the phosphate industry, 
for use in fire resistant panels and as a binding material in cements (Stratful et al, 
2001). 
 
1.7.4 Struvite Crystal Structure: 
1.7.4.1 Struvite Crystals:  
In calculi, struvite is rarely found in the pure state but usually is associated with 
varying amounts of hydroxyapatite (Ca5(PO4)3OH) and carbonate apatite 
(Ca5(PO4,CO3,OH)3OH) (Leusmann, 1991). Abbona et al (1979) investigated 
struvite crystal growth and crystal morphology. They described the structure as 
regular PO43- tetrahedra, Mg (H20)62+ octahedra and NH4+ groups all held together by 
hydrogen bonding. They showed that crystal morphology was associated with the rate 
of growth of crystals: very high supersaturations (i.e. high growth kinetics where 
pH>8.0) promoted formation of bidimensional or tridimensional twinned crystals; 
whereas high supersaturation (pH about 7.0) promoted tabular crystals; and 
decreasing supersaturation (pH 6.7) promoted crystals that were less tabular and more 
elongated. In summary their results showed that high growth kinetics promoted flat 
crystals with large faces, whereas low growth kinetics promoted stick-like crystals, 
flat and without faces. 
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1.7.4.2 In-vitro struvite crystal growth: 
McLean et al (1985) examined the initial events in the production of infection stones. 
A culture flask was aseptically filled with artificial urine.  A ureolytic strain of 
Proteus mirabilis was isolated from a patient with a urinary calculus and maintained 
on a slant of tryptic soy agar. The artificial urine was inoculated with a 1% inoculum 
of Proteus mirabilis and the flask was agitated and aerated. Waste urine and air were 
removed through a side tube in the flask. Fresh artificial urine was added at a rate of 
60ml/hr. Several substances were suspended in the culture medium to act as surfaces 
for bacterial colonisation. These substances included resin blocks, urinary catheter 
material, glass rods and nichrome wire. The pH increased to between 8.5 and 9.5 
within 4 hours and by 6-8 hours optical density had reached maximum turbidity. 
Scanning electron microscopy of the substances in the culture medium showed 
progressive colonisation of Proteus mirabilis. Crystals, resembling struvite and 
apatite, were seen covered by an amorphous substance. Energy-dispersive X-ray 
analysis revealed the presence of Mg2+, Ca2+ and PO43- suggesting the presence of 
struvite and apatite. Transmission electron microscopy examination revealed Proteus 
mirabilis surrounded by an amorphous material stained by ruthenium red and thought 
to be bacterial glycocalyx. They hypothesised that bacteria, such as Proteus mirabilis, 
colonise the renal epithelium, shed their glycocalyx and form glycocalyx-enclosed 
micro-colonies. Urease, secreted by these bacteria, causes hydrolysis of urea to 
ammonia, increasing the pH of the urine and therefore causes struvite and apatite to 
precipitate. The glycocalyx traps these crystals and mucoproteins and poysaccharides 
present in the urine. The bacteria are well protected from the body’s defences within 
these glycocalyx-enclosed micro-colonies, which then mature into large renal calculi. 
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McLean et al (1990) modified this technique by growing crystals in solution, rather 
than on surfaces, and the solution examined by light microscopy. This revealed a 
large number of crystals in solution, confirmed to be struvite with X-ray diffraction. 
The pH, [NH3], optical density, urease activity and bacterial cell numbers all 
increased with time. 
 
Bouropoulos et al (2000) investigated the formation of struvite from aqueous 
solutions, whereby reactant solutions of magnesium chloride and ammonium 
dihydrogen phosphate were mixed together at 25oC and samples withdrawn and 
examined by X-ray diffraction, scanning electron microscopy and FTIR spectroscopy. 
Struvite was exclusively precipitated at pH 8.5.  
 
Some debate exists about the formation of struvite and its subsequent transformation 
to another compound newberyite (MgHPO4.3H20) (Abbona et al 1982). There have 
been a few reports of newberyite deposition in human renal calculi (Sutor 1968). 
Babic-Ivancic et al (2004) investigated the formation of struvite in aqueous solutions 
under conditions similar to physiological at 37oC, over a wide range of pH values and 
observed its transformation into newberyite.  Having chosen a system where the 
initial concentration of the reactants resulted in formation of both struvite and 
newberyite, they studied the system over a range of pH values. In the range pH 5.0–
7.0, only newberyite formed. Upon mixing the reactants at pH 7.0, there was an 
immediate decrease in pH to 6.0 within the first minute of the process and only 
newberyite formed and remained since it is stable at pH 6.0. At pH 7.4, within the 
first minute, both struvite and newberyite formed, but at 5 hours only newberyite 
remained. At pH 8.0 the initial precipitate of struvite was 28.8 %wt and then 3.4 %wt 
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at 5 hours, whereas at pH 9.0 the initial precipitate increased from 52.6 %wt to 72.9 
%wt at 5 hours. The authors suggested the reason for this might be the rate of 
nucleation for struvite being greater than that of newberyite.  
 
1.7.4.3 In-vivo struvite crystal growth: 
Nickel et al (1987) have also performed in-vivo growth of struvite stones in a rat 
animal model.  Rats were anaesthetised and via a laparotomy incision, two zinc discs 
were placed directly into the bladder. Seven days later the rats were anaesthetised 
again and catheterised for vesical infusion of a 1x108 CFU/ml Proteus mirabilis 
bacterial infusion. Sequential struvite calculogenesis was investigated by direct 
ultrastructural observation and using microbiological techniques, when rats were 
sacrificed on days 0 to 8 and then days 15 and 30 after infusion of the bacterial 
suspension. The control group showed no significant calculus formation and there 
were no histological changes in the bladder or upper renal tracts. In the experimental 
group the urinary pH, urinary bacterial counts and urease activity increased rapidly. 
By 48 hours scanning electron microscopy showed the presence of struvite crystals 
within an extensive bacterial biofilm. Transmission electron microscopy (TEM) 
showed a layered stratification of these biofilm layers interspersed with layers of 
crystals. The biofilm layer was composed of dehydrated residue of the bacterial 
glycocalyx. By 30 days, all remaining rats had developed large bladder calculi, 
bilateral hydronephrosis and pyelonephritis, whilst 40% also had large renal staghorn 
calculi. 
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1.7.5 Ultrastructure of human infected stones: 
McLean et al (1989) investigated infected kidney stones removed from humans using 
transmission and analytical electron microscopy. TEM along with energy dispersive 
analysis of X-rays showed localised deposits of calcium, phosphate and magnesium 
close to bacterial cells. Bacterial exopolysaccharides were present, using ruthenium 
red staining, but only as a small percentage of the stone matrix. They concluded that 
the bacterial slime/exopolysaccharide production was intimately involved in the 
initiation of stone deposition. 
 
1.7.6 Manipulating struvite crystallisation in artificial urine: 
Studies have shown variations in urease-induced activity and struvite deposition in 
different human urine samples. This effect was not thought to be due to urinary pH or 
the phosphate content and indicated that struvite crystallisation may be influenced by 
other compounds. Hedelin et al (1989) showed that zinc reduced and citrate promoted 
urease activity in synthetic urine. This influenced struvite and calcium phosphate 
precipitation, but these results could not be reproduced in human urine (five samples 
only) and they suggested caution should be taken by investigators when extrapolating 
from results obtained in synthetic urine to the situation in human voided urine. 
 
McLean et al (1990) concluded that inhibitors of calcium oxalate crystallisation, such 
as chondroitin sulphate A and heparin sulphate, had no effect in reducing struvite 
precipitation. Although citrate did not inhibit struvite crystal formation, it did reduce 
the rate at which struvite crystals formed, due to the fact that octahedral crystals 
formed slowly as compared with X-shaped crystals associated with rapid growth. 
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They concluded that the physico-chemical basis for struvite stone precipitation was 
quite different from calcium oxalate formation.   
 
1.7.7 Manipulating struvite crystallisation in human urine: 
Choong et al (2001) described the nucleation pH for stone formation (the pH at which 
calcium salt precipitation occurred in patients undergoing long-term catheterisation). 
Two groups of patients were examined, those whose catheters blocked (‘blockers’) 
and those whose catheters did not (‘non-blockers’). They showed that the nucleation 
pH (pHn) was 7.66 and the voided pH (pHv) 6.26 in the ‘non-blockers’. In the 
‘blockers’ group the pHn was similar 7.58, however the pHv was more alkaline at 
7.85.  Thus the voided pH of ‘blockers’ was more similar to the nucleation pH. 
 
Continuing on from this Suller et al (2005) investigated methods of manipulating the 
pHn of the urine with a view to maintaining more of the calcium and magnesium salts 
in solution, despite more alkaline conditions. Both in-vitro urine dilution and in-vivo 
dilution (due to increased oral consumption) naturally caused a decrease in urinary 
[Ca2+] and [Mg2+] - measured using atomic absorption spectroscopy - and actually 
increased the pHn of both Ca2+ and Mg2+.  In-vitro addition of varying amounts of 
Ca2+ and Mg2+ to collected urine samples to create a concentration range of 0-200 
µg/ml, showed that at higher concentrations of both ions, the pHn of both decreased. 
Addition of pyrophosphate, Na+ or Cl- had little effect on pHn. In-vitro addition of 
citrate to urine and in-vivo increase in urinary citrate concentration (due to increased 
oral consumption) both showed that there was an increase in pHn. The presence of 
bacterial cells did not encourage precipitation of salts. ‘Debris’ in the urine, consisting 
of desquamated epithelial cells, leucocytes and bacteria, (Clapham et al, 1990) varies 
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between patients and had been proposed to possibly act as nucleation sites for crystal 
development and growth, but Suller et al (2005) showed that there was no change in 
the pHn. They concluded that increasing fluid intake along with increased citric acid 
consumption may reduce the extent of encrustation.  
 
Subsequent experiments in a laboratory model of Proteus mirabilis infection 
confirmed that dilute, citrate-containing urine with a nucleation pH greater than 8.3 
did not favour crystalline biofilm formation (Stickler 2006). 
 
1.8 BACTERIOLOGY ASSOCIATED WITH STRUVITE STONES: 
 
Bacteria which are urease producers include species of Proteus, Staphylococcus, 
Pseudomonas, and Klebsiella. Escherichia coli rarely or never produce urease, 
whereas Proteus species always do (Table 1.2; Griffith, 1978).  
 
There have been relatively few bacteriological studies of patients who have 
undergone surgical removal of renal calculi. Thompson et al (1973) showed that 77% 
of calculi removed showed bacterial growth. This was in contrast with Dajani et al 
(1983) who showed that of 142 stones, only 14% were infected. Lewi et al (1984) 
showed that out of 63 patients undergoing removal of intrarenal calculi, 17 patients 
had struvite calculi, 58% of which had a positive pre-operative MSU, 76% had 
positive culture from aspirated pelvic urine, and 82% demonstrated significant 
bacterial culture from the stone itself. Overall infection rates (for all 63 patients) were 
29%, 30% and 38% respectively. 
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Table 1.2: A list of urease-producing bacteria (from Griffith, 1978). 
Organism % of bacterial isolates showing positive 
indication of urease activity 
Proteus vulgaris 
Proteus mirabilis 
Proteus morganii 
Proteus rettgeri 
Providencia al caliifaciens 
Providencia stuarti 
Klebsiella pneumoniae 
Pseudomonas aeruginosa 
Serratia marescens 
Serratia liquefaciens 
Enterobacter aerogenes 
Citrobacter freundii 
Escherichia. coli 
99.6 
98.7 
91.8 
99.0 
99.0 
97.1 
63.6 
32.6 
29.0 
5.0 
2.6 
0 
0 
 
In the above studies, the commonest organism isolated was Proteus mirabilis in the 
‘struvite’ group and Escherichia coli in the ‘calcium oxalate’ group. Interestingly in 
two patients within each group, the urine culture differed from the stone and pelvic 
urine cultures, reflecting possible secondary infection of the bladder urine, following 
antibiotic treatments, suggesting that pelvic urine more accurately reflects the urine 
environment in which the stone forms and bacteria grow. McCartney et al (1985) 
showed similarly that in 24 patients studied, 42 % were shown to have struvite calculi. 
Of this group, 57 % had positive cultures in per-operative mid-stream urine, 71 % had 
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positive pelvic urine culture and 86 % had positive stone culture. They also showed 
that bacteria were present deep within the stone, because bacterial cultures from when 
the stones were crushed were significantly higher than when the stones were just 
washed and the resultant washings cultured. 
 
Two studies suggested different bacteriological overviews. Bratell et al (1990) 
showed that in a significant number of patients with infection / magnesium 
ammonium phosphate stones, no urease-producing organism could be cultured, 
however Escherichia coli was frequently cultured from the stone. This raised the 
possibility that Escherichia coli could be involved in stone formation. Hugosson et al 
(1990) showed that in 215 patients, of those with struvite calculi, only 48% grew 
urease-secreting organisms from stone culture, again suggesting that urease-producing 
organisms were not obligatory for this type of stone formation. Gault et al (1995) also 
showed that out of 36 patients with struvite calculi, 31 had negative stone cultures and 
20 had negative urine cultures. 
 
Ureaplasma urealyticum is also found in the lower urinary tract of sexually active 
individuals. It is thought that it invades the upper urinary tract, and then stone 
formation results in the kidney due to its urease-producing activity. In-vitro 
experiments have shown struvite crystallisation when synthetic urine has been 
inoculated with Ureaplasma urealyticum (Grenabo et al, 1984). In-vivo experiments 
showed that inoculation of Ureaplasma urealyticum into the bladder of rats resulted in 
rapid bladder stone formation (Grenabo et al, 1985). A study by Hedelin et al (1984) 
showed that Ureaplasma urealyticum was cultured in seven patients with infection 
stones. Four of these seven patients showed no other urease-producing organism, 
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showing that it can be present as the only urease-producing organism and may be 
associated with stone formation. The presence of Ureaplasma urealyticum can go 
unnoticed since it is not detected by routine cultures or urine cultures in the presence 
of renal calculi (Hedelin et al, 2002). It can however cause significant problems with 
rapid large stone formation and recurrent stones (Grenabo et al, 1986). 
  
Thus, there remain some questions regarding the bacteriology of stones Rodman 
(1999): 
1. Voided urine may not be representative of urine within the renal pelvis and hence 
voided urine cultures may therefore be an inaccurate reflection of the true 
scenario within the kidney. For this reason, removed stones should always be 
cultured directly. 
2. When mid-stream urine samples are sent for analysis, laboratories may be 
missing or ignoring organisms growing small numbers of colonies, since it is 
common practice to label counts of <10,000 or <50,000 as ‘not significant’. 
However, smaller colony numbers will provide very useful information and all 
organisms, regardless of number, should be grown and recorded in such patients.  
3. The biofilm matrix creates a micro-environment which prevents organisms from 
being shed into the surrounding urine and makes it difficult to treat the infection. 
4. As mentioned previously, urea-splitting bacteria are not always cultured from 
struvite stones, such as Ureaplasm urealyticum (Clerc et al, 1984). 
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1.9  CLINICAL IMPLICATIONS OF STRUVITE STONES  
 
1.9.1 Survival rates and sepsis: 
Staghorn calculi are branched calculi that sit in the renal collecting system, filling the 
renal pelvis, with branches that extend into the calices. They are usually infection-
induced and can grow rapidly. They can be asymptomatic, however patients usually 
present with recurrent cystitis and abdominal radiographs identify staghorn calculi. 
An untreated staghorn calculus can destroy the kidney and result in life-threatening 
sepsis (Griffith, 1978; Ganpule et al, 2008).  
 
Priestley et al (1949) first pointed out that staghorn calculi were rarely unassociated 
with severe urinary symptoms, and they showed that it was better to remove the stone 
rather than a nephrectomy, but still better than doing nothing.  At this time some felt 
that staghorn calculi were generally silent and that patients were better left alone. 
Singh et al (1973) stated that if staghorn stones were silent, this was a very rare 
occurrence (0.05%). They showed that of 54 patients with ‘untreated’ staghorn 
calculi, 81% had pain, 48% had haematuria and 79% had infection. Forty-five patients 
had unilateral, whilst nine patients had bilateral staghorn calculi. Of the 45 patients 
with unilateral staghorn calculi, 16 out of 20 patients (80%) survived with primary 
nephrectomy, as did nine out of 12 patients (75%) with delayed nephrectomy, but 
only four of 13 patients (31%) survived with no surgical treatment. They confirmed 
that patients who had a nephrectomy fared better than those in whom a stone was left 
in-situ, and that a stone in-situ not only increases the risk of pyonephrosis within that 
kidney, but also poses a constant threat to the other kidney. Singh et al (1973) 
compared these figures with 81 out of 86 patients (94%) surviving after they 
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performed extended pyelolithotomy to remove staghorn calculi. 70 patients had 
unilateral stones and 16 patients had bilateral calculi. Of the 103 kidneys operated on, 
only three (3%) required nephrectomy and 13 (13%) recurred. 
 
Grenabo et al (1985) conducted a retrospective study of 391 stone cases. 66% of 
stones were calcium stones, 30% were infection stones, 4% were uric acid stones and 
1% were cystine stones. Of the infection cohort, 10% were staghorn stones. They 
found that the infection stones placed a greater strain on the patient. 61% of the 
infection stones were recurrent stones as compared to 48% of the calcium stones. 
Spontaneous passage of the stone was more common with calcium stones (42%) than 
with infection stones (12%). Kidney stone surgery was performed in 60% of patients 
with infection stones compared with 23% of patients with calcium stones. A positive 
urine culture was found in 15% of calcium stone cases in contrast with 63% of the 
infection stone cases. 
 
Struvite staghorn calculi can form a real threat to the kidney and hence their presence 
is an indication for active treatment in most individuals (Segura, 1997).  Staghorn 
struvite stones can be embedded with gram-negative bacteria, which can also produce 
endotoxins. Sepsis syndrome may occur after surgical therapy or endoscopic 
manipulation of infected or staghorn calculi (McAleer et al, 2002). Sepsis can occur, 
despite perioperative antibiotic use, possibly due to bacteremia or endotoxemia. 
Perinephric abscess can be a common manifestation of a renal staghorn stone.  
Patients may present with signs of sepsis, flank pain and discharge and this may then 
lead to diagnosis of a perinephric abscess secondary to a staghorn stone (Tsukagoshi 
et al, 2006). 
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Though it is fairly well-known that the main component of staghorn calculi are 
magnesium ammonium phosphate and carbonate apatite (Resnick et al, 1980), it is 
thought that a large proportion of patients with staghorn stone disease may have a 
metabolic abnormality contributing to their stone formation (Resnick, 1981). Wall et 
al (1986) showed that 21 out of 31 patients with renal staghorn disease had 
magnesium ammonium phosphate within the stone, however calcium phosphate was 
the most common constituent in 30 of the 31 patients. They also showed that 24 hour 
urine analysis was normal in only three of the 31 patients, and they suggested that a 
metabolic evaluation of all patients with staghorn stones was required post-
operatively to decrease the high recurrence rate in these patients. 
 
1.9.2 Renal function impairment: 
Vargas et al (1982) clinically evaluated 95 patients (105 kidneys) with staghorn 
calculi. Complications occurred in 53 per cent of the patients (20% had pyonephrosis, 
8% had xanthogranulomatous pyelonephritis, 20% had severe/end-stage 
pyelonephritis or renal failure, and 5% had a perinephric abscess). They suggested 
complete removal of the calculus early in the course of the disease in order to prevent 
complications and renal deterioration.  
 
Kristensen et al (1987) showed that of 75 patients with struvite stones, 52 were 
women. They suggested that women presented themselves with infection rather than 
stone passage, which is more commonly the presentation in men. Women are also less 
frequently hypercalciuric and have a higher frequency of surgery and contralateral 
stone formation compared to men. They concluded the primary struvite 
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nephrolithiasis was a serious form of stone disease and that both men and women 
were at high risk for reduced glomerular filtration rate, especially once a staghorn 
calculus had formed. 
 
Worcester et al (2003) showed that females had a two-fold risk above that of males 
for losing the kidney, and that kidney loss did not worsen stone disease. They also 
showed that there was an accelerated rate of loss of creatinine clearance among stone 
formers in general as compared to normal subjects. Their study showed that the stones 
that led to kidney loss were frequently struvite stones or stones producing a large 
mass effect in the kidney.  
 
Worcester et al (2006) investigated renal function in different stone formers. 1,856 
stone formers were compared with 153 normal individuals. They showed that 
creatinine clearance was decreased in all stone formers, compared to normal subjects, 
but was particularly low in cystine and struvite stone formers. 
 
1.9.3 Encrustation and blockage of urethral catheters: 
Urethral catheters can be inserted for a short period (e.g. monitoring urine output) or 
long-term catheterisation may be used for patients with incontinence or where other 
methods of management have been excluded.  Long-term catheterisation carries an 
increased risk of urinary tract infection and catheter encrustation (blockage). This can 
create a large and continual demand on hospital and community health services. A 
postal survey by Kohler-Ockmore et al (1996) showed that of 467 patients with long-
term catheters, there were 506 emergency referrals during a six-month period. 
Detailed study of 54 patients showed that 48% suffered catheter blockage, 37% had 
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urine by-passing the catheter and 30% had haematuria. They concluded that the 
prevalence and morbidity associated with long-term catheterisation caused 
considerable pressure on district and hospital nursing services and that further 
research was required to reduce catheter blockage and encrustation. 
 
Catheters allow external bacteria to have easy access to the bladder and thus 
catheterisation results in bacteriuria. The catheter may be disconnected from the 
collection tube and bacteriuria has been associated with such interruptions (Warren, 
2001). Bacteria contaminating the lumen of the drainage tube, from the catheter bag, 
can ascend into the bag, to the collection tube and up the catheter. Bacteria that enter 
the catheterised urinary tract are able to multiply to high concentrations within a day 
(Stark & Maki, 1984).  Warren et al (1994) suggested that complications of long-term 
catheter-associated bacteriuria could be divided into two groups. The first includes 
symptomatic urinary tract infections and pyelonephritis (Warren et al, 1987). The 
second group includes urinary obstruction, urinary tract stones, and chronic 
pyelonephritis. 
 
Cox & Hukins (1989) showed hydroxyapatite and struvite deposition onto catheter 
materials, using scanning electron microscopy, in the presence of urease. Morgan et al 
(2009) studied the encrustation of silver Foley catheters in six patients undergoing 
long-term catheterisation. They showed that after being in-situ for 11 days, there was 
clear occlusion of one catheter with extensive deposits of crystalline material with the 
presence of apatite and struvite. Encrustation was visible around the eye-holes of the 
catheter and these crystalline deposits were revealed to be the bacterial biofilm. They 
suggested that layers of microcrystalline material are deposited onto the catheter 
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surface and then bacteria attach to these layers and grow into mature biofilms. The 
silver catheters used had been claimed resistant to bacterial colonisation (Davenport 
& Keeley, 2005).  However, the above study showed this not be the case and 
suggested that in order to prevent catheter encrustation, it was essential to prevent the 
pH of urine rising above that at which crystals form. 
 
Stickler et al (1993) indicated that Proteus mirabilis was the species most commonly 
recovered from patients’ encrusted catheters. Sabbuba et al (2003) developed a 
method for genotyping Proteus mirabilis and identified that the same genotype 
persisted in a patient’s urinary tract despite many catheter changes, courses of 
antibiotics and even periods when the patient was not catheterised. They also showed 
that the strains of Proteus mirabilis from catheter encrustations were identical to those 
in the bladder stones (Sabbuba et al, 2004). Proteus mirabilis is an enteric organism 
and analysis by Mathur et al (2005) showed that bacteria from faecal and catheter 
biofilm isolates from the same patients were identical. 
 
Stickler (2008) suggested that biological, physical and chemical factors were 
causative in the formation of biofilms as follows.  
Biological factors: initially the prosthetic device (e.g. catheter) is rapidly coated by a 
film of host proteins from the urine. Bacteria then attach to the proteins, via their 
fimbriae (Ong et al, 2008).  
Physical factors: scanning electron microscopy has shown that catheter surfaces are 
rough and irregular in nature (Cox, 1990). Scanning electron microscopy showed the 
eye-holes in catheters to be particularly vulnerable to bacterial colonisation (Stickler 
et al, 2003).  
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Chemical factors: an alkaline urine has been shown to promote biofilm formation 
(Stickler et al, 2006). The nucleation pH is the pH at which urine becomes turbid due 
to crystallisation of struvite and apatite. Choong et al (2001) showed that catheters 
become encrusted if the pH of the urine is greater than the nucleation pH. 
 
Strategies to prevent catheter encrustation include: dilution of urine by increasing 
fluid intake; increasing the urinary concentration of citrate; raising the nucleation pH 
(Suller et al, 2005) and; triclosan, a biocide used to inflate the catheter balloon and 
shown to inhibit biofilm formation; Jones et al, 2005). Norberg et al (1983) suggested 
monitoring the time taken for patients’ catheters to block and then implementing a 
schedule for catheter replacement, specific to that patient, so that the catheter may be 
changed prior to the predicted time of blockage. An alternative approach is a simple 
sensor in the drainage system which signals the early encrustation and Proteus 
mirabilis infection, thus indicating need for change of catheter (Stickler et al, 2006). 
 
1.9.4 Ureteric Stent Encrustation: 
Ureteric stent encrustation is less commonly associated with infection (Shaw et al, 
2005) and is most commonly composed of calcium oxalate, whereas urethral catheter 
encrustation is often composed of struvite. Keane et al (1994) examined ureteric 
stents from 40 patients. They found that 58% of stents were encrusted and 28% of 
stents had a significant biofilm. The most common biofilm organism isolated was 
Enterococcus faecalis and not Proteus sp.  
 
The manifestation of stent encrustation may include painful hydronephrosis and if 
prolonged can lead to irreversible renal damage, as well as development of sepis 
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proximal to the obstruction with subsequent more rapid renal impairment. These 
circumstances may necessitate change of stent or urgent nephrostomy insertion. 
Occasionally if encrustation is very severe, it can be quite difficult removing the stent 
and may require several complex operative procedures in a specialist centre (Shaw et 
al., 2005). 
 
Different types of stents have been used to try and minimise encrustation. Silicone 
was the first generation polymer to be used, but these were replaced by polyethylene 
and subsequently the third generation polymer polyurethane, which has excellent 
properties (Venkatesan et al, 2010a). Approaches to reduce bacterial adherence and 
encrustation include coating the stents with different materials or blending 
antiencrustation agents into the polymer. Coatings include hyaluronic acid, hydrogel, 
heparin and silver. More research is being conducted on the effect of uropathogens on 
in-vitro encrustation of ureteral stents (Venkatesan et al, 2010b). Triclosan, an 
antimicrobial agent, has also been incorporated into ureteric stent materials. However, 
Cadieux et al (2009) showed that there was no clinical benefit in terms of urine and 
stent cultures, or overall symptoms when compared with controls. They felt that 
triclosan-eluting stents alone were not sufficient to reduce associated infections. 
 
1.9.5 Metabolic syndrome  
The metabolic syndrome consists of a cluster of physical and laboratory abnormalities 
including hypertension, hyperglycemia, hyperlipidemia and abdominal obesity 
(Peralta et al, 2006). West et al (2008) showed that the prevalence of stones increased 
amongst subjects with more metabolic syndrome traits, showing an association 
between stone formation and the metabolic syndrome. In particular, uric acid 
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nephrolithiasis is associated with the metabolic syndrome. A low urinary pH is 
required for uric acid stone formation and urinary acidity is recognized to be one of 
the features observed in the metabolic syndrome. This acidity is thought to be due to 
increased acid excretion, and impaired buffering due to defective urinary ammonium 
excretion (Sakhaee & Maalouf, 2008a).  
 
Abate et al (2004) showed that a possible renal manifestation of insulin resistance was 
a low urinary pH and ammonium concentration. The concentration of urinary 
ammonium was measured using a glutamate dehydrogenase method.  Sakhaee 
(2008b) suggested we needed to further our understanding of the mechanisms linking 
nephrolithiasis and the metabolic syndrome in order to develop more effective 
preventive and therapeutic treatment strategies. 
 
1.9.6 Summary: 
The management strategy for patients with struvite stones was outlined above (section 
1.7.2). However, at present there are no truely effective treatments to prevent or treat 
struvite stones. Problems are associated with: 
• Bacteria are embedded within the layers of the stone and matrix – since 
antibiotics are unable to penetrate deep within the stone, they are ineffective. 
• Once a patient is said to be rendered stone-free, even a small remaining nidus not 
evident at operation or on imaging can cause recurrence  
• At present the only real treatment strategy is prevention of infections once a 
patient is stone free. 
• There are no current monitoring strategies apart from urine cultures. 
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• The physical chemistry of NH4+ and Mg2+ in the aqueous environment of urine is 
not known.  For example, the urinary concentration of these reactants are not 
routinely measured and the conditions that result in crystallisation are therefore 
unclear.  
 
1.10 THE USE OF ION-SELECTIVE ELECTRODES IN MONITORING 
URINE COMPOSITION.  
 
A new generation of potentiometric ion-selective electrodes has played an integral 
part in aiding our understanding of the physico-chemical basis for stone formation. 
Langley & Fry (1995) measure the ionised fraction of Ca2+ in urine, the variation in 
the concentration  in urine samples from stone-formers and control patients and 
introduction of the concept of nucleation pH at which calcium salts crystallise in 
urine. Previously theoretical calculations were used to calculate urinary Ca2+ using 
computer programs such as Equil2 (Werness et al, 1985). Langley & Fry (1995) 
showed a poor correlation between the measured Ca2+ concentration using ion-
selective electrodes and calculation methods, such as with Equil2.  They suggested 
that calculations relied on accurate knowledge of the concentration of all Ca2+-binding 
ligands and of their binding constants in urine, and that the poor correlation between 
the two methods further demonstrated that our knowledge of Ca2+-binding ligands in 
urine was incomplete. They suggested that spot urinary measurements of Ca2+ 
concentration at a standard pH provided a more discriminative test than total calcium 
(ionised and bound) for the presence of urinary tract stones.  
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Ion-selective electrodes for NH4+ and Mg2+ have been developed but have not been 
used for extensive measurement of urinary concentrations.  NH4+-selective electrodes 
have been based on the ionophore nonactin and used for analysis of water and plasma 
samples, for example (Cooke & Jensen, 1983; Schwarz et al., 2000), but more 
recently other ionophores have been devised based on crown ether structures (Benco 
et al., 2003; Chandra et al., 2006).  A recent study used NH4+-selective electrodes for  
the determination of nitrogen-containing substances (urea and creatinine) in urine 
samples but did not undertake an extensive analysis of urinary [NH4+] (Gutiérrez et 
al., 2008). 
 
Mg2+-selective electrodes have been made from several neutral ionophores and used 
to measure ionised [Mg2+] in biological samples such as plasma and serum (Rouilly et 
al., 1990; Brookes & Fry, 1993; Hafen et al., 1996).  However, there use in urine 
samples has not been reported.  One problem with Mg2+-selective electrodes has been 
a poor selectivity with respect to Ca2+. 
 
A major objective of this thesis was to develop NH4+-selective and Mg2+-selective 
electrodes for use in urine samples and to ascertain whether differences existed in the 
concentration of these ions using urine samples from struvite stone formers and stone-
free controls 
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1.11 HYPOTHESES, AIMS AND OBJECTIVES OF THE THESIS.  
 
 There has been considerable research into in-vitro struvite crystal growth in artificial 
urine.  However there has been less work investigating crystal growth in human urine 
or with in vivo animal studies. Furthermore, there has been no research involving 
characterisation of human urine from struvite stone-formers.  The goal of this project 
was to understand the reasons for struvite stone formation in the human urinary tract 
and aid us in creating future treatments and possible preventative medications. 
 
1.11.1 Hypotheses 
The NH4+ and Mg2+ concentrations in urine from stone-formers are different from 
that in control subjects. 
The NH4+ and Mg2+ concentrations in urine show a significant dependence on pH, 
and will increase the possibility of crystallisation as urine pH increases. 
 
1.11.2 Aims and experimental objectives of the thesis 
Development and characterisation of an NH4+-selective electrode at room temperature 
and at 37°C 
Determination of selectivity coefficients of the NH4+-selective electrode against 
interferent ions. 
Development and characterisation of a Mg2+-selective electrode at room temperature 
and at 37°C. 
Determination of selectivity coefficients of the Mg2+-selective electrode against 
interferent ions. 
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Measurement of the NH4+ and Mg2+ concentrations of urine from normal subjects at 
room temperature and 37°C. 
Measurement of the pH-dependence of the urinary [NH4+] at room temperature and 
37°C. 
Validation of the NH4+-selective electrode data against colour spectrophotometry 
Validation of the NH4+-selective electrode data against an empirical calculation 
method 
Measurement of the NH4+ and Mg2+ concentrations of urine from patients with 
staghorn stones or urinary tract stone disease. 
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CHAPTER 2 
METHODS AND PATIENT SAMPLES 
 
2.1 PATIENT GROUPS: 
 
Healthy individuals from the laboratory were recruited for normal urine samples.  
Patients were recruited from those attending the Urology Stone Unit at University 
College Hospital. Patients were predominantly attending for a urological procedure 
including percutaneous nephrolithotomy and ureteroscopy, except for three patients who 
attended outpatient clinics.  
A further group of patients were recruited from the renal stone clinic at the Royal Free 
Hospital, London. This is a specialised clinic dealing with patients with recurrent stones 
and problematic stones. 
 
Prior to taking the urine sample, a consent form and patient information sheet (see 
appendix) were completed. The patient information sheet included the patient’s personal 
details, information on their urological history, previous urological procedures, previous 
knowledge of stone type, and prior urinary tract infections. A past medical history, drug 
history and allergies, were also recorded. At this point the patient was assigned a number, 
which was written on the patient information sheet and consent form, to allow for 
confidentiality.  Subsequent data handing and construction of experimental groups used 
only the patient number. 
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2.2 URINE COLLECTION AND CLINICAL BIOCHEMISTRY: 
 
2.2.1 Urine collection.   
Because all but three patients were attending for urological procedures, all urine samples 
were collected between 7.15 and 8.00 a.m. By taking early morning urine samples, two 
purposes were served. Firstly, this allowed better comparison of urine samples by 
reducing variability of urine biochemistry during the day. Secondly, since patients had all 
been nil-by-mouth from the previous night, as a requirement for their clinical procedure, 
this reduced the effect that diet and fluid intake may have had on urinary constituents.  
Samples were collected in sterile MSU (mid-stream urine) bottles. Each patient provided 
about 20-40 ml of urine. The MSU bottles were then labelled with the patient’s assigned 
number. 
 
2.2.2 Urine storage: 
After sample collection, urine samples were temporarily stored in a portable cooling 
container for transport back to the laboratory. Ice packs were present within the cooling 
container to maintain a cool (4°C) environment for transport. 
 
2.2.3 Clinical Biochemistry:  
For each patient, a mid-stream urine sample was sent to microbiology to investigate for 
evidence of current urinary infection. A sample was also sent to the clinical biochemistry 
department to measure urinary [Na+] and [K+] with a commercial ion-selective analyser 
(Orion); creatinine and urea with a Sequential Multiple Analyzer (SMA6, Technicon 
Instruments) and osmolality by freezing point depression. 
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2.3 MANUFACTURE OF ION-SELECTIVE ELECTRODES 
 
2.3.1  General procedure for the manufacture of ion-selective plastics: 
The ion-selective membrane is the key component of the ion-selective electrode. The ion-
selective membrane is a plastic generated by mixing an ion-selective ligand with a 
polyvinylchloride (PVC) solution and a plasticiser to permit the ligand to disperse evenly 
within the PVC solution.  Prior to manufacture of the ion-selective plastics, all the glass 
bottles/pots and equipment were cleaned with tetrahydrofluran (THF).  The source of all 
chemicals in this thesis was the Sigma Chemical Company. 
 
Firstly, one 10 ml glass bottle (Pot 1) was cleaned with THF and allowed to dry. High 
molecular weight PVC, in the form of a dry powder, was added to the pot and was 
dissolved in THF: see Table 2.1.  The mixture was slowly, but continuously stirred for 
10-20 minutes to ensure that all the PVC was dissolved.   To a second glass bottle (Pot 2) 
was added the ion-selective ligand and plasticiser, which was then stirred slowly for 
about ten minutes to ensure adequate mixing of these two components. Different 
plasticisers were used for different ion-selective plastics, see Table 2.1. 
 
For all ion-selective ligands, except that for NH4+, K-tetrakischlorophenylborate 
(KtClPhB) was also added to the ionophore/plasticiser mixture.  This material confers a 
significant conductance to the eventual ion-selective plastic, enabling electrodes with a 
lower resistance (about 1 MΩ) to be manufactured, thus reducing electrical noise in the 
experimental system, thus permitting the signal-to-noise ratio to be greatly increased.  
KtClPhB was omitted from the NH4+-selective electrodes as the salt confers a significant 
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K+-selectivity to the resulting ion-selective plastic and it was important to reduce this 
already significant property of the NH4+-selective electrode.  For the remaining ion-
selective plastics where K+-interference was less significant the molar ratio of KtClPhB 
to the primary ion ionophore was <1.0. 
 
Finally the PVC solution was added to the ionophore/plasticiser/(KtClPhB) mix and 
again slowly stirred for about five minutes.  The final composition of the mixture (w/w) 
was plasticiser:PVC:ionophore:(KtClPhB) of 66%:33%:1%:0.4%. 
 
The pot containing the mixture was covered with aluminium foil, to prevent light 
oxidising the THF, and the solvent was then allowed to evaporate slowly over several 
days.  The slow evaporation was achieved by placing, under pressure, about fifty layers 
of fine filter paper over the mouth of the glass bottle to minimise the evaporation space.  
A clear, solid plastic, with no visible precipitations, resulted and could be stored in the 
dark, using silver foil around the container, for several months prior to preparation of the 
ion-selective electrodes. 
 
Table 2.1 lists the materials used to manufacture ion-selective plastics for different ions 
measured in this thesis.   
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Table 2.1.  Components of the different ion-selective plastics used to manufacture ion-
selective electrodes. 
 Pot 1 Pot 2 
Primary 
ion 
High mw 
PVC 
THF Selective  
ionophore 
KtClPhB  Plasticiser 
   NB          DBS        EHS     
NH4+ 700 mg 6ml 2.4 mg  
nonactin 
- - 144 mg  - 
K+ 300 mg 7ml 3.2 mg 
valinomycin  
0.3 mg  200 mg - 596 mg 
Mg2+  165mg 6ml 5.5 mg  
ETH 5506/7025   
3.0 mg - - 330 mg 
Ca2+ 95mg 6ml 10 mg  
ETH 1001 
2.5 mg - - 190 mg 
PVC:  polyvinylchloride 
THF:  tetrahydrofuran 
NB:  nitrobenzene 
DBS:  dibutyl sebacate  
EHS:  bis (2-ethylhexyl) sebacate  
KtClPhB:   potassium tetrakis(p-chlorophenyl)-borate 
2.3.2  Manufacture of the electrode template: 
The main part of the electrode was made of a five-cm length of hollow PVC tubing, 0.8 
mm inside, 1.0 mm outside diameter. PVC tubing was flexible and was sufficiently 
supportive when placed in the apparatus. A length (2-3 mm) of ceramic plug (frequentite, 
Morgan Matroc, Worcestershire, UK) that had been reduced in diameter to fit tightly into 
the bore of the PVC tube was wedged into the tubing and the exposed ceramic plug 
surface smoothed down using fine-grade sandpaper. The ceramic rod acted as surface on 
which the ion-selective membrane could be applied. By being porous, the ceramic rod 
allowed the filling solution, within the electrode, to diffuse through the rod and come into 
  48  
close contact with the ion-selective membrane. This system formed the template for both 
the reference and ion-selective electrodes. 
 
2.3.3  Coating the electrode template with the ion-selective membrane: 
The ion-selective plastic was first re-dissolved with THF. Only a small amount of THF 
was required (about 1 ml). The resulting solution was left to stir very slowly, in order to 
allow the THF to evaporate. Once the mixture was of a suitable consistency (e.g. treacle-
like), the electrode templates were dipped into it. The aim was to coat the exposed 
ceramic rod and the distal part of the PVC tube to form a continuous coating. The tip of 
the electrode template was held in the solution for 1-2 seconds, and then raised above the 
solution for a further 10 seconds to allow any remaining solvent to evaporate slowly and 
so leave a uniform coat of ion-selective plastic. This process was repeated twice more at 
15-minute intervals ensuring that the electrodes received an adequate coating of the ion-
selective membrane. Care was taken to remove air bubbles from the dipped coating, by 
touching the tip of the electrode against the side-wall of the glass pot. The electrodes 
were left to dry in open air for 2-3 days, allowing the plastic ion-selective membrane to 
form around the distal tip of the electrode. Usually batches of five electrodes were dipped 
once the ion-selective plastic had been re-dissolved.  The ion-selective plastic solution 
was allowed to re-form a solid that could be subsequently re-used. 
 
2.3.4 Ion-selective electrode filling solutions: 
The bore of the PVC tube that formed the ion-selective electrode was filled with a 
solution of known concentration of the primary ion. Thus, the voltage across the ion-
selective plastic membrane was a function only of the ion activity gradient and hence the 
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activity of the ion in the test solution into which the ion-selective electrode was placed. 
Generally the concentration of the primary ion was similar to that in the test solutions so 
that excessively large voltages across the ion-selective membrane were not generated. In 
addition, the total cation concentration of the filling solution was about 150 mM so that 
excessive osmotic gradients across the electrode were also minimised, thus limiting water 
flux across the membrane.  
 
Each of the stock filling solutions was saturated with AgCl, by adding a small amount of 
solid AgCl to them. This minimised the filling solution from dissolving away the AgCl 
on the Ag/AgCl electrode (section 2.3.5) and therefore limited voltage drift at the 
interface between the filling solution and Ag/AgCl electrode. When filling the electrodes, 
care was taken to ensure that the column of fluid was continuous, without any air 
bubbles, to allow good contact between the Ag/AgCl electrode and the ion-selective 
membrane. Bubbles were removed by gently flicking the electrode after injecting the 
filling solution. 
 
2.3.5 Manufacture of reference electrodes: 
The reference electrode was made using an electrode template, with no coating, and 
filling it with a 3 M KCl solution, saturated with AgCl. The ceramic rod again provided a 
good porous support for a stable liquid junction potential between the filling solution and 
the test solution.  
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Table 2.2.  Composition of filling solutions used with the different ion-selective 
electrodes. 
Ion-selective 
Electrode 
Filling Solution Reference Electrode 
NH4+-selective electrode 1 mM NH4Cl /150 mM NaCl 
Saturated with AgCl 
3 M KCl 
K+-selective electrode 4 mM KCl /146 mM NaCl 
Saturated with AgCl 
3 M KCl 
Mg2+-selective electrode 1 mM MgCl2 / 150 mM NaCl 
Saturated with AgCl 
3 M KCl 
Ca2+-selective electrode 1 mM CaCl2 / 150 mM NaCl 
Saturated with AgCl 
3 M KCl 
 
2.3.6  Manufacture of the Ag/AgCl electrodes: 
These electrodes were used to connect the filling solutions within the ion-selective and 
the reference electrodes to a voltmeter.  A coating of AgCl over a bare silver (Ag) wire 
electrodes provides a large surface area of conductor for the electrode size and minimises 
polarisation at the electrode surface, thus reducing electronic drift. A 6-cm length of 
Shellac-coated Ag wire (25 μm diameter) was prepared by scraping away the coating 
from a 2-cm length of one end with a blunt scalpel blade, revealing the bare Ag wire. 
Only the terminal region of the Shellac coating was removed for AgCl coating, as this 
was the region that made contact with the ion-selective filling solution (below).  Leaving 
the coating on the remainder of the Ag wire external to the electrode ensured that water 
vapour in the air did not condense onto the Ag electrode.  The extreme part of the other 
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end was similarly cleaned to permit a solder connection to a wire and hence connection 
with a voltmeter – see Figure 2.1, section 2.3.7).  
  
Several bare Ag wires were coated with AgCl in a batch. To coat the Ag wire with AgCl 
the bare ends were first cleaned by connecting them to the cathode of a 9 V battery. The 
anode of the battery was connected to a 2 mm diameter Ag rod and the system immersed 
in 100mM KCl for 30 seconds, causing the silver bare wires to generate bubbles as water 
was hydrolysed. At the anode, the Ag rod gained a coarse, white granular layer of AgCl.  
This process served to clean the silver wires of surface impurities. The coarse AgCl 
deposit was scraped from the silver rod with fine emery paper and the system re-
immersed in fresh 100 mM KCl solution. The polarity on the system was now reversed 
with the Ag wires now attached to the anode so that they would be coated with AgCl.  To 
generate a more stable AgCl coating, the current through the system was reduced by 
placing a large (220 kΩ) resistor in the circuit. The AgCl coat developed over 40-45 
minutes and appeared as a brown/purple deposit on the wire. The coated electrodes were 
then removed and stored in a dry container until they were required for use. 
 
2.3.7 Experimental Arrangement: 
An electrochemical cell was created by measuring the potential difference (p.d.) between 
the ion-selective electrode and reference electrode when both were immersed in the test 
solution. The p.d. was measured with a differential amplifier manufactured in the 
laboratory, using high input impedance operational amplifiers as input stages (J-FETs, 
input impedance 1012 Ω, RadioSpares, UK).  The high input impedance was significantly 
greater than the impedance of the ion-selective electrodes (1-10 MΩ), ensuring that the 
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differential amplifier did not affect the p.d. generated by the ion-selective/reference 
electrode pair.  The differential amplifier output was connected to a liquid-crystal 
numerical display and the values recorded.  A schematic of the arrangement is shown in 
figure 2.1. 
 
Figure 2.1. A schematic diagram of the electrochemical cell used for the measurement of 
ion activities with ion-selective electrodes.  
 
The test chamber in which the electrodes were dipped was a 4 ml Perspex water-jacketted 
holder (Figure 2.2).  Water was circulated through a water-jacket at 25 or 37°C.  A 
commercial glass pH combination electrode was also immersed into the chamber through 
a side-wall so that the pH of the test solution could be continually monitored.  A Perspex 
insert formed the top of the test chamber with small holes drilled through it.  These holes 
held the ion-selective and reference electrodes so that only the tips were immersed in the 
test solution.  An additional hole enabled a needle from a Hamilton Microlitre syringe 
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(10-100 μl) to be inserted into the test solution for the addition of calibrating solutions.  
The insert also minimised evaporation of the test solution for the duration of the 
recording – up to 30 minutes.  The chamber was placed on a magnetic stirrer and a small 
Teflon-coated magnetic bar in the test chamber allowed adequate mixing throughout the 
measurement protocols. 
 
Figure 2.2: Test chamber: A – side view with combination pH electrode projecting from 
the left-hand side.  The chamber sits on top of a rotating magnetic chamber to allow 
rotation of the magnetic Teflon-coated bar placed in the test solution B – top view of 
experimental chamber. 
 
2.4 CALIBRATION OF ION-SELECTIVE ELECTRODES  
 
2.4.1 Calibration solutions:   
The ion-selective electrodes were calibrated in a base solution of 150 mM NaCl or 140 
mM NaCl + 10 mM 4-(2-hydroxyethyl)-1-piperazine ethane-sulphonic acid (MES) 
buffered to pH 6.0. Aliquots of aqueous stock calibrating solutions were added to the 
base solution, appropriate to the electrode being tested. Below is a list of the different 
calibration solutions used: 
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NH4+-selective electrode: 100 mM and 1 M NH4Cl solutions. 
K+-selective electrode: 100 mM and 1 M KCl solutions. 
Ca2+-selective electrode: 100 mM and 1 M CaCl2 solutions. 
Mg2+-selective electrode: 100 mM and 1 M MgCl2 solutions.  
 
2.4.2  Manufacture of calibrating solutions: 
Using the example of 1 M and 100 mM NH4Cl: the molar weight of NH4Cl is 53.49g. 
Therefore to create a 1 M solution, 53.49 g of NH4Cl would need to be dissolved in one 
litre of water. Using a weighing boat and calibrated scales, 1.07g of NH4Cl was weighed 
and dissolved  in 20ml of deionised water. To measure out 20 ml of water accurately, a 
P5000 (R75275N) pipette was used to measure 5 ml and this was then added into the 
weighing boat to allow the NH4Cl to dissolve, prior to pouring the solution into a sterile 
20 ml plastic container. A further three measures of 5 ml of water were pipetted and used 
to rinse the weighing boat prior to transfer to the final plastic container, thus ensuring that 
the entire weighed salt was present in the final solution. This method therefore made a 
stock of 1 M solution NH4Cl. 
 
To make a 100 mM NH4Cl solution, 2 ml of the 1 M NH4Cl was diluted with 18ml of 
deionised water and stored in a cleaned plastic bottle. The same procedure was followed 
to manufacture the KCl, CaCl2 and MgCl2 solutions. 
 
2.4.3  Experimental Protocol:  
Aliquots of stock solution were added to change the concentration of the primary ion 
between 0.1 and 40 or 80 mM (see Table 2.3). The actual concentration of the primary 
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ion took into account the small increase of total volume with each incremental addition of 
stock solution. This is represented in the ‘calculated conc’ column in Table 2.3. 
 
Table 2.3.   Example of a calibration protocol for the NH4+-selective electrode 
Concentration of 
NH4Cl (mM) 
Quantity of 100 mM 
NH4Cl added, µl 
Quantity of 1 M 
NH4Cl added, µl 
Calculated  
conc (mM) 
0  - -  
0.1 4 - 0.10 
0.2 4 - 0.20 
0.4 8 - 0.40 
1.0 24 - 0.99 
2.0 40 - 1.96 
4.0 - 8 3.91 
10.0 - 24 9.73 
20.0 - 40 19.3 
30.0 - 40 28.6 
 40.0 - 40 37.8 
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2.5 THEORY OF IONIC SOLUTIONS AND THE CALCULATION OF 
SELECTIVITY COEFFICIENTS.   
 
2.5.1 Concentration and ionic activity 
The quantity of solute in a given volume or weight of solvent defines concentration.  The 
Systeme Internationale  (S.I.) unit of molality, m, is the number of moles of solute.kg-1 
solvent.  The definition of molarity, c, is the number of moles of solute.litre-1 solvent.  In 
this thesis units or molarity are used. 
 
When a salt is added to a suitable solvent, such as water, the solute components tend to 
dissociate into its constituent ions.  Arrhenius theory proposes that an equilibrium exists 
between undissociated solute molecules and ions which arise from electrolytic 
dissociation.  For strong acids and bases and salts such as NaCl and KCl this dissociation 
is almost complete but not complete.  The effective concentration of an ion in solution is 
termed the activity, a.  The relationship between concentration, c, and activity for any 
ion, i, is  
 
ai = γ i .ci     1 
where γi is termed the activity coefficient.  Ion-selective electrodes measure the activity 
rather than concentration of an ion in solution, which would be proportional to 
concentration if is γi constant.  The value of γi is however dependent on a number of 
solution properties including the concentration of the ion itself, the temperature of the 
solution and the ionic strength, I, of the solution: where I=
 
1
2
cz2∑  of each ionic 
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constituent ion (valency, z) in the solution.  The relationship between γi and solution 
parameters is given by the Debye-Hückel equation: 
 
lnγ i = −Azi
2 I     2 
where A is a function of absolute temperature and at 25°C has a value of 1.172 
mol−1/2.kg1/2.  For the variation of temperature and ionic strength experienced in these 
experiments γi varies little and so ionic activity will be considered throughout to be 
proportional to ionic concentration.  All values of ionic concentration will therefore be 
proportionately related to the concentration of calibration solutions. 
 
2.5.2 The relationship between electrode potential and ion activity – the Nikolsky 
equation. 
The potential difference between the ion-selective and reference electrodes is given by 
the Nikolsky equation (equation 3): where R is the gas constant (8.314 J.°K-1.mole-1), T is 
the absolute temperature (°K) and F is the Faraday constant (96,500 coulombs.J-1) and  z 
is the valency of the primary ion (z=1 for NH4+, K+, Na+, H+; z=2 for Ca2+, Mg2+).  The 
variable E0 is a constant. 
    
 
E = E 0 +
RT
zF
ln aNH 4 + kNH 4 j
pot a j
z*
j =k,l,m..
∑
 
  
 
  
 
 
E = E0 + 2.303 RT
zF
aNH 4 + kNH 4 j
pot a j
z*
j= k ,l ,m
∑



   3 
The term z* as the exponent in the aj term on the right-hand side of the equation is the 
ratio of valencies of the primary ion, i, and the interferent ion, j (=k,l,m,…).  For primary 
and interferent ions of the same valency z*=1.  This will be the case for the most 
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important interferent ions for the respective NH4+-selective and Mg2+-selective electrodes 
in this study and so will be set to unity here with no loss of generality. 
 
 
 
kij
pot  is the potentiometric selectivity coefficient for the jth interferent ion (j=k,l,m…), 
Na+, H+, K+, Ca2+, Mg2+, etc with respect to the primary ion, i, (e.g. NH4+).  Here the 
activity, a, of the primary and interferent ions are used in place of their respective 
concentrations.  The values of 
 
kij
potare quoted in the text as log
 
kij
pot  values. 
 
A plot of p.d. (E) as a function of the logarithm (log10) of the primary ion concentration 
would yield a straight-line (Nernstian) plot if the electrode was perfectly selective to the 
primary ion.  The slope of the plot would be 61.5 mV or 58.5 mV for a 10-fold increase 
in concentration of a monovalent primary ion, at 37.5 and 25°C respectively. An ideal 
electrode for a divalent primary ion would generate a 31.5 mV and 28.5 mV increase 
over a 10-fold increase in concentration of the primary ion, at 37.5 and 25°C respectively.  
 
However at lower concentrations of the primary ion, ion-selective electrode responses 
deviate from such a linear response as evidenced by a reduction of slope. This is due to 
significant effects of other, interferent, ions on the electrode response, the effect of which 
is to cause an apparent increase in the concentration of the primary ion in the electrode 
response.  For accurate measurement of the primary ion concentration the magnitude of 
the interferent effect must be determined.  This is achieved by estimation of the 
potentiometric selectivity coefficient, 
 
kij
pot , for each ion in conjunction with the Nikolsky 
equation. 
  59  
 
There are two standard methods for the estimation of 
 
kij
potvalues: the separate solution 
method (SSM) and the fixed interference method (FIM). 
1. Separate solution method: this compares the p.d. generated by a pure solution of 
the primary ion, Ei, with the p.d. generated by a pure solution of the interferent ion, Ej. 
The selectivity coefficient is then calculated from the Nikolsky equation: 
 
kij
pot = 10
(Ei −E j )zi F
2.303RT ai
(a j )
zi / z j
    4 
This method is not the method of choice since the concentration of the interferent ion and 
concentration of the primary ion may be quite different in biological solutions. 
2. Fixed interference method: this is the method recommended by the International 
Union of Physical and Applied Chemistry (IUPAC) for determining selectivity 
coefficients (
 
kij
pot) of interferent ions.  The concentration of the interferent ion is kept 
constant and the response of the ion-selective electrode to varying concentrations of the 
primary ion is measured. In effect, the ion-selective electrode is calibrated in a 
background solution that has a constant concentration of interferent ion. This is the 
recommended method since the chosen concentrations of the primary and interferent ions 
can be similar to the concentrations found in biological solutions. 
 
Figure 2.3 shows a calibration curve of an ion-selective electrode in a background 
solution with a particular concentration of interferent ion. At higher concentrations of the 
primary ion, i, the calibration curve approaches a Nernstian straight line with a slope 
RT/ziF.  At the lowest concentrations of the primary ion, the calibration curve approaches 
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a horizontal line, because the fixed concentration of the interferent ion contributes more 
than the primary ion in generating the resultant p.d. At intermediate primary ion 
concentrations the slope of the plot is between these two extremes.  At a certain primary 
ion concentration the slope is half the predicted Nernstian value, i.e. the primary ion and 
the interferent ion both contribute equally to the ion-selective electrode p.d. This 
concentration of the primary ion is known as the limit of detection and may be obtained 
by extrapolating the two linear sections of the calibration curve to the concentration at 
which they meet. At this point, where Ei=Ej, then the Nikolsky equation reduces to: 
 
kij
pot =
ai
a j( )zi / zj
     5 
 
Figure 2.3: Sample calibration curve for an NH4+-selective electrode, calibrated in a 
solution of 140 mM NaCl + 25 mM KCl. The horizontal hashed line corresponds to the 
horizontal section of the curve and the diagonal line to the Nernstian slope at higher 
[NH4+]. The concentration where the two hashed lines meet is the limit of detection. 
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2.5.3 Experimental protocol for calculating potentiometric selectivity coefficients, 
 
kij
pot  
for an ion-selective electrode:   
The general method will use the example for a NH4+-selective electrode. Specific 
variations for other ion-selective electrodes will be enunciated later.  Note that although 
the Nikolsky equation uses values for ion activity, a, for practical purposes the 
concentration, c, of primary and interferent ions are used for the calculation of 
 
kij
pot  
values.  This does not reduce the generality of the situation assuming that the relationship 
between ion activity and concentration remains unchanged (see section 2.5.2).   
 
The electrode was calibrated in known concentrations of each potential interferent ion in 
a base solution of 140 mM NaCl, 10 mM HEPES, adjusted to pH 6 with NaOH, i.e. the 
total [Na+] was approximately 150 mM. In the first instance calibration was carried out in 
the base solution to estimate the interference from Na+. Next another potential interferent 
cation of known final concentration was added, as the Cl- salt, to this background 
solution. The ion-selective electrode was then re-calibrated.  
 
The Nikolsky equation assumes that each interferent ion is transported independently of 
others.  Thus, the 
 
kij
pot  values for separate interferent ions are linearly independent, i.e. the 
term 
 
kik
potak + kil
potal + kim
potam….  may be calculated from the calibration curve, where k, m, 
n represent different interferent ions. 
 
Thus, data from the calibration curves were fitted to the general equation. 
 
E = m1 + slog(ci + m2)     6 
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where E is the recorded p.d.; ci is the concentration of the primary ion; m1 is a constant 
equivalent to E0, and m2 is a constant equivalent to
 
kij
potc j
j =k,l ,m,...
∑ .  Thus, calibration in the 
base solution yielded a value for 
 
m2 = kiNa
potcNa  and subsequent calibrations in solutions of 
further interferent ions enabled 
 
kij
pot  values for these ions also to be calculated. 
 
For the NH4+-ion-selective electrode the major potential interferent was K+ and 
calibrations of these electrodes were repeated in four different K+ concentrations (2 mM, 
5 mM, 25 mM and 50 mM). Ca2+ interference was evaluated by calibrating the electrode 
in a background solution containing 2 mM and 5 mM CaCl2 (experiments were repeated 
three times for each concentration of Ca2+). The quantities of solution added to produce 
the concentrations of the interferent ions in the background 140mM NaCl solution is 
shown in Table 2.4.  
 
Table 2.4  Composition of solutions for determination of potentiometric selectivity 
coefficients for NH4+-selective electrodes. 
Interferent 
ion 
Solution added 
to 140mM NaCl 
Concentration of interferent ion  
achieved in chamber (mM) 
Na+ - 140 mM 
 
 
K+ 
8 μl 1 M KCl 2 mM 
20 μl 1 M KCl 5 mM 
100 μl 1 M KCl 25 mM 
200 μl 1 M KCl 50 mM 
 
Ca2+ 
8 μl 1 M CaCl2 2 mM 
20 μl 1 M CaCl2 5 mM 
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A similar protocol was used to measure the potentiometric selectivity coefficients for K+, 
Mg2+, and Ca2+-selective electrodes. 
For K+-selective electrodes calibration was carried out in additional Mg2+-containing 
solution (2 mM) and NH4Cl (25 and 50 mM). 
For Mg2+-selective electrodes the most serious interferent ion was Ca2+.  Electrodes were 
calibrated first in 140 mM NaCl/10 mM HEPES (pH 6.0) and then in additional 1 mM 
CaCl2 solution. 
For Ca2+-selective electrodes calibration was carried out in additional K-containing 
solution (50-200 mM) and NH4Cl (40 mM). 
 
2.5.4 Effect of pH on ion-selective responses: 
Potentiometric selectivity coefficients were not calculated for H+ as above due to the low 
concentration of [H+] and the fact that due to large concentrations of H+ buffers this ion 
was not in simple equilibrium with the ion-selective electrode. 
 
Electrodes were calibrated in solutions of varying pH over a range likely to be 
encountered during experiments. The three chosen solutions were: 140 mM NaCl/10 mM 
HEPES adjusted to pH 7.5; 140 mM NaCl/10 mM HEPES adjusted to pH 6.5; 140 mM 
NaCl/10 mM MES adjusted to pH 5.5. 
 
Note: MES; 2-(N-morpholino)ethanesulfonic acid 
 HEPES; (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
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2.5.2 The effects of altered osmolality on ion-selective electrode responses: 
Because the osmolality of urine varies several-fold and thus might cause water fluxes 
across the ion-selective layer, it was important to determine any effect such solutions may 
have on electrode responses. 
 
The NH4+ ion-selective electrode was calibrated in a variety of solutions to examine the 
effects of osmolality on response. To increase the osmolality of the solution without 
increasing the ionic activity of the solution, sucrose was chosen since it is an unionised in 
solution. The protocol used and the effect on osmolality is shown in Table 2.5. 
Experiments were repeated three times for each solution and conducted at room 
temperature. 
 
Table 2.5.  Solution composition to test the effect of changes to solution osmolality on 
ion-selective electrode response. 
Background  
Solution (mM) 
Sucrose 
Conc (mM) 
Total  
Osmolality (mOsm) 
Effects on  
resultant solution 
150 mM NaCl - 300 N Na+ / N Osm 
50 mM NaCl - 100 ↓ Na+ / ↓ Osm 
300 mM NaCl - 600 ↑ Na+ / ↑ Osm 
150 mM NaCl 300 mM 600   N Na+ / ↑ Osm 
50 mM NaCl 200 mM 300 ↓ Na+ / N Osm 
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2.5.3 Effect of temperature on ion-selective NH4+ and K+-selective electrode responses: 
NH4+-selective electrodes were calibrated in a solution of 140 mM NaCl and 10 mM 
MES, which was adjusted to pH 6.0. Experiments were repeated 24 times at 37oC and 
compared with 40 calibrations of the electrode in a similar solution at room temperature. 
 
Because K+ was the major interferent ion on the NH4+-selective electrodes they were 
calibrated in four different K+ concentrations (2 mM, 5 mM, 25 mM and 50 mM) at 37oC 
to calculate the 
 
kNH 4 K  selectivity coefficient at this temperature. 
 
K+-selective electrodes were also calibrated in 140 mM NaCl/10 mM MES (pH 6.0) at 
37°C and compared to responses obtained at room temperature.   
 
2.6 EXPERIMENTAL PROTOCOLS 
 
2.6.1 Estimation of urinary [NH4+]. 
2.6.1.1 Measurements from the NH4+-selective electrode.   
The experimental chamber was first cleaned thoroughly with three washouts of deionised 
water and the NH4+-selective electrode was set up as described above (section 2.3.7). The 
electrode was then calibrated in a background solution of 150 mM NaCl or 140 mM 
NaCl/10 mM MES (pH 6): this was repeated three times until the calibration curves were 
similar. The chamber was washed out between calibrations with water and prior to 
urinary testing. 
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To measure urinary [NH4+], a 4-ml aliquot of urine was accurately instilled into the 
chamber through the top and the system allowed to equilibriate. The p.d. of the ion-
selective/reference electrodes system was then recorded using the voltmeter at the 
existing pH.   Control experiments showed that the pH of the urine sample was constant 
(±0.02 pH units) after voiding for up to three hours if the sample was kept in tightly-
stoppered plastic bottles and stored at 4°C.  Henceforth this pH will be called voided pH.    
After recording the readings with urine the chamber was then washed out three times 
with deionised water prior to testing the next urine sample. The electrode was then re-
calibrated after three urinary samples had been tested. 
 
Drift within the system was seen as a gradual change in the p.d. recorded in a solution 
containing a constant concentration of the primary ion. There was little drift within the 
system, but if it was present then a systematic examination of the experimental setup was 
undertaken to identify the cause. Firstly, connections between Ag/AgCl electrodes and 
recording wires were checked and these electrodes were changed. If the drift persisted the 
ion-selective electrode or reference electrode or both were changed. These measures 
usually resolved any drift within the system. An electrode drift of less than 1.0 mV per 
hour was deemed acceptable for the NH4+-selective electrode, as the calibration and urine 
testing protocol was generally complete in 30 minutes. 
 
 
2.6.1.2 Measurement of urinary [K+] 
Because K+ ions caused significant interference with the NH4+-selective electrode, 
urinary [K+] was measured separately with a valinomycin-based K+ -selective electrode.  
The interference from NH4+ on this electrode was negligible (see Results) and hence the 
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[K+] could be measured accurately in the presence of a significant [NH4+]. The method 
for measuring the urinary [K+] was the same as for measuring the urinary [NH4+] (section 
2.6.1.1). 
 
Initially the estimation of urinary [NH4+] and urinary [K+] was done separately: first the 
NH4+ electrode was calibrated, then the urine samples tested; second the K+ electrode 
was calibrated and then the same urine samples tested. We later modified our technique 
and developed the following experimental arrangement to measure both ion 
concentrations simultaneously (Figure 2.4).  This had several advantages: 
i) the time for the experimental protocol was shortened and hence minimised any 
problems of drift: 
ii) the same reference electrode was used at the same time to eliminate any systematic 
effect that urine samples may have had on the reference electrode potential. 
iii) the voided pH was the same for measurement of [NH4+] and [K+] to avoid any 
possible effect of altered pH on these two ionic measurements. 
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Figure 2.4: The experimental arrangement with two ion-selective electrodes in the 
chamber for simultaneous measurement of [NH4+] and [K+].  
 
2.6.1.3 Protocol to measure urinary [NH4+] from calibration curves: 
i) The mean calibration curve of the NH4+-selective electrode was plotted (figure 
2.5) and the potentiometric selectivity coefficient for Na+, 
 
kNH 4 Na
pot
, estimated using 
equation 6 – section 2.5.3 
 
E = m1 + slog(ci + m2)     6 
where the constant m1 is equivalent to the electrode constant, E0 and the constant m2 is 
equivalent to aNa*
 
kNH 4 Na
pot ; here aNa was set at 150 mM.  The term s is the slope factor of 
the electrode and was set to values of 58.5 or 61.5 (mV per 10-fold change of primary ion 
concentration) at room temperature and 37°C respectively. 
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ii) The ENH4 reading from the NH4+-selective electrode when in the urine sample 
was converted to an equivalent [NH4+] (figure 2.5).  This value will be an overestimate as 
the ENH4 has a contribution from Na+ in the urine sample, and more significantly K+ in 
the sample. 
 
Figure 2.5.  A sample calibration curve used to estimate the [NH4+] in a urine sample.  
The thick black horizontal line shows the ENH4 value in the urine sample and the 
extension to the x-axis shows the uncorrected value of [NH4+] – see text for details. 
 
iii) The urine [K+] was calculated from the K+-selective electrode calibration curve. 
iv) The product 
 
aK kNH 4 K
pot  was calculated 
v) The Nikolsky equation was employed using terms for interferent ions only for 
Na+ and K+ and rearranged to yield a value for the aNH4. aNH4 was made equivalent to 
[NH4+] according to section 2.5.1. 
 
ENH4 = E
0 + slog(aNH4 + kNH4 Na
pot aNa + kNH 4 K
pot aK )    7 
re-arranging 
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aNH4 = 10
ENH4 −E
0( )
s − (kNH4 Na
pot aNa + kNH4 K
pot aK )    7a 
Values of [NH4+] were recorded along with the [K+], urine pH and temperature. 
 
2.6.1.4 Protocol to measure urinary [Mg2+] from calibration curves: 
Exactly the same procedure was followed to calculate the [Mg2+] in urine samples using 
Mg2+-selective and Ca2+-selective electrodes.  In this case Ca2+ were the most serious 
interferent ion.  In addition the slope factor, s, was divided by two as required for divalent 
ions. 
 
2.6.2 Effects of storage on urinary [NH4+]: 
Experimental protocol: 
Urine samples from seven healthy subjects were used. A 20 ml sample was collected and 
divided into two 10 ml aliquots. One aliquot was tested immediately for urinary [NH4+] 
and [K+] (designated time = 0), which were measured at room temperature. This 10 ml 
aliquot was then left on the bench at room temperature. The other 10 ml aliquot was 
frozen immediately to be tested after one week (designated time = 7 days).   
 
The other 10 ml aliquot of urine, which was left on the bench, was tested for urinary 
[NH4+] and [K+] after 1 hour, 2 hour and 7 days.  This therefore permitted comparison of 
the urinary [NH4+] and [K+] at time = 7 days between the sample left at room temperature 
and the sample which had been frozen. We were also able to assess the effects of freezing 
samples as a method of storage, by comparing the frozen sample urinary concentrations 
with the concentrations measured immediately after voiding at time = 0. 
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2.7 VALIDATION OF NH4+-SELECTIVE ELECTRODE DATA AGAINST 
COLOUR SPECTROPHOTOMETRY  
 
Urine samples were taken from 28 healthy subjects and were tested immediately for 
urinary [NH4+] and [K+] using the respective ion-selective electrodes. At the same time, 
an aliquot of the urinary sample was stored in the freezer for testing at a later stage. 
 
The values of urinary [NH4+] obtained using ISEs were compared to those using a 
conventional spectrophotometric assay on stored (-20°C) urine samples as above.  
Urinary [NH4+] was measured using a phenol-hypochlorite reaction detection method 
(Weatherburn, 1967). Urine samples were diluted (1/80) by the addition of trichloroacetic 
acid (15% final) and centrifuged at 10,000 rpm for 10 minutes at 4oC to remove any 
dissolved protein. The supernatant (50 µl) was incubated in a 96-well plate at 30oC for 3 
hours in 200 µl of a solution containing: phenol, 10 mM; Na hypochlorite, 10 mM; Na 
nitroprusside, 10 mM as a catalyst; and NaOH, 0.5 mM.  Ammonium ions react with 
alkaline phenol to produce indophenol which has an intense blue color. The concentration 
was determined against a standard curve of NH4Cl solutions over the range 5 – 200 µM 
measured at 630 nm in a 96-well plate reader (Tecan Sunrise, Austria). All 
determinations were at 25°C. 
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2.8 ALGORITHM TO CALCULATE URINARY [NH4+]. 
 
The algorithm to estimate urinary [NH4+] is derived from calculation of the urinary anion 
gap (AG). The AG is calculated as the difference between the concentrations of the major 
cations (Na+ and K+) and the major anion (Cl-) (Hoge et al, 1974): 
 Urine AG = Urine (Na+ + K+ - Cl-)  
The urinary AG is used to help in the differential diagnosis of metabolic acidosis and is 
representative of the unmeasured ions in urine, the most important of which is NH4+.  
 
In patients with a metabolic acidosis and a normal renal response, the urinary AG has a 
negative value, due to an increase of the urinary [NH4+], as NH4Cl, in order to excrete 
excess acid (Batlle et al. 1988). When patients are unable to excrete NH4+ normally (e.g. 
renal failure, type 1 renal tubular acidosis), the urine AG has a positive value.  
 
The urine [NH4+] can be estimated from calculation of the urine osmolal gap, which is 
the difference between the measured and calculated urine osmolality (Rose 1994). The 
calculation requires measurement of urine osmolality, the urine Na, K, urea nitrogen and 
glucose concentration (if dipstick positive for glucose). The calculated urine osmolality is 
then estimated: 
 
Calculated urine osmolality = 
 
2([Na] + [K]) +
urea nitrogen
2.8
+
glucose
18
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The multiple of 2 accounts for anions accompanying Na and K, and the divisors 2.8 and 
18 reflect adjustments required to convert from routinely used units of mg/dl to mmol/l or 
mosmol/kg. The osmolal gap is then estimated: 
 
 Osmolal gap = Measured osmolality – Calculated osmolality. 
 
The osmolal gap then approximates the concentration of ammonium salts and the [NH4+] 
itself will be half of this value, as the other half are anions accompanying NH4+.  Thus,  
 
Urine [NH4
+] = 0.5* Measured osmolality -  2([Na] +[K]) +
urea
2.8
+
glucose
18
 
 
 
 
 
There are several variants for this calculation and the one used at the Royal Free Hospital, 
London, in the recurrent stone former clinic is: 
( )urea +[K])+2([Na] - osmolality Measured*5.0][NH Urine +4 =  
We collected urine samples from patients attending the Renal Stone Clinic at the Royal 
Free Hospital. We calculated the urinary [NH4+] using the above formula, from the 
urinary Na, K, urea and osmolality. We also independently measured the urinary [NH4+] 
using the ISE technique so that a comparison could be made between the two methods for 
measuring urinary [NH4+]. 
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2.9 DATA PRESENTATION AND STATISTICAL ANALYSIS 
 
Data are presented as mean values ± standard deviation (SD), except in a number of cases 
specifically mentioned where median values and 25% and 75% interquartile ranges are 
quoted. 
 
Comparison of two data sets was carried out using Student’s t-test.  When median values 
are quoted, comparison of data sets used a non-parametric Wilcoxon’s test.  For 
comparison of multiple data sets, analysis of variance was used.  The null hypothesis was 
rejected when p<0.05.   
 
Curve-fitting of data sets to described functions used an iterative least-squares method 
with the program Kaleidagraph (Synergy software Inc).  This program permitted writing 
the fitting function with an independent variable output in terms of a dependent variable 
and a number of parameters that used initial estimates.  All functions are described in the 
text (Methods and Results chapters). 
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CHAPTER 3 
RESULTS: 
 
3.1 Calibration of the NH4+-selective electrode 
Typical calibration data for the NH4+-selective electrode in 140 mM NaCl buffered to pH 
6.0 with 10 mM MES is shown in Table 3.1. The table shows the nominal and calculated 
NH4Cl concentration.  The latter was calculated after consideration of the increased 
chamber volume following addition of the NH4Cl aliquot.  The corresponding calibration 
curve is displayed in Figure 3.1, below.  All calibrations were performed at room 
temperature. 
 
3.1.1 Selectivity and sensitivity of the NH4+-selective electrode: 
The presence of other ions within a solution can affect the electrode response, and if 
significant will diminish the response of the electrode to the primary ion. Therefore the 
potentiometric selectivity coefficient potijk was determined experimentally for each 
possible interferent ion present in urine. This was performed using the fixed interference 
method described in the Methods. In figure 3.1 the data were fitted to the modified 
Nikolsky equation (equation 6, section 2.5.3): 
  
 
E = m1 + slog(ci + m2)  6 
this allowed estimation of the potentiometric selectivity coefficient, k. In this case the 
only major interferent ion was Na+.  The value of the slope constant s was 58.5 mV per 
10-fold change of [NH4+] and thus k is equivalent to 
 
kNH 4 Na
pot : in this example the value 
was 0.00247. 
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Table 3.1  Typical NH4+-selective electrode calibration data in a base solution of 140 mM 
NaCl, 10 mM MES solution (pH 6.0).  NH4Cl was added in aliquots to the base solution 
from a 0.1 or 1 M stock solution (section 2.4.3).  
 
 
 Nominal [NH4+] (mM) Actual [NH4+] in 
the chamber (mM)  
E NH4+ (mV) 
0.100 0.100 -67.6 
0.200 0.200 -62.0 
0.400 0.398 -53.6 
1.00 0.99 -38.3 
2.00 1.96 -24.2 
4.00 3.91 -10.4 
10.0 9.73 12.0 
20.0 19.3 29.0 
30.0 28.6 38.7 
40.0 37.8 45.6 
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Figure 3.1. Typical calibration curve of a NH4+-selective electrode in 140 mM NaCl and 
10 mM MES at pH 6.0. The total [NH4+] following each addition is plotted against the 
p.d. produced by the ion-selective/reference electrode pair, henceforth referred to as ISE. 
The line was fitted to the Nikolsky equation, see text for details: 
 
ENH4 = E
0 + slog10([NH4
+] + k)where the slope factor s=58.5 mV per 10 fold change of 
[NH4Cl]. 
 
The ISE response to NH4+ was good (i.e. roughly linear using the axes scale in Figure 
3.1) in this base solution above a concentration of 1 mM. 
 
Quantification of the interference from different ions on the ISE response permitted 
significant interferent ions to be identified.  The concentration of these ions was 
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subsequently measured to allow subtraction of their influence on the NH4+-selective ISE 
response for each urine solution tested and thus permit evaluation of the true 
concentration of NH4+.  The approach was to utilise the full Nikolsky equation - equation 
3, section 2.5.2: 
 
 
ENH4 = E
0 + slog10(ai + kij
pot a j( )
zi / z j
+ kik
pot ak( )
zi / zk ...)  3 
where E0 is the constant; ai is the concentration of the primary ion, NH4+; aj, ak,… the 
concentrations of interferent ions; and potijk , 
pot
ikk ,… the selectivity coefficients of the 
respective interferent ions.  The value of the selectivity coefficient can then be calculated 
from fitting the data to equation 3 using the calibration curve data as exemplified in 
Figure 3.1.   For several interferent ions the value of one, say potijk , may first be calculated 
alone and then added to equation 3 for estimation of subsequent coefficients.  Note: 
concentration values rather than activities, a, for each are used throughout - see Methods 
- and assumes that changes in the relationship between activity and coefficient is 
unaltered in any of the test and calibration solutions. 
 
The smaller the value of potijk  then the less is the interference of that ion on the ISE 
response. For the NH4+-selective electrode, the interferent ions of most concern were 
Na+, K+, Ca2+ and H+. We examined the individual and combined effects of each of these 
ions on the NH4+-selective electrode. The values of each potijk will be tabulated together 
after individual values have been evaluated.  The potijk values henceforth will be quoted as 
-log potijk  values for convenience.  For the 
 
kNH 4 Na
pot  value of 0.00247 obtained from Figure 
3.1, the log potijk was -2.607.  An interpretation of the 
pot
ijk  value may be obtained from its 
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reciprocal, in this instance with a value of 404.9; this means the electrode is about 405-
times more sensitive to NH4+ than Na+.  For some interferent ions, because their 
influence on the ion-selective electrode was so small, it was not always possible to 
calculate a potijk  value and hence in these experiments interference was described as ‘not 
detectable’.  
 
 
3.1.2 Na+ interference: 
All calibration curves were performed in a background solution containing 140 mM NaCl 
+10 mM MES (at pH 6.0) –referred to as the baseline solution. Because Na+ was the 
predominant cation in all the calibration curves, the initial calibration was performed in 
the baseline solution to calculate the interference from Na+, i.e. estimate log
 
kNH 4 Na
pot .  This 
mean value was then substituted into the Nikolsky-Eisenmann equation 3 to permit 
calculation of the potentiometric selectivity coefficients of other interferent ions.  From 
40 determinations a value for log
 
kNH 4 Na
pot  of -2.61±0.11 was obtained. Where error bars 
have been included in the following figures, they may be too small to be visible. 
 
3.1.3 K+ interference: 
Because K+ caused the greatest interference, the NH4+-selective electrode was tested in 
base solutions containing four different concentrations of KCl: 2, 5, 25 and 50 mM, to 
determine if the 
 
kNH 4 K
pot value itself was independent of the [K+]. Ten NH4+-selective 
electrodes were calibrated in each of the four solutions, as well as the base solution, to 
calculate a mean log
 
kNH 4 K
pot  for each concentration; the values are displayed in Table 3.2.  
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Figure 3.2 shows calibration curves in 2 and 5 mM KCl; figure 3.3 shows curves in 25 
and 50 mM KCl; figure 3.4 combines curves from all KCl concentrations.  Each 
calibration curve was normalised to 0 mV for the reading in 40 mM NH4Cl.  The 
deviation from a relatively linear calibration curve in a zero-KCl solution, using the semi 
logarithmic axes as shown, was increasingly significant as the [K+] increased. 
 
Table 3.2 shows that 
 
kNH 4 K
pot values were independent of the [K+], yielding a mean value of 
0.141.  This value was inserted into the Nikolsky equation with the appropriate [K+] for 
each urine sample for the determination of the true [NH4+] in K+-containing urine. 
  
Table 3.2. K+ potentiometric selectivity coefficients of NH4+-selective electrodes in the 
base-solution with varying background concentrations of K+. 
 
 
 
[K+] 
NH4+-ISE (room temperature) 
Mean log
 
kNH 4 K
pot  Mean 
 
kNH 4 K
pot  Mean 
 
kNH 4 K
pot  
Overall  
Mean 
 
kNH 4 K
pot  
2mM -0.84 + 0.038 0.143 
0.140 
 
0.141 5mM -0.86 + 0.029 0.137 
25mM -0.85 + 0.010 0.141 
0.141 
50mM -0.85 + 0.007 0.142 
 
 
 
 81 
-120
-100
-80
-60
-40
-20
0
20
0.1 1 10 100
  
  E NH
4
+ (mV)
[NH
4
+] (mM)
  
 
 
  
 
 
 
-120
-100
-80
-60
-40
-20
0
20
0.1 1 10 100
    
   
E NH
4
+ (mV)
[NH
4
+] (mM)
  
 
 
  
 
 
  
 
 
  
 
 
 
Figure 3.2. Calibration curves of an NH4+-selective electrode in a solution containing 140 
mM NaCl + 10 mM MES + 2 mM KCl (upper graph), 140 mM NaCl + 10 mM MES + 5 
mM KCl (lower graph).  The closed circles represent determinations in base solution, the 
open triangles in the K-containing base solution Individual calibration curves were 
normalized to 0 mV for the reading in 40 mM NH4Cl. All solutions were at pH 6.0. Error 
bars have been added to calibration curves in base solution for both graphs. 
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Figure 3.3. Calibration curves of an NH4+-selective electrode in a solution containing 140 
mM NaCl + 10 mM MES + 25 mM KCl (upper graph), 140 mM NaCl + 10 mM MES + 
50 mM KCl (lower graph).  The closed circles represent determinations in base solution, 
the open triangles in the K-containing base solution Individual calibration curves were 
normalized to 0 mV for the reading in 40 mM NH4Cl. All solutions were at pH 6.0. Error 
bars have been added to calibration curves in base solution for both graphs. 
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Figure 3.4. Calibration curves of the NH4+-selective electrode in the following solutions: 
140 mM NaCl + 10 mM MES + 2 mM KCl (open triangles), 140 mM NaCl + 10 mM 
MES + 5 mM KCl (crosses), 140 mM NaCl + 10 mM MES + 25 mM KCl (open circles), 
140 mM NaCl + 10 mM MES + 50 mM KCl (closed triangles). Each determination was 
performed 10 times, error omitted for clarity. The open circles were data obtained in base 
solution, 140 mM NaCl + 10 mM MES. The individual calibration curves were 
normalized to 0 mV for the reading in 40 mM NH4Cl. All solutions were at pH 6.0. 
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3.1.4  Ca2+ interference: 
The NH4+-selective electrode was calibrated in base solution containing either 2 mM or 5 
mM CaCl2. The resulting mean calibration curves (n=3) for the two concentrations of 
Ca2+ are shown in Figure 3.5.  There was no significant effect on the calibration curve in 
base solution.  Thus, there was no detectable interference from Ca2+ on the NH4+-
selective electrode. 
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Figure 3.5. Calibration curves of the NH4+-selective electrode in base solution (closed 
circles), base solution with 2 mM CaCl2 (open triangles) and base solution with 5 mM 
CaCl2 (open squares). Each determination was performed 3 times, error bars refer to data 
in base solution. 
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3.1.5  H+ ion interference: 
There was no detectable interference caused by H+ ions on the NH4+-selective electrode 
when the electrode was calibrated in three solutions of varying pH: 140 mM NaCl + 10 
mM HEPES (pH 7.5), 140 mM NaCl + 10 mM HEPES (pH 6.5), and 140 mM NaCl + 10 
mM MES (pH 5.5). The mean calibration curve for each pH is shown in Figure 3.6.  All 
three calibration curves were not distinguishable from that in base solution (pH 6.0).  
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Figure 3.6.  Calibration curves for the NH4+-selective electrode in base solution (pH 6.0), 
140 mM NaCl + 10 mM HEPES (pH 7.5, open triangles), 140 mM NaCl + 10 mM 
HEPES (pH 6.5, open squares) and 140 mM NaCl + 10 mM MES (pH 5.5, open circles). 
Each determination was performed 3 times.  Error bars refer to data in the base solution. 
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Any pH-dependence was also examined in a K-containing solution to reflect more closely 
the situation in urine.  Figure 3.7 shows in a solution containing 10 mM KCl there was 
also negligible interference from H+ over the same range of pH values from 5.5 to 7.5. 
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Figure 3.7. Calibration curves for the NH4+-selective electrode in a base solution 
containing 10 mM KCl and with pH varying from 5.5 to 7.5 using the same buffers as in 
Figure 3.6.  Solutions were: pH 7.5 open triangles; pH 6.5 open squares; pH 5.5 open 
circles.  Each determination was performed three times. Error bars refer to data in the 
base solution(pH 6.0 – no background KCl, closed circles). . 
 
Table 3.3 summarises the values of the potentiometric selectivity coefficients for the  
NH4+-selective ISE against potential interferent ions.  It is seen that the NH4+-ISE has a 
406-fold selectivity for NH4+ over Na+, and a 7-fold selectivity over K+. 
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Table 3.3 Potentiometric selectivity coefficients for NH4+ ion-selective electrodes against 
potential interferent ions, j, mean values±s.d. Values (±sd) for the
 
logk
NH4 j
pot , as well as 
values of 
 
kNH 4 j
pot  and
 
1/kNH 4 j
pot , calculated from the mean 
 
logk
NH4 j
pot  value. Not detectable 
means no significant deviation from the calibration in base solution alone was detected  
Interferent ion 
NH4+-ISE (room temperature) 
 
logk
NH4 j
pot  
 
kNH 4 j
pot  
 
1/kNH 4 j
pot  
Na+ -2.61 ± 0.11 0.00247 405.5 
K+ -0.85 ± 0.0086 0.141 7.1 
H+ not detectable not detectable - 
Ca2+ not detectable not detectable - 
 
 
3.1.6  Determination of the effect of osmolality on the NH4+-ISE response: 
The osmolality and ionic strength of urine varies greatly. Therefore the sensitivity and 
selectivity of the NH4+-selective electrode was tested in solutions of varying osmolalities 
and differing ionic activities to determine if these affected the ISE response. This was 
done by estimating the potentiometric selectivity coefficient for Na+ (e.g. 
 
kNH 4 Na
pot ), relative 
to the base-solution. Table 3.1.4 shows the solutions used for these experiments.  A 
solution of low ionic strength and osmolality was achieved by replacing 150 mM NaCl 
with 50 mM NaCl in a base solution. A solution of normal osmolality but reduced ionic 
strength used a solution of 50 mM NaCl + 200 mM sucrose.  Hyperosmolar solutions 
were achieved with addition to base solution of 300 mM sucrose (normal ionic strength) 
or a further 150 mM NaCl (raised ionic strength). Table 3.4 also shows the 
 
kNH 4 Na
pot values 
(as log
 
kNH 4 Na
pot ) in these various solutions. Figures 3.8 and 3.9 show calibration curves in 
 88 
the different solutions.  The values of log
 
kNH 4 Na
pot in the different solutions were not 
significantly different from the value in base solution and therefore it may be concluded 
that solution ionic strength and osmolality per se had no effect on the NH4+- selective 
ISE response. 
 
Table 3.4: Values of log
 
kNH 4 Na
pot  for the NH4+-selective electrode in solutions of varying 
osmolality and ionic activity 
Solution log
 
kNH 4 Na
pot  
Base solution (150 mM Na) -2.61±0.11 
50 mM NaCl  -2.05 + 0.13 
50 mM NaCl + 200 mM Sucrose  -2.59 + 0.07 
300 mM NaCl  -2.77 + 0.01 
150 mM NaCl + 300 mM Sucrose -2.77 + 0.06 
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Figure 3.8.  Calibration curves of the NH4+-selective electrode in: 50 mM NaCl (upper 
graph); 50 mM NaCl + 200 mM sucrose (lower graph) - open symbols - in comparison to 
base solution - closed symbols. All determinations were performed 3 times.  Error bars 
refer to data from base solution. 
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Figure 3.9.  Calibration curves of the NH4+-selective electrode in: 150 mM NaCl + 300 
mM sucrose (upper graph); 300mM NaCl only (lower graph) - open symbols - in 
comparison to base solution - closed symbols. All determinations were performed 3 
times. Error bars refer to data from base solution. 
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3.2 Calibration of the K+-selective electrode: 
Calibration of the K+-selective electrode was essential to determine if urinary [K+] could 
be measured sufficiently accurately to permit estimation of the [NH4+] in the presence of 
interferent concentrations of K+. 
 
3.2.1 Calibration of K+-selective electrode:  
Typical calibration data for a K+-selective electrode in 140 mM NaCl buffered to pH 6.0 
with 10 mM MES is shown in table 3.5. The corresponding calibration curve is displayed 
in figure 3.10.  
 
Table 3.5 Typical K+-selective electrode calibration data for calibration in 140 mM NaCl 
and 10 mM MES at pH 6.0. 
 
Nominal  
[K+], mM 
Actual  
[K+], mM  
E K+ (mV) 
0.10 0.10 -49.1 
0.20 020 -44.2 
0.40 0.40 -37.5 
1.0 0.99 -24.2 
2.0 1.96 -11.5 
4.0 3.91 3.4 
10 9.73 27.6 
20 19.3 45.4 
30 28.6 55.6 
40 37.8 63.8 
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Figure 3.10: Typical calibration curve of a K+-selective electrode in 140 mM NaCl and 
10 mM MES at pH 6.0. 
 
3.2.2 Selectivity of the K+-selective electrode: 
For the K+-selective electrode, the interferent ions of most concern were Na+, NH4+, Ca2+ 
and H+. We examined the individual and combined effects of each of these ions on the 
K+-selective electrode using the methods as for the NH4+-selective electrode.  
 
3.2.3   Na+ interference: 
To calculate Na+ interference, 40 calibration curves were performed in a base solution 
containing 140 mM NaCl + 10 mM MES (at pH 6.0). The mean value for 
 
logkKNa
pot
 was 
-2.91±0.33. The anti-logarithm of this value was equivalent to a mean 
 
kKNa
pot value of 
0.0012. This value was substituted into the Nikolsky-Eisenmann equation to calculate the 
potentiometric selectivity coefficients of the other interferent ions. 
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3.2.4.   NH4+ interference: 
The K+-selective electrode was tested in two different solutions containing 25 mM and 50 
mM background concentrations of NH4Cl. The K+-selective electrode was calibrated ten 
times in each solution to calculate a mean 
 
log kKNH4
pot  value of -1.63±0.06, equivalent to a 
mean 
 
kKNH 4
pot value of 0.0232. A mean calibration curve was produced from the ten 
calibrations for each background concentration of NH4+ and this was compared to a mean 
baseline calibration, see figure 3.11.  
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Figure 3.11. Mean calibration curves of a K+-selective electrode in a solution containing 
140 mM NaCl + 10 mM MES (closed circles – base solution), with a background of 25 
mM NH4Cl (open triangles), and background of 50 mM NH4Cl (open squares). Each 
determination was performed ten times, error bars refer to data in base solution. All 
solutions were at pH 6.0. 
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The figure shows that NH4+ at concentrations between 25 and 50 mM reduce the 
sensitivity of the K+-selective electrode, but is significant only at [K+] values less than 10 
mM.  However, the [K+] values measured in urine were always greater than 10 mM 
(below, section 3.4.2).  Thus, the measurement of urinary [K+] will be sufficiently 
accurate and unaffected by the urinary [NH4+] to permit correction of the NH4+ -
electrode reading for the interference caused by K+. 
 
3.2.5   Ca2+ interference: 
There was no detectable interference from Ca2+ on the K+-selective electrode when it was 
calibrated three times in a background concentration of 2 mM CaCl2. The resulting mean 
calibration curves for the background concentration of Ca2+ are shown in figure 3.12. 
 
3.2.6   H+ ion interference: 
There was no detectable interference caused by H+ ions on the K+-selective electrode 
when the electrode was calibrated in three solutions of varying pH (7.5, 6.5, and 5.5). The 
mean calibration curve for each pH can be seen in figure 3.13.  
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Figure 3.12. Mean calibration curves of K+-selective electrodes in a base solution (open 
symbols) and in the solution containing also 2 mM CaCl2. Error bars refer to data in base 
solution. 
 
 96 
-120
-100
-80
-60
-40
-20
0
20
0.1 1 10
    
 
 
 E K
+ (mV)
[K+] (mM)
  
 
 
  
 
 
  
 
 
  
 
 
 
Figure 3.13. Mean calibration curves of K+-selective electrodes in a base solution (closed 
symbols, pH 6) and in solutions buffered to pH 7.5 (open triangles), 6.5 (open squares) 
and 5.5 (open circles). All solutions contained 140 mM NaCl and 10 mM HEPES (pH 
6.0, 6.5 and 7.5) or 10 mM MES (pH 5.5). Error bars refer to data in base solution. 
 
The summarised values of 
 
logkKj
pot , 
 
kKj
pot , 
 
1 / kKj
pot and are summarised in table 3.6. 
Table 3.6. Values of 
 
logkKj
pot , 
 
kKj
pot , 
 
1 / kKj
pot  for the K+-ISE against potential interferent 
ions, mean±s.d. Not detectable, no significant deviation from calibration in base solution. 
 K+-ISE (room temperature) 
Interferent ion 
 
logkKj
pot  
 
kKj
pot  
 
1 / kKj
pot  
Na+ -2.91 + 0.33 0.0012 819.5 
NH4+ -1.63 + 0.06 0.0232 43.1 
H+ not detectable not detectable - 
Ca2+ not detectable not detectable - 
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3.2.7  Determination of the effect of osmolality on the K+-selective electrode: 
The K+-selective electrode was unaffected by changes in osmolality and ionic activity of 
the solution as seen by the unchanged 
 
kKNa
pot  values in the different solutions, using the 
protocols as described for similar measurements with the NH4+-selective electrode, 
section 3.1.6.  The values are summarized in table 3.7 and mean calibration curves shown 
in figure 3.14; they show that alterations to ionic strength and osmolality had no effect on 
the selectivity of the K+-ISE to K+ in the presence of Na+.  
 
 
 
 
Table 3.7.  Values of log
 
kKNa
pot  and 
 
kKNa
pot  in solutions of varying ionic strength and 
osmolality – see section 3.1.6 for further details 
Solution log
 
kKNa
pot  
Base solution (150 mM Na) -2.61±0.11 
50 mM NaCl  -2.72±0.08 
50 mM NaCl + 200 mM Sucrose  -2.88±0.25 
300 mM NaCl  -3.87±0.12 
150 mM NaCl + 300 mM Sucrose -3.69±0.21 
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Figure 3.14. Calibration curves of the K+-selective electrode in base solution (150 mM 
Na, closed circles); 50 mM NaCl (open triangles); 50 mM NaCl + 200 mM sucrose (open 
circles); 300 mM NaCl (crosses); and 150mM NaCl + 300mM sucrose (open squares). 
All determinations were performed three times. Error bars refer to data in base solution. 
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3.3 Characteristics of Patient Groups and Normal Subjects 
i) Normal subjects: these were entirely chosen from healthy members within the 
laboratory and with no history of renal stone disease / urological disease. The 
average age was 40 years and all were male. Only men were asked to provide 
samples for appropriateness and ease of providing a sample. 
 
ii) Patient subjects: patients who were attending the urology in-patient ward for a 
stone-related (on the whole) urology procedure were requested to take part. 
Volunteers who agreed were provided with a patient information sheet and a 
consent form to be completed and signed. Twenty-nine patients were able to 
provide urine samples, 28 were voided samples and one was a renal pelvic 
sample, obtained from flexible uretero-renoscopy. Unfortunately we were unable 
to collect any more renal pelvic samples since there was usually too little urine 
within the renal pelvis for sampling either during flexible uretero-renoscopy or 
during percutaneous nephrolithotomy (PCNL). The patient from whom a renal 
urine sample was obtained was because the person had a dilated renal pelvis or 
hydronephrosis allowing for more urine in the renal pelvis.  Of the 28 patients, 
14 each were male and female. For the female group the mean age was 
42.4±15.5 years; for the male group the mean was 52.1±14.6 years.  
 
iii) Patient subjects: a second group of patients was examined who attended an 
outpatient appointment at the Renal Stone Clinic at the Royal Free Hospital. 
This is a specialised clinic dealing with patients with recurrent stones and 
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problematic stones. Following clinical biochemical analysis of their renal stone 
and a full assessment, they received personalised advice, including advice on 
their diet, with a view to prevent further stone episodes. 
 
3.4   Urinary [NH4+] and [K+] measurements using the NH4+- and K+-selective 
electrodes at room temperature: 
 
Urine from normal subjects (group I, section 3.3):  Measurements were made by placing 
both ion-selective electrodes into the recording chamber and then adding a 4 ml sample 
of urine. A p.d. was recorded for each electrode. 
 
3.4.1 Sample calculations.  Urinary [K+] measurement: 
Due to the lack of significant interferent effects of other ions on the K+-selective 
electrode response the K+ concentration of urine samples was calculated first.  The 
electrode response may be approximated by a simplified version of the Nikolsky equation 
(equation 3, section 2.5.2) in which only the Na+ interference was taken into account: 
 
EK = E
0 + slog10([K
+])   7 
Note that ion concentrations rather than activities have been substituted into equation 7, 
and the justification for doing this was described in section 2.5.3. 
 
The mean urine [Na] was 52 mM, which yields a value for 
 
kKNa
pot [Na] of 0.0012*52 = 
0.0624 mM.  That is the Na+ in the urine sample will contribute to the K+-selective 
electrode a potential equivalent to this concentration of K+.  In a worst case of urinary 
[Na] = 300 mM the equivalent contribution would be equivalent to 0.36 mM K+. For this 
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reason the effect of interferent ions was ignored and the electrode K+-selective response 
curve described by the Nernst equation. 
 
EK = E
0 + slog10([K
+])   8 
E0 is merely an offset that moves the calibration curve along the y-axis but does not 
change the shape of the calibration curve and may be calculated from a fit of equation 7 
to the calibration curve data at noting the value of EK for 1 mM KCl, i.e. at 1 mM KCl  
EK = E0 as slog10(K+]) = 0 using a millimolar scale of concentrations.  Thus from 
equation 8: 
5.58
))0.29(2.56(10][ −−=+K     9 
As an example let the values from one urine sample be EK = 56.2 mV, E0 = -29.0 mV. 
The slope factor s is 58.5 mV.  From equation 9 
mM6.28
5.58
))0.29(2.56(10][ =−−=+K   
Note if the urinary Na interference was taken into account the value of the [K+] would be 
corrected down to 28.4 mM in the worst case and 28.5 mM if the mean [Na] was used.  In 
all subsequent data the [K+] values have been reduced by 0.1 mM from initial 
calculations using equation 9. 
 
3.4.2 Urinary [NH4+] measurement: 
K+ was the major interferent ion with a 
 
kNH 4 K
pot  value of 0.141. To calculate the true 
urinary [NH4+], a direct urinary [K+] measurement was required. Continuing with the 
above urine sample, where [K+] = 28.5 mM: 
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The ENH4 reading from the NH4+-selective electrode was 43.5 mV and from the 
calibration curve E0= -21.0 mV.  The slope factor is again 58.5 mV for a monovalent ion.  
The value of 
 
kNH 4 K
pot [K +] = 4.0 mM.  Thus the Nikolsky equation becomes. 
 
ENH4 = E
0 + slog10([NH4
+ + kNH4 K
pot [K +])  10 
thus,    
 
ENH4 − E
s
0
= log10([NH4
+ + kNH4 K
pot [K +])  
and   
 
10
ENH4 −E
s
0
= ([NH4
+ + 4.02) 
 
[NH4
+] = 10
43.5 − (−21.0))
58.5
 
 
 
 
− 4.0 = 8.7mM 
From this example it can be seen that correction for the [K+] is essential; if it was ignored 
the apparent [NH4+] = 12.7 mM. 
Note the contribution from the urine [Na+] is small.  For a 
 
kNH 4 Na
pot =0.00247 and a mean 
[Na+] = 52 mM the contribution to ENH4 would be equivalent to 0.1 mM.  This was not 
taken into account in subsequent calculations due to the much more significant 
interference from K+. 
 
3.4.3     Values of urinary [NH4+] and [K+] at room temperature: 
The urinary [NH4+] and [K+] in 28 urine samples were: 
 [NH4+]: 26.6 ± 11.5 mM.  Range, 8.7 - 55.2  mM 
[K+]: 44.8 ± 16.9 mM. Range 12.4 - 77.6 mM.   
The pH of the samples was 5.96±0.76 (range 4.97-7.33). Individual values are shown in 
Table 3.8.  
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Table 3.8.  Individual values of urinary [NH4+] and [K+] at room temperature. 
Urine 
Sample [K+], mM [NH4+], mM 
Urine 
Sample [K+], mM  [NH4+], mM 
1 28.4 8.7 15 42.2 38.0 
2 54.4 30.3 16 77.6 23.1 
3 59.8 30.2 17 63.9 22.6 
4 63.7 48.2 18 30.2 12.0 
5 20.3 13.1 19 56.8 19.5 
6 37.6 33.3 20 52.6 20.3 
7 56.8 40.7 21 30.8 19.9 
8 45.1 20.8 22 51.4 19.0 
9 45.7 29.5 23 60.2 28.2 
10 56.8 30.1 24 45.8 15.3 
11 34.8 31.0 25 55.8 41.8 
12 15.9 33.6 26 12.4 8.6 
13 16.6 55.3 27 63.6 26.6 
14 29.6 14.9 28 45.6 29.4 
 
 
3.4.4 The relationship between [NH4+] and [K+]: 
The urinary [NH4+] was plotted as a function of the urinary [K+], figure 3.15. There was 
no significant relationship between the two variables (r2=0.040).  
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Figure 3.15.  The relationship between urinary [NH4+] and urinary [K+]. 
 
3.4.5    Effects of storage on urinary [NH4+] and [K+]:  
If urine samples were to be obtained at distant centres it may be necessary to freeze the 
samples for subsequent storage and transport.  To determine if freezing altered the 
urinary [NH4+] and [K+], samples were frozen at -20°C for varying periods, thawed and 
then analysed. Seven samples were used to examine any effects of storage at -20 °C.  
Each sample was divided into two aliquots and one aliquot was analysed immediately 
after collection and kept at room temperature, whilst the other aliquot was kept in the 
freezer at -20 °C and then analysed after seven days of storage.   
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The mean value of urinary [NH4+] was 20.9±13.6 mM immediately after collection, day–
0. The aliquot kept at room temperature was analysed on day 2 and day 7 and the mean 
values of urinary [NH4+] were 21.7±12.0 and 29.2±16.5 mM respectively – see Table 3.9.  
ANOVA using comparisons between the groups showed no significant difference 
between the values obtained at days 0, 2 and 7.  Note: a non-parametric analysis of 
variance did reveal a significant increase of the median values for the values obtained 
from day 7 samples.  The median values (25 and 75% interquartiles are also shown for 
the data in table 3.9. 
 
Table 3.9: Effects of up to seven days storage at room temperature and -20oC on urinary 
[NH4+]. 
Urine 
Sample 
Day 0 
Room temp 
Day 2, 
Room temp 
Day 7, 
Room temp 
Day 7, 
Frozen 
1 18.3 21.7 49.6 16.9 
2 36.2 35.7 - 42.8 
3 42.5 38.6 47.2 36.3 
4 3.3 4.6 7.8 3.5 
5 15.5 20.6 30.4 16.7 
6 14.5 14.1 18.6 14.6 
7 16.1 16.6 21.5 13.1 
Mean 20.9 + 13.6 21.7 + 12.0 29.2 + 16.5 20.6  + 13.8 
Median 16.1 (15.0, 27.3) 20.6 (15.4, 28.7) 26.0 (19.3, 43.0) 16.7 (13.9, 26.6) 
 
 
Table 3.9 also shows values of urinary [NH4+] after seven days frozen storage, the mean 
value was 20.6±13.8 mM.  Paired t-test analysis showed no significant difference 
between these values and those at day 0.  It may be concluded that storage for up to seven 
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days as a frozen sample had no effect on the value of urinary [NH4+], whilst there was 
some evidence that storage at room temperature caused an increase.  Storage as a frozen 
urine sample was therefore used for such subsequent analyses.  Figure 3.16 shows the 
values of urinary [NH4+] when frozen for seven days, as a proportion of the values 
obtained at day 0. 
0.0
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Figure 3.16: Urinary [NH4+] in freshly voided and 7-day stored, frozen samples.  The 
values in the stored samples are expressed as a proportion of the freshly voided values in 
the same samples (n=7).  Mean data ± s.d. 
 
Table 3.10 shows values for urinary [K+] at day 0 and after seven days frozen storage.  
The mean values were 26.1±17.4 and 38.0±21.6 mM respectively.  Paired t-test analysis 
showed no significant difference between the two sets.  However, one sample (sample 3) 
showed a very large increase after seven days and will have skewed the data set.  A 
Wilcoxon rank test did show a significant difference (p=0.04) between the two data sets.  
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A larger data set will be required to determine if the seven days frozen storage does lead 
to an increase of urinary [K+]. There was no obvious cellular material in the urine 
samples and so the increase of urinary [K+] if real is unlikely to result from cell lysis as a 
result of storage. The reproducibility of the K+-selective electrode was very good and 
running the samples in duplicates was not required from reproducibility experiments. 
 
Table 3.10.  Urinary [K+] measured at day 0 and after seven days frozen storage at -20°C. 
Urine sample Time=0 7 days Frozen 
1 50.9 50.1 
2 47.0 55.1 
3 12.4 66.3 
4 7.9 10.5 
5 32.7 46.5 
6 16.6 18.4 
7 15.0 19.2 
Mean 26.1±17.4 38.0±21.6 
Median 16.6 (13.7, 39.9) 46.5 (18.8, 52.6) 
 
 
3.4.6    Validation of urinary [NH4+] measurements with a NH4+-selective electrode in 
comparison to colour spectrophotometry: 
 
Figure 3.17 shows the relationship between values for [NH4+] in the 28 individual urine 
samples described above as determined both by colour spectrophotometry (CS) and ion-
selective electrodes; the straight-line is the line of best fit close to the one of identity 
through the origin.  The sample values showed a large variability to enable validation of 
the ISE determinations over a wide range of concentrations.  The mean values were 
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26.3±12.5 by colour spectrophotometry and 26.6±11.5 mM by ion-selective electrode 
analysis, see table 3.11.  
0
10
20
30
40
50
60
0 10 20 30 40 50 60
   
     
y = 3.2001 + 0.8868x   R= 0.95901 
[NH
4
+] 
measured by 
Ion-Selective 
Method (mM)
[NH
4
+] measured by Colour Spectrophotometry (mM)
 
Figure 3.17: Comparison of urinary [NH4+] measurements using colour 
spectrophotometry (CS) and ion-selective electrodes (ISE).  The straight-line is a line of 
best fit, close to the line of identity, through the origin. 
 
The data fitted well a straight-line relationship and approximated well to the line of 
identity shown in figure 3.4.3.  The ratio of [NH4+] as determined by ISE and CS, 
R[NH4+], was 1.04±0.16 and was not significantly different from identity.  Moreover, there 
was no significant relationship between the value of R[NH4+] as a function of the [NH4+] 
 109 
as determined by CS (r2=0.152), showing that the values measured by the two methods 
were consistent over the entire range. 
 
Table 3.11. [NH4+] values from 28 samples as determined with CS and the ion-selective 
electrode.  The ISE data are the same as shown in Table 3.8.  Also shown are the pH 
values of the sample and the ratio of [NH4+] determined by ISE and CS, R NH4+. 
 CS ISE    CS ISE   
Urine 
Sample 
[NH4+], 
mM 
[NH4+], 
mM 
pH RNH4+ Urine 
Sample 
[NH4+]
, mM  
[NH4+], 
mM 
pH RNH4+ 
1 8.5 8.7 6.88 1.02 15 39.7 38.0 5.43 0.956 
2 29.1 30.3 5.86 1.04 16 26.3 23.1 5.68 0.878 
3 26.3 30.2 5.57 1.15 17 23.0 22.6 6.80 0.981 
4 47.8 48.2 5.25 1.01 18 8.7 12.0 7.00 1.38 
5 10.9 13.1 5.34 1.20 19 13.5 19.5 7.30 1.44 
6 31.1 33.3 5.39 1.07 20 18.7 20.3 6.70 1.08 
7 33.0 40.7 5.74 1.23 21 22.1 19.9 6.43 0.901 
8 22.3 20.8 7.04 0.932 22 18.1 19.0 4.97 1.05 
9 31.9 29.5 5.63 0.926 23 21.4 28.2 6.88 1.31 
10 33.0 30.1 5.69 0.916 24 16.6 15.3 5.49 0.919 
11 34.8 31.0 5.49 0.893 25 49.2 41.8 5.10 0.850 
12 32.9 33.6 5.46 1.02 26 7.8 8.6 7.33 1.10 
13 55.8 55.3 5.30 0.991 27 23.7 26.6 6.71 1.12 
14 15.2 14.9 5.10 0.979 28 36.4 29.4 5.45 0.808 
     Mean 26.3 26.6 5.96 1.04 
     ±sd ±12.5 ±11.5 ±0.76 ±0.16 
 
The same comparison between values for urinary [NH4+] obtained by CS and ISE was 
also available for the seven frozen samples analysed above.  The data are shown in Table 
3.12 and also show similar values obtained by the two methods.  The ratio, RNH4+ was 
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also not significantly different from unity, although the range of RNH4+ values was greater 
than above. 
 
Table 3.12. [NH4+] values from seven samples frozen for seven days, as determined with 
CS and the ion-selective electrode.  The ISE data are the same as shown in Table 3.9. 
Urine 
Sample 
CS 
[NH4+], 
mM 
ISE 
[NH4+], 
mM RNH4+ 
1 17.9 16.9 0.94 
2 34.6 42.8 1.24 
3 45.0 36.3 0.81 
4 2.4 3.5 1.46 
5 10.8 16.7 1.55 
6 8.5 14.6 1.72 
7 12.3 13.1 1.07 
Mean 18.8±15.4 20.6±13.8 1.25±0.34 
 
 
3.4.7    The pH-dependence of the [NH4+] at room temperature: 
Figure 3.18 shows the dependence of the urinary [NH4+] as a function of the voided pH, 
the [NH4+] values as determined by colour spectrophotometry and ion-selective 
electrodes are plotted.  There was a significant negative association between voided pH 
and [NH4+], whether the latter was estimated by colour spectrophotometry (r2=0.340) or 
with ion-selective electrodes (r2=0.263).  Straight-lines through the values yielded slopes 
of -9.6 mmoles.l-1 NH4+.pH unit-1 and -7.8 mmoles.l-1 NH4+.pH unit-1 respectively. The 
figure shows that four samples seemed to form a separate group in the lower left-hand 
side of the plot (their significance is considered in the Discussion).  Omission of these 
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values gave respective slopes of -13.5 (r2=0.792) and -11.2 (r2=0.675) mmoles.l-1 
NH4+.pH unit-1.   
 
0
10
20
30
40
50
60
4.5 5.0 5.5 6.0 6.5 7.0 7.5
[NH
4
+], mM
voided pH  
Figure 3.18. The variation of [NH4+] as a function of voided pH. The [NH4+] was 
measured by ion-selective electrodes (ISE, open squares) or colour spectrophotometry 
(CS, closed circles).  The dotted line is through the ISE data, solid line through the CS 
data.  The four boxed values were omitted from calculation of the straight-line plots.   
 
3.4.8 Summary of results at room temperature 
1. The urinary [NH4+] was measured in 28 urine samples with a mean value of 
26.6±11.5 mM.  It was necessary to measure simultaneously the [K+] as the 
concentration was large enough to affect significantly the electrode potential of the 
ion-selective electrode. 
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2. Storage of urine samples frozen at -20°C for up to seven days had no significant 
effect on measured urinary [NH4+] values.  However, there was some evidence that 
seven days storage at room temperature tended to increase urinary [NH4+], although 
storage for two days did not.  Urinary [K+] values increase after seven days from 
storage. 
3. The urinary [NH4+] measured with ion-selective electrodes was validated against a 
standard colour spectrophotometry method at room temperature.  There was an 
excellent correlation between the values estimated by the two methods in the same 
urine samples. 
4. Urinary [NH4+] decreased as a function of increasing voided pH.  This was not 
reproduced by titrating individual urine samples from voided pH to pH 5.0 and 7.5. 
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3.5   Urinary [NH4+] and [K+] measurements using the NH4+- and K+-selective 
electrodes at 37°C. 
Urine from the urology patient group subjects (group ii, section 3.3):  Measurement of 
[NH4+] and [K+] was carried out at room temperature in part to permit validation of the 
ion-selective electrode technique against a standard colour spectrophotometry assay that 
is conventionally performed under this condition and also because many other clinical 
biochemical assays are carried out at room temperature.  However, to measure [NH4+] 
and [K+] under more physiological conditions and describe more precisely the conditions 
that might lead to stone (struvite) formation in situ also required measurements carried 
out at 37°C.  To ensure accurate determination of the urinary [NH4+] at this temperature 
it was important to characterise the calibration curves at this temperature also, in 
particular to determine the temperature-dependence of the potentiometric selectivity 
coefficients. 
 
3.5.1   Calibration of NH4+-selective electrode at 37oC:  
Typical calibration data for the NH4+-selective electrode in 140 mM NaCl buffered to pH 
6.0 with 10 mM MES at 37oC are shown in Table 3.13.  The corresponding calibration 
curve is displayed in figure 3.19 and is compared to a calibration curve performed at 
room temperature; data from Tables 3.1.  The values of ENH4 at 40 mM NH4Cl have been 
normalised to zero mV to allow better comparison of the two curves.  At lower [NH4Cl] 
the calibration curve at 37°C deviated more from a Nernstian straight-line relationship 
indicating that interference from Na+ in this case was greater at the elevated temperature 
– section 3.5.2. 
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Table 3.13 Typical NH4+-selective electrode calibration data for calibration in 140 mM 
NaCl and 10 mM MES at pH 6.0 at 37oC. 
Nominal 
[NH4+], mM 
Actual  
[NH4+], mM  E NH4+ (mV) 
0.200 0.200 -73.1 
0.400 0.398 -65.0 
1.00 0.99 -52.8 
2.00 1.96 -40.0 
4.00 3.91 -27.0 
10.0 9.73 -5.6 
20.0 19.27 12.0 
30.0 28.6 22.4 
40.0 37.8 29.8 
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Figure 3.19.  Calibration curve for NH4+-selective electrodes in 140 mM NaCl and 10 
mM MES at pH 6.0 at room temperature (open symbols) and 37oC (closed symbols).  
Values have been normalized to 0 mV for the ENH4 in 40 mM NH4Cl.  The lines are a fit 
of equation 6. 
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3.5.2    Selectivity of the NH4+-selective electrode at 37oC: 
To calculate Na+ interference on the NH4+-selective electrode at 37oC, 20 calibration 
curves were performed in a background solution containing 140 mM NaCl + 10 mM 
MES (pH 6.0) at 37oC. The mean log
 
kNH 4 Na
pot  was -2.40+0.11, equivalent to a mean 
 
kNH 4 Na
pot  
value of 0.00402.  The log
 
kNH 4 Na
pot value was significantly lower than obtained at room 
temperature, indicating greater interference from Na+ at the raised temperature.  
 
To calculate K+ interference on the NH4+-selective electrode, 10 calibrations were 
performed in four baseline solutions containing 2 mM, 5 mM, 25 mM, and 50 mM KCl. 
The mean log
 
k
NH4K
pot  and 
 
k
NH4K
pot values for each K+ concentration are shown in Table 3.14. 
 
Table 3.14. 
 
k
NH4K
pot values of the NH4+-selective electrode in four different background 
concentrations of K+ at room temperature and 37oC 
K+ 
concentration 
(mM) 
NH4+-ISE 
Room temperature 
 
Mean log
 
k
NH4K
pot  
Mean 
 
k
NH4K
pot  
Mean 
 
k
NH4K
pot  
Overall 
Mean 
 
k
NH4K
pot  
2 -0.84 ± 0.038 0.143  0.140 ± 
0.003 0.141 ± 
0.025 
 
5 -0.86 ± 0.029 0.137 
25 -0.85 ± 0.010 0.141 0.141 ± 
0.008 50 -0.85 ± 0.007 0.142 
 
37oC 
 
2 -0.65 ± 0.037 0.224 0.223 ± 
0.027 0.208 ± 
0.038 
 
5 -0.65 ± 0.015 0.222 
25 -0.71 ± 0.013 0.194 0.195 ± 
0.010 50 -0.71 ± 0.008 0.195 
 
 116 
The modulus of the values for -log
 
k
NH4K
pot  were smaller at 37°C than at room temperature, 
indicating a greater interference from K+ at the higher temperature.  The mean 
-log pot
KNH4
k ++ value from the 20 calibration curves in 25 mM and 50 mM KCl 
concentrations was -0.71±0.01, equivalent to a mean 
 
k
NH4K
pot value of 0.195, and this figure 
was substituted into the Nikolsky equation with the urinary [K+], to obtain the 
contribution due to K+, and thus evaluate the true urinary [NH4+].  At lower background 
concentrations of K+ (2 mM and 5 mM) the mean -log
 
k
NH4K
pot value was significantly 
smaller (0.223±0.027) indicating that K+ interference was greater.  Thus the extent of 
interference from K+ is concentration-dependent, less at higher [K+].  Because the mean 
[K+] of the urine values was 44.8 mM ± 16.9, the 
 
k
NH4K
pot  value of 0.195 (from the mean 
 
k
NH4K
pot obtained from the 25 mM and 50 mM background KCl concentration calibration) 
was chosen to substitute into the Nikolsky equation to calculate the contribution due to 
K+. The mean calibration curves in the four different [K+] solutions, as well as the base 
solution, are shown in figure 3.20.  
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Figure 3.20. Calibration curves of NH4+ selective electrode in 140 mM NaCl + 10 mM 
MES (base solution) (buffered to pH 6, open circles) and background concentrations of 2 
mM (open triangles), 5 mM (open squares), 25 mM (open diamonds) and 50 mM 
(crosses) KCl at 37°C. Error bars refer to data in base solution. 
 
3.5.3  Calibration and selectivity of K+-selective electrode at 37oC:  
Typical calibration data for the K+-selective electrode in 140 mM NaCl buffered to pH 
6.0 with 10 mM MES at 37oC is shown in Table 3.15. The corresponding calibration 
curve is displayed in Figure 3.21 and is compared to a calibration curve performed at 
room temperature.  The EK values were normalised to 0 mV for the highest [K+] used (40 
mM) as in Figure 3.19. 
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Table 3.15. Sample K+-selective electrode calibration data for calibration in 140 mM 
NaCl and 10 mM MES at pH 6.0 at 37°C 
Nominal 
[K+], mM 
Actual  
[K+], mM E K+ (mV) 
0.1 0.10 28.3 
0.2 0.20 33.3 
0.4 0.40 40.9 
1 0.99 59.7 
2 1.97 74.6 
4 3.91 88.9 
10 9.73 111.3 
20 19.3 128.8 
30 28.6 138.3 
40 37.8 146.3 
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Figure 3.21. Mean calibration curves of K+-selective electrodes in 140 mM NaCl and 10 
mM MES (pH 6.0) at 37oC (closed symbols) and at room temperature (open symbols). 
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To calculate Na+ interference on the K+-selective electrode at 37oC, 20 calibration curves 
were performed in a background solution containing 140 mM NaCl + 10 mM MES (pH 
6.0) at 37oC. The mean log
 
kKNa
pot  was -2.76±0.10, equivalent to a mean 
 
kKNa
pot  value of 
0.00173, i.e. the K+-selective electrode is 578 times more selective for K+ than Na+ at 
37oC.  This selectivity for K+ compared to Na+ was not significantly different from the 
value at room temperature, section 3.2.2. 
 
To calculate NH4+ interference on the K+-selective electrode, 10 calibrations were 
performed in two baseline solutions containing 25 mM, and 50 mM NH4Cl. The mean 
log
 
kKNH 4
pot  and 
 
kKNH 4
pot values for each K+ concentration are shown in Table 3.16.   
 
Table 3.16. Comparison of NH4+ interference values, 
log
 
kKNH 4
pot , on the K+-selective 
electrode in 25 and 50 mM NH4Cl at room temperature and 37oC 
Background 
[NH4+] 
(mM) 
K+- ISE 
ROOM TEMPERATURE 
Mean log
 
kKNH 4
pot  
 
kKNH 4
pot  
Overall Mean 
 
kKNH 4
pot  
25 -1.580 + 0.038 0.026 0.023 + 0.064 
 50 -1.689 + 0.025 0.020 
 37oC 
25 -1.577 + 0.030 0.026 0.025 + 0.035 
 50 -1.611 + 0.032 0.024 
 
The mean log
 
kKNH 4
pot value from the 20 calibration curves in 25 mM and 50 mM KCl 
concentrations was -1.59±0.035, equivalent to a mean 
 
kKNH 4
pot value of 0.025, meaning that 
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the K+-selective electrode is 40 times more selective for K+ than for NH4+. This 
interference is not significantly different from that measured at room temperature, section 
3.2.2.  The mean calibration curves in the two solutions are shown in figure 3.22.  
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Figure 3.22.  Mean calibration curves of the K+-selective electrode in 140 mM NaCl + 10 
mM MES (buffered to pH 6, closed circles) and in a background concentration of 25 mM  
(open triangles) and 50 mM (open squares) NH4Cl at 37oC. Error bars refer to data in 
base solution. 
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3.6   Values of urinary [NH4+] and [K+] measured at 37oC: 
Twenty-four patients attending the in-patient ward for urology operations were recruited. 
Each was nil-by-mouth from midnight to reduce the effects of dietary intake on urinary 
NH4+. Samples were obtained between 7 and 8 am, to minimise diurnal variability.  
 
3.6.1   Urinary values of [NH4+] and [K+]: 
Urinary [NH4+] and [K+] were 15.0±9.8 and 35.9±15.8 mM respectively, n=28. The 
ranges of values were 1.12 - 44.1 and 11.2 - 72.3 mM respectively.  The voided pH of the 
samples was 6.70±0.92 (range 5.50 - 8.52). These values are shown in table 3.17.  
 
Table 3.17.  Individual values of urinary [NH4+], [K+] and voided pH at 37°C. 
Urine 
Sample 
[K+], 
mM 
[NH4+], 
mM 
Voided 
pH 
Urine 
Sample 
[K+], 
mM  
[NH4+], 
mM 
Voided 
pH 
1 12.9 7.3 6.10 13 51.0 14.2 7.55 
2 28.9 25.3 8.20 14 44.6 16.3 6.85 
3 72.3 44.1 5.65 15 35.4 13.6 6.21 
4 28.5 11.2 5.60 16 44.4 11.1 6.85 
5 50.6 24.6 5.68 17 19.7 13.1 6.48 
6 45.4 18.8 5.64 18 32.8 17.4 7.27 
7 38.0 1.1 7.70 19 28.9 4.6 6.60 
8 26.0 19.0 6.10 20 40.9 4.7 6.37 
9 37.4 7.0 5.50 21 11.2 18.8 8.10 
10 24.9 34.1 6.93 22 25.4 15.3 5.30 
11 22.0 14.8 8.52 23 47.2 6.6 7.55 
12 22.0 12.5 6.97 24 71.3 6.5 6.96 
    Mean 35.9 15.0 6.70 
    ±sd 15.8 9.8 0.92 
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3.6.2 The relationship between urinary [NH4+] and [K+]. 
Figure 3.23 plots the value of urinary [NH4+] as a function urinary [K+] at voided pH.  
There was no significant relationship between the two variables. This lack of significant 
relationship was also observed at room temperature (section 3.4.3). 
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Figure 3.23: The relationship between urinary [K+] and urinary [NH4+] at the voided pH 
of urine. 
 
3.6.3 The pH dependence of urinary [NH4+] at 37°C. 
The variability of urinary [NH4+] as a function of voided pH at 37°C was plotted, as it 
was for room temperature data (Figure 3.18, section 3.4.7).  The relationship is shown in 
Figure 3.24. 
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Figure 3.24.  Urinary [NH4+] plotted as a function of voided pH, measured at 37°C. 
 
A negative relationship between the two variables was recorded, as for measurements at 
room temperature.  However, the association failed to achieve statistical significance at 
37°C (r2 = -0.066).  
 
 3.6.4  Effect of adjusting urinary pH to 6.0 on urinary [NH4+] and [K+]: 
The difference at room temperature and 37°C regarding the pH-dependency of the 
[NH4+] may reflect intrinsic variability of the data between samples as a trend was 
observed at 37°C and a strong relationship at room temperature. The potential pH-
dependence of the value of the urinary [NH4+] at 37°C was further investigated by 
altering the pH of individual samples and successively measuring the [NH4+].  
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The data from urine samples at 37°C (Table 3.17) are also shown in Tables 3.18 and 
3.19, but in this instance values for urinary [NH4+] and [K+] are also shown when pH was 
adjusted to pH 6.0.   Each urine sample was divided into two aliquots. The first was 
tested at voided pH for urinary [NH4+] and [K+] as above. The pH of the second aliquot 
was adjusted to 6.0 by addition of NaOH or HCl. The objective was to analyse the effect 
of pH on the values of [NH4+] and [K+] and to determine the variability of the values at a 
fixed pH value.  
 
Urinary [NH4+] and [K+] in the 24 urine samples were significantly greater (paired t-test) 
at pH 6.0 than at the voided pH, i.e. 6.70±0.92.  The values at pH 6.0 were 19.1±12.4 and 
40.8 ±17.6 mM respectively. The ranges of values were 3.4–49.3 and 17.4–90.5 mM 
respectively and individual results are shown in Table 3.18 and 3.19. Shown are the 
values of urinary [NH4+] and [K+] as well as the change of [NH4+] and [K+] (∆[NH4+] 
and ∆[K+]) as the pH was adjusted.  Negative values for ∆[NH4
+] and ∆[K+] mean that 
the concentration was less at pH 6.0 than at voided pH.  For the ∆pH values, these are 
negative if the pH was adjusted in an alkaline direction to achieve pH 6.0 and vice versa. 
The summaries at the bottom of the tables show mean (±SD) and median (25,75% IQs) 
values, as the data sets appear skewed. 
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Table 3.18.  Values of urinary [NH4+] at voided pH and pH 6.0 and the change of 
[NH4+], ∆[NH4+].  Values of voided pH and ∆pH to achieve pH=6.0 are also listed 
Urine 
Sample 
[NH4+], mM ∆[NH4+] Voided pH ∆pH 
Void pH pH 6.0    
1 7.3 5.4 -1.9 6.10 0.10 
2 25.3 45.8 20.5 8.20 2.20 
3 44.1 37.1 -7.0 5.65 -0.35 
4 11.2 9.2 -2.0 5.60 -0.40 
5 24.6 23.9 -0.7 5.68 -0.32 
6 18.8 12.3 -6.5 5.64 -0.36 
7 1.1 3.4 2.3 7.70 1.70 
8 19.0 21.8 2.8 6.10 0.10 
9 7.0 9.5 2.5 5.50 -0.50 
10 34.1 41.1 7.0 6.93 0.93 
11 14.8 21.9 7.1 8.52 3.52 
12 12.5 13.8 1.3 6.97 0.97 
13 14.2 17.6 3.4 7.55 1.55 
14 16.3 18.5 2.2 6.85 0.85 
15 13.6 15.0 1.4 6.21 0.21 
16 11.1 15.3 4.2 6.85 0.85 
17 13.1 15.6 2.5 6.48 0.48 
18 17.4 18.6 1.2 7.27 1.27 
19 4.6 5.9 1.3 6.60 0.60 
20 4.7 11.0 6.3 6.37 0.37 
21 18.8 49.3 30.5 8.10 2.10 
22 15.3 22.0 6.7 5.30 -0.70 
23 6.6 12.9 6.3 7.55 1.55 
24 6.5 12.5 6.0 6.96 0.96 
Mean (SD) 15.1±9.7 19.1±12.4 4.1±7.7 6.70±0.92 0.74±1.02 
Median (IQ) 
13.9 
(7.2,18.8) 
15.5 
(12.0,21.9) 
2.5 
(1.3,6.3) 
6.72 
(6.00,7.34) 
1.02 
(-0.01,1.34) 
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Table 3.19.  Values of urinary [K+] at voided pH and pH 6.0 and the change of [K+], 
∆[K+].  Values of voided pH and ∆pH to achieve pH=6.0 are also listed 
Urine 
Sample 
[K+], mM ∆[K+] Voided pH ∆pH 
Void pH pH 6.0    
1 12.9 18.6 5.7 6.10 0.10 
2 28.9 38.6 9.7 8.20 2.20 
3 72.3 90.5 18.2 5.65 -0.35 
4 28.5 39.5 11 5.60 -0.40 
5 50.6 67.8 17.2 5.68 -0.32 
6 45.4 46.9 1.5 5.64 -0.36 
7 38.0 48.2 10.2 7.70 1.70 
8 26.0 19.1 -6.9 6.10 0.10 
9 37.4 40.7 3.3 5.50 -0.50 
10 24.9 30.1 5.2 6.93 0.93 
11 22.0 33.6 11.6 8.52 3.52 
12 22.0 28.1 6.1 6.97 0.97 
13 51.0 53.1 2.1 7.55 1.55 
14 44.6 40.8 -3.8 6.85 0.85 
15 35.4 33.4 -2 6.21 0.21 
16 44.4 44.5 0.1 6.85 0.85 
17 19.7 17.4 -2.3 6.48 0.48 
18 32.8 47.4 14.6 7.27 1.27 
19 28.9 37.7 8.8 6.60 0.60 
20 40.9 44.7 3.8 6.37 0.37 
21 11.2 18.4 7.2 8.10 2.10 
22 25.4 21.5 -3.9 5.30 -0.70 
23 47.2 51.0 3.8 7.55 1.55 
24 71.3 67.5 -3.8 6.96 0.96 
Mean (SD) 35.9±15.7 40.8±17.6 4.9±6.9 6.70±0.92 0.74±1.02 
Median (IQ) 
34.1 
(25.2,44.8) 
40.1 
(29.6,47.6) 
4.5 
(-0.4,9.8) 
6.72 
(6.00,7.34) 
1.02 
(-0.01,1.34) 
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The data for the ∆[NH4+] and ∆[K+] as a function of ∆pH are plotted in Figure 3.25 
(urinary [NH4+]) and Figure 3.26 (urinary [K+]). Figure 3.25 shows that an increase of 
[NH4+] (positive ∆[NH4+]) was significantly associated with acidification of the urine 
(positive ∆pH: r2=0.396, p<0.05). Figure 3.26 shows a similar plot for the change of [K+] 
(∆[K+] ) where no significant relationship was observed with ∆pH (r2=0.023).  Thus, as 
the urine was made more acid the [NH4+] increased (or the [NH4+] decreased as urine 
was alkalinised).  
 
Figure 3.25. Change of urinary [NH4+], ∆[NH4+], as a function of alteration of pH, ∆pH, 
from the voided value to pH 6.0.  
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Figure 3.26. Change of urinary [K+], ∆[K+], as a function of alteration of pH, ∆pH, from 
the voided value to pH 6.0.  
 
3.6.5 Summary of results at 37°C 
1. The NH4+ and K+-selective electrodes showed a similar performance at 37°C as at 
room temperatures.  There was slight variation in the selectivity to interferent ions 
but did not limit their use in urine samples.  Of most significance was a 
concentration-dependence on the interference of K+ on the NH4+-selective 
electrodes. 
2.  The urinary [NH4+] was measured in 24 urine samples with a mean value of 
15.1±9.7 mM at the voided pH (6.70±0.92).  The urinary [K+] in the same 
samples was 35.9±15.8 mM. 
3. There was no significant relationship between urinary [NH4+] and voided pH as 
measured at room temperature. However, if the pH was adjusted to pH 6.0 mean 
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urinary [NH4+] increased.  There was significant relationship between the change 
of urine pH and urinary [NH4+]: if pH was reduced urinary [NH4+] increased and 
if pH was increased urinary [NH4+] decreased.  There was no dependence of 
urinary [K+] on voided pH or changes to urine pH.  
 
 
3.7  Urinary [NH4+] and [K+] from patients at a Renal Stone Clinic:  (group iii, 
section 3.3): 
 
3.7.1 Measured values of urinary [NH4+] and [K+] at room temperature and 37°C. 
This group of patients represented a different cohort or people and it was of interest to 
determine if the measured urinary [NH4+] and [K+] values, measured at 37oC and room 
temperature, were different from the previous groups.  In addition, because these 
measurements were carried out at the two temperatures on the same samples any 
temperature-dependence was more easily compared.  Table 3.20 shows the values of 
urinary [NH4+] and [K+] measured at both room temperature and at 37oC and the mean 
values are summarised in Figure 3.26.  The urinary osmolality and voided pH were also 
measured and recorded in Table 3.20.   
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Table 3.20: Urinary values of [NH4+] and [K+] measured at room temperature and 37oC 
from patients attending the renal stone clinic (RFH).   
Urine 
Sample 
[NH4+] 
mM 
RT  
[NH4+] mM 
37°C  
[K+] mM 
RT  [K+] mM 
37°C  
Urine 
osmolality 
mOsm.kg-1 
Voided 
pH 
1 29.9 33.1 40.2 54.8 804 5.44 
2 15.8 17.4 42.7 49.0 664 6.83 
3 14.2 13.9 33.9 39.4 464 5.78 
4 11.8 11.1 44.9 64.2 575 7.74 
5 5.7 4.9 10.0 10.6 177 7.33 
6 4.8 3.5 29.2 35.5 321  
7 9.3 8.7 22.9 25.0 238 6.99 
8 10.3 9.5 31.9 33.1 495 5.05 
9 5.6 1.6 41.0 59.6 516 7.90 
10 4.8 2.7 36.4 44.3 432 8.24 
11 14.5 11.2 47.8 72.4 833 7.50 
12 2.9 2.8 7.6 8.3 87 6.00 
13 27.2 30.9 26.9 38.8 840 5.08 
14 8.3 6.7 52.0 58.3 463 7.38 
15 25.6 28.9 24.9 33.8 458 6.61 
16 5.0 3.9 56.2 65.0 474 6.96 
17 4.9 5.0 7.9 7.9 110 6.89 
18 26.8 30.6 32.3 45.7 584 5.85 
19 12.8 14.9 18.9 31.8 461 6.97 
20 11.7 9.8 29.2 35.4 631 6.34 
21 34.3 38.4 29.6 41.7 970 5.79 
22 14.2 13.5 26.5 35.8 395 6.37 
23 14.4 13.0 20.1 22.0 636 7.55 
24 16.1 15.2 24.0 25.2 183 5.15 
Mean 13.8 13.8 30.7 39.1 492 6.60 
SD 8.9 10.8 13.0 17.7 234 0.94 
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The mean values are summarized in figure 3.27. 
 
Figure 3.27  Urinary [NH4+] and [K+] at room temperature and 37oC.  Mean values ± SD. 
  
There was no significant difference between the urinary [NH4+] measurements made at 
room temperature and those made at 37oC; however, the urinary K+ values were 
significantly higher (Student’s paired t-tests).      
 
Figure 3.28 shows the relationship between the [NH4+] measurements at the two 
temperatures, with a good correlation between the two sets of data (r2 = 0.98).  The figure 
also shows the line of identity (solid line) and the best-fit line (dotted line).  The two were 
not exactly superimposable with the best-fit line having a positive intercept on the 
abscissa (2.8 mM) and a slope of 1.20.  
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[NH4+]@37°C = 1.20*[NH4+]@RT – 2.78 
Thus [NH4+]@37°C  = [NH4+]@RT at 13.9 mM, which is almost the mean value (table 
3.7.1).  At values lower than this [NH4+]@RT tends to overestimate [NH4+]@37°C and 
underestimate it at higher values.  For the highest value at RT (34.3 mM) this represented 
an estimated underestimate of 4.1 mM at 37°C, whilst for the lowest value at RT (2.9 
mM) it represented an overestimate of 2.2 mM. 
 
Figure 3.28.  The [NH4+] measured at 37°C and at room temperature from urine samples 
of patients at the Renal Stone Clinic.  The line of identity (solid line) and the best-fit line 
(dotted line ) are shown 
 
For the [K+] measurements there was a greater discrepancy between the two data sets, as 
evidenced by the paired t-test comparison above, although there was also a significantly 
significant association between the two sets of data (r2=0.91). Figure 3.29 plots the paired 
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[K+] values at RT and 37°C; the line of best-fit showed an intercept on the abscissa at 0.7 
mM, but with a slope of 1.30. Thus equivalent values were obtained at 2.4 mM.  In this 
case the highest and lowest values at RT (56.2 and 7.6 mM) were underestimated 
compared to calculated values at 37°C by 14.2 and 1.5 mM respectively.  
 
Figure 3.29.  The [K+] measured at 37°C and at room temperature from urine samples of 
patients at the Renal Stone Clinic.  The line of identity (solid line) and the best-fit line 
(dotted line) are shown. 
 
3.7.2 The dependence of urinary [NH4+] and [K+] on urine osmolality. 
Figure 3.30 and 3.31 show a positive association between urine osmolality and urinary 
[NH4+] (r2=0.487, 0.311; ion-selective data at room temperature and 37°C respectively) 
and [K+] (r2=0.307, 0.368; room temperature and 37°C).  
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Fig 3.30.  The association between urinary [NH4+] and osmolality.  The [NH4+] values 
were measured at room temperature (open circles) or at 37°C (closed circles). 
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Fig 3.31.  The association between urinary [K+] and osmolality.  The [K+] values were 
measured at room temperature (open circles) or at 37°C (closed circles). 
 135 
3.7.3 The dependence of urinary [NH4+] and [K+] on urine voided pH. 
Previous sections determined any association between values of urinary [NH4+] and [K+] 
and voided pH and this was also possible in samples from this cohort of patients.  Figure 
3.32 shows a significant negative association between urinary [NH4+] and voided pH, 
whether [NH4+] was measured at room temperature (r2=0.25, p=0.015) or at 37°C 
(r2=0.34, p=0.003). 
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Fig 3.32.  The association between urinary [NH4+] and voided pH.  The [NH4+] values 
were measured at room temperature (open circles) or at 37°C (closed circles). 
 
The values of urinary [K+] as a function of voided pH are shown in Figure 3.33 and no 
significant relationship was observed at room temperature (r2=0.04, p=NS) or at 37°C 
(r2=0.05, p=NS). 
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Fig 3.33.  The association between urinary [K+] and voided pH.  The [K+] values were 
measured at room temperature (open circles) or at 37°C (closed circles). 
 
3.7.4 Summary of measured urinary [NH4+] and [K+]. 
The data in sections 3.4 and 3.6 have demonstrated urinary [NH4+] and [K+] at the two 
temperatures using urine samples from a non-stone forming population.  The data in 
section 3.7 used samples from a stone-forming group.  It was of interest to determine if 
there were differences in values between samples from the two cohorts of volunteers.  
Table 3.21 shows these data. 
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Table 3.21 Values of urinary [NH4+] and [K+] in urine samples from a non-stone forming 
and a stone-forming cohort of volunteers, * p<0.05 non-stone former vs stone formers at 
RT. 
 Non-stone 
formers 
Stone formers 
RFH patients (stone 
clinic) 
UCLH 
patients(operative) 
Room temp Room temp 37°C 37°C 
[NH4+], mM 26.1±11.5 * 13.8±8.9 13.8±10.8 15.0±9.8 
[K+], mM 44.8±16.9 30.7±13.0 39.1±17.7 35.9±15.8 
Voided pH 5.96±0.76 * 6.60±0.94 6.60±0.94 6.70±0.92 
 
The urinary [NH4+] and voided pH were significantly different in the non-stone formers 
samples measured at room temperature.  Because the voided pH was significantly more 
acid in the latter group this may account for the significantly greater [NH4+]. In addition, 
the increased alkalinity of urine in the stone formers group may certainly be contributory 
to their increased stone deposition (see Discussion, section 4.6.4). 
 
Figure 3.34 provides further evidence that all four sets of data came from similar groups.  
All the data summarized in Table 3.21 are plotted as a function of voided pH.  It is 
difficult to separate any individual data set apart from the remainder.  This plot 
emphasizes the crucial importance of recording voided pH when measuring urinary 
[NH4+], if it is not possible to standardize the pH prior to the measurement.  The plot also 
indicates that there was no difference per se in the values of urinary [NH4+] in samples 
from a non-stone forming and stone forming group. 
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Fig 3.34.  The association between urinary [NH4+] and voided pH in urine samples 
analysed at room temperature (closed symbols) and at 37°C (open symbols): non-stone 
formers (closed circles), RFH stone formers at room temperature (closed squares), RFH 
stone formers at 37°C (open squares), and UCLH stone formers at 37°C (open circles). 
 
3.7.5 Validation of the algorithm for calculation of the urinary [NH4+]: 
Table 3.22 shows urinary values of [NH4+] measured by the NH4+-selective electrode and 
the values obtained by the algorithm to calculate urinary values, see Methods, section 2.8. 
Some values produced by the algorithm were negative suggesting that it is not an 
accurate estimate of the urinary [NH4+]. The measured values obtained at room 
temperature were used, although similar conclusion in the analysis below were obtained 
if the data at 37°C were used. 
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Table 3.22: Calculated urinary [NH4+] compared to ion-selective electrode values 
Urine 
Sample 
Calculated 
[NH4+] 
(mM) 
ISE 
[NH4+] 
(mM) 
Urinary 
pH 
Urine 
Sample 
Calculated 
[NH4+] 
(mM) 
ISE 
[NH4+] 
(mM) 
Urinary 
pH 
1 28.0 29.9 5.44 13 30.0 27.2 5.08 
2 5.0 15.8 6.83 14 -7.0 8.3 7.38 
3 21.5 14.2 5.78 15 25.5 25.6 6.61 
4 -8.5 11.8 7.74 16 -4.0 5.0 6.96 
5 0 5.7 7.33 17 2.0 4.9 6.89 
6 -4.5 4.8 - 18 30.0 26.8 5.85 
7 8.0 9.3 6.99 19 11.0 12.8 6.97 
8 7.5 10.3 5.05 20 15.0 11.7 6.34 
9 8.5 5.6 7.90 21 49.5 34.3 5.79 
10 -3.5 4.8 8.24 22 18.0 14.2 6.37 
11 4.0 14.5 7.50 23 -2.5 14.4 7.55 
12 2.0 2.9 6.00 24 11.0 16.1 5.15 
    Mean  10.3 13.8 6.60 
    SD 14.5 8.9 0.94 
 
Figure 3.35 shows a plot of the calculated values as a function of the measured values.  
Apart from the negative calculated values the association was significant (r2=0.54), but 
the straight-line fit has a slope of 1.41 with an intercept on the y-axis of -9.1 mM.  
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Figure 3.35.  Calculated values of urinary [NH4+] as a function of measured values using 
an ion-selective electrode. 
 
Figure 3.36 plots the differences between the calculated and measured values as a 
function of the measured [NH4+].  In most cases the calculated value was smaller than the 
measured value.  However, there was no significant association between the two values 
(r2=0.20) so that the difference is not a proportional error between the two values. 
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Figure 3.36.  The difference between calculated and measured values of urinary [NH4+] 
as a function of measured values. 
 
Figure 3.37 plots the difference between the calculated and measured values as a function 
of urinary pH. At pH values above 6.0 there was a systematic and growing deviation 
between the two values.  This suggests there is an in-built error in the calculation 
algorithm that is pH-dependent, or that the measured values have an error inherent in the 
pH-dependence of the ion-selective electrodes.  The latter possibility is considered less 
likely due to the rigorous attempts to correct for any such behaviour. 
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Figure 3.37.  The difference between calculated and measured values of urinary [NH4+] 
as a function of urine pH. 
 
Finally, figure 3.38 plots the pH-dependence of the calculated and measured values of 
urinary [NH4+] values.  In both cases pH declined significantly as a function of increasing 
pH, with r2 values of 0.42 and 0.30 respectively. 
. 
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Figure 3.38.  Calculated (closed symbols) and measured (open symbols) values of urinary 
[NH4+] as a function of urine pH.  
 
3.7.6 Urinary [NH4+] in ‘struvite’ vs ‘non-struvite’ patients: 
Analysis was performed on the sub-groups within patients attending for an operation at 
UCLH. The mean urinary [NH4+] was unchanged (15.0, 15.3 and 15.2 mM) amongst the 
three sub-groups (those with various stones, previous struvite stones and those currently 
presenting with struvite stones).  
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Table 3.23.  Urinalysis of patients with struvite and non-struvite stones. 
Urine 
Sample 
[NH4+] 
 
[K+] Voiding pH Stone type Current 
previous 
Gender Age 
Various stones 
1 7.3 12.9 6.10 CaOx/CaPO4 current F 26 
3 44.1 72.3 5.65 Urate (99%) / CaOx current M 63 
4 11.2 28.5 5.60 CaOx (100%) current F 34 
5 24.6 50.6 5.68 Operation cancelled - M 54 
6 18.8 45.4 5.64 CaOx (99%)/CaPO4  previous F 55 
13 14.2 51.0 7.55 CaOx/CaPO4  previous F 48 
14 16.3 44.6 6.85 CaOx (98%)/CaPO4 current M 47 
15 13.6 35.4 6.21 CaOx  (97%)/CaPO4  current M 52 
16 11.1 44.4 6.85 no stone  previous F 15 
17 13.1 19.7 6.48 stones - cystinuria previous M 32 
18 17.4 32.8 7.27 no stone - F 43 
20 4.7 40.9 6.37 CaPO4 (79%)/ CaOx  current F 44 
23 6.6 47.2 7.55 CaOx (89%)/ CaPO4 current M 40 
24 6.5 71.3 6.96 Bladder TCC - M 60 
Mean 15.0 42.7 6.5 - - - 44 
Previous Struvite 
7 1.1 38.0 7.70 Struvite (13%)/CaPO4 previous F 55 
8 19.0 26.0 6.10 Struvite (80%)/CaPO4 previous F 22 
9 7.0 37.4 5.50 Struvite (36%)/CaPO4 previous F 56 
10 34.1 24.9 6.93 Struvite(27%)/CaPO4 previous F 42 
Mean 15.3 31.6 6.6 - - - 44 
Current Struvite 
2 25.3 28.9 8.20 Struvite (22%)/CaPO4 current M 67 
11 14.8 22.0 8.52 Struvite (37%)/CaPO4 current F 73 
19 4.6 28.9 6.60 Struvite (7%)/CaPO4 current F 48 
21 18.8 11.2 8.10 Struvite (20%)/CaPO4 current F 32 
22 15.3 25.4 5.30 Struvite (37%)/CaPO4 current M 47 
12 12.5 22.0 6.97 Struvite (34%)/CaPO4 current M 49 
Mean 15.2 23.1 7.3 - - - 53 
 
Urinary [K+] was lower in patients with previous / current struvite stones as compared to 
those with other stones. Mean pH was higher in patients with current / previous struvite 
stones (7.3 / 6.6) as compared to those with other stones (6.5). Five out of six patients 
with current struvite stones also presented with staghorn stones, and including those with 
previous struvite stones was eight out of ten. In ten of the total twenty four patients 
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cultures were performed on the stones. Four cultures were returned with a result other 
than ‘no growth’ and all were present within the group of patients with current struvite 
stones (one positive with Strep milleri, one with Proteus; one with fecal flora; and one 
culture showed mixed growth of doubtful significance). 
 
3.8 Measurements with a Mg2+ ion-selective electrode: 
3.8.1 Calibration of the Mg2+-selective electrode:  
Typical calibration data for the Mg2+-selective electrode in 140 mM NaCl buffered to pH 
6.0 with 10 mM MES is shown in Table 3.24. All experiments are at 37°C. The 
concentration of Mg in the reaction chamber took into account any dilutional effect cased 
by adding significant volumes of MgCl2 solution during the calibration procedure. 
 
Table 3.24: Sample Mg2+-selective electrode calibration data in a medium containing 140 
mM NaCl and 10 mM MES at pH 6.0.  The values of EMg are offset to zero mV at the 
highest [Mg].  
[Mg2+] added 
(mmol/l) 
[Mg2+] in the 
chamber (mM) EMg , mV 
0.1 0.10 -34.9 
0.2 0.20 -32.8 
0.4 0.40 -30.2 
1 0.99 -25.8 
2 1.96 -21.7 
4 3.91 -17.5 
10 9.73 -10.7 
20 19.27 -5.3 
40 37.81 0 
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Figure 3.39 shows the calibration plotted as a calibration curve and fit to the equation 
(see also section 3.1) 
EMg = E
0 + m log10([Mg
2 + ] + k)
 
where E0 is a constant; m the slope (RT/zF) factor and k a constant that is equivalent to 
the sum of the potentiometric selectivity constant to other ions, here mainly Na+. 
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Figure 3.39.  Sample calibration curve of a Mg2+-selective electrode in 140mM NaCl and 
10mM MES at pH 6.0.  
 
In Figure 3.39 the value of m was set to 29 mV per 10-fold change of the [Mg2+].  The 
calibration curve shows that the data were a relatively poor fit to the above equation.  
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This necessitated calculating carefully the potentiometric selectivity coefficients for 
different ions, and for each ion-selective electrode, and subtracting their effect from the 
overall electrode response at each experiment.  
 
When used in the base solution of 140 mM NaCl, 10 mM MES the value of the 
potentiometric selectivity coefficient, potijk  to Na
+ expressed as the logarithm of the value, 
log pot
MgNak was -1.59±0.15, i.e. the mean value of 
pot
MgNak  was 0.025. This was calculated 
from 40 calibrations in the base solution. 
 
 
3.8.2 Selectivity of the Mg2+-selective electrode and use of a Ca2+-selective electrode: 
The most interferent ion was potentially Ca2+, and its effect as well as the effect of Na+ 
and K+ were all estimated by the methods and procedures described in detail above 
(sections 3.1 and 3.2).  Figure 3.40 shows examples of calibration curves of a Mg2+-
selective electrode in the absence and presence of 1 mm CaCl2. 
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Figure 3.40. Mean calibration curves of the Mg2+-selective electrode in 140mM NaCl and 
10mM MES at pH 6.0, in the absence (closed symbols) or presence (open symbols) of 1 
mM CaCl2. Each determination was performed ten times. All calibrations were 
performed at 37oC. Error bars have been included for both curves. 
 
The mean value of log pot
MgCak  as determined from ten experiments was 0.66 + 0.02.  A 
value less than unity means that the electrode is more selective to the ‘interferent’ ion 
than Mg2+.  As with K+ interference on the NH4+ electrode, this necessitated separate 
measurement of the [Ca2+] with a Ca2+-ion-selective electrode, which was relatively 
unaffected by Mg2+, to allow the interferent effect of varying [Ca2+] on the electrode 
response to be subtracted. 
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Table 3.25 shows data for a Ca2+-selective electrode 
 
Table 3.25.  Data for a sample calibration of a Ca2+-selective electrode in 140 mM NaCl 
and 10 mM MES at pH 6.0.  The values of ECa are offset to zero mV at the highest [Ca]. 
 
[Ca2+] added 
(mmol/l) 
[Ca2+] in the 
chamber (mM) ECa , mV 
0.2 0.20 -64.7 
1 0.99 -49.1 
2 1.96 -41 
10 9.73 -19.7 
20 19.3 -9.6 
40 37.8 0 
 
The data are plotted in Figure 3.41 and show a more selective response to the primary 
ion, Ca2+, over this range. 40 calibrations were performed in 140 mM NaCl base solution 
and the log potCaNak   was -3.58 + 0.59, showing that the Ca
2+-selective electrode had good 
selectivity for Ca2+ over Na+. Moreover, the calibration curve was unaffected by the 
presence of MgCl2, 1-5 mM.  Therefore the Ca2+-selective electrode may be used to 
measure the [Ca2+] in urine samples and used to subtract the interferent effect on the 
Mg2+-selective electrode response. 
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Figure 3.41. Sample calibration curves of a Ca2+-selective electrode in 140mM NaCl and 
10mM MES at pH 6.0.  The line is calculated through the data points as in figure 3.38 
 
 
 
Figures 3.42 shows the response of the electrode to inclusion of a large [K] in the 
calibrating solution (200 mM).  The data show that the K+ interference is about the same 
as that from Na+. 
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Figure 3.42. Mean calibration curves of a Mg2+-selective electrode in 140mM NaCl and 
10mM MES in the absence (closed circles) and presence (open circles) of 200 mM KCl.  
The lines are calculated through the data points as in figure 3.38. Determinations were 
performed 3 times at 37oC, error bars are shown for both curves. 
 
The calibration was carried with a high concentration of K as with smaller 
concentrations, up to 50 mM, and significant interferent effect was not consistently 
observed.   
 
Table 3.26 shows a summary of the interference estimations to Ca2+, Na+ and K+ from the 
above experiments.  Ca2+ is the most interferent ion and requires monitoring along with 
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the use of the Mg2+-selective electrode.  Although significant, the effects of Na+ and K 
were more than two orders of magnitude smaller.  In subsequent measurements averaged 
values of the [Na] and [K] were used in the Nikolsky equation to subtract away 
interferent effects of these ions. 
 
Table 3.26  Values of the log potijk  (mean ± sd, n=10)for the Mg
2+-selective electrode in 
the presence of Ca2+, Na+ and K+ as interferent ions.  The mean value of log potijk  is 
transformed to potijk and 
pot
ijk / 1 values.  The value is 
pot
ijk / 1 a measure of the fold-
selectivity for Mg2+ over the interferent ion. 
 Mg2+-ISE (room temperature) 
Interferent ion Log potijk  
pot
ijk  
pot
ijk / 1  
Na+ -1.59 + 0.15 0.025 39.35 
Ca2+ 0.66 + 0.02 4.532 0.22 
K+ -1.50 + 0.08 0.031 31.82 
H+ 2.71 + 0.05 517.261 0.002 
 
 
Figure 3.43 shows the effect of a pH change on the Mg2+-selective electrode response. 
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Figure 3.43 Sample calibration curves of a Mg2+-selective electrode in 140mM NaCl and 
10mM MES at control pH (6.0, closed circles) and at pH 5.5 (open squares).  The lines 
are calculated through the data points as in figure 3.38. Each determination was 
performed three times at 37oC. Error bars are shown for both curves. 
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3.8.3 Values of urinary [Mg2+]: 
Table 3.27 shows values of urinary [Mg2+] as estimated using the Mg2+-selective 
electrode at voided pH and after titration to pH 6.0.  Reliable experiments using urine 
samples of 14 separate subjects were possible.  Median values and 25%, 75% 
interquartiles are quoted because of the large variation of data.  
 
Table 3.27.  Values of urinary [Mg2+] at voided pH and after adjustment to pH 6.0. 
Urine 
sample 
[Mg2+], 
mM 
voided 
pH 
[Ca2+] 
mM 
voided 
pH 
[Mg2+] 
mM 
pH 6.0 
[Ca2+] 
mM 
pH 
6.0 
Urinary 
[Na+] 
mM 
Urinary 
[K+] 
mM 
Urinary 
osm 
mOsm 
Urinary 
[creat] 
mM 
Voided 
pH 
1 1.3 0.3 3.4 0.2 14 6 64 895 6.10 
2 37.4 0.2 16.7 0.1 62 77 668 8488 5.64 
3 7.1 0.02 9.4 0.1 26 52 249 3235 7.70 
4 13.9 0.002 9.0 0.03 55 46 440 10419 5.50 
5 4.9 0.2 11.6 0.7 58 36 439 11313 6.93 
6 9.0 0.0 15.0 0.005 45 36 289 6564 8.52 
7 21.5 0.4 14.9 0.6 44 74 544 11281 6.85 
8 14.5 1.4 19.2 0.4 145 56 584 5881 6.85 
9 11.3 0.4 10.4 0.2 47 14 257 3944 6.48 
10 7.5 0.8 14.7 1.9 95 37 510 7731 7.27 
11 3.5 0.4 11.5 0.8 69 44 430 6119 6.37 
12 3.2 0.0 57.6 0.2 46 33 352 2981 8.10 
13 8.7 0.3 21.8 1.0 107 59 521 9769 7.55 
14 14.9 0.1 19.7 0.4 96 103 265 8604 6.96 
Median 8.9 0.25 14.8 0.3 56.5 45 434.5 7148 6.89 
25, 75% 
interquartiles 
5.5, 
14.4 
0.04, 
0.4 
10.7, 
18.6 
0.13, 
0.68 
45.3, 
88.5 
36, 
58.3 
271, 
518.3 
4428, 
9478 
6.40, 
7.48 
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There was no significant association between the value of [Mg2+] and voided pH. 
However, a paired non-parametric rank test (Kruskal-Wallis) indicated that the values 
[Mg2+] were marginally significantly greater (p=0.048) when the pH was titrated to 6.0. 
 
Figure 3.44 plots the change of the [Mg2+], ∆[Mg2+], as a function of the change of pH, 
∆pH required to bring the value to pH=6.0 – negative ∆pH values indicate the urine was 
alkalinized.  In this plot the data pair for sample 12 in Table 3.27 was omitted.  There was 
a significant association (r2=0.324, p=0.042), indicating that acidifying the urine (+∆pH) 
increased the [Mg2+], probably by increasing the ionized fraction of the total urinary 
[Mg]. 
 
Figure 3.44. Values of ∆[Mg2+] as a function of ∆pH as urine pH is normalized to pH 6.0 
from the voided value.  Negative values indicate urine was alkalinized to achieve pH=6.0. 
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CHAPTER 4 
DISCUSSION 
 
4.1 URINARY TRACT STONES 
4.1.1 The clinical problem.  
Urolithiasis is a common disorder, with calcium oxalate / phosphate stones being the 
commonest type and 10% of Caucasian men developing a kidney stone by the age of 
70.  The peak incidence is between age 20 and 40, with males more commonly 
affected than females (Finlayson, 1974) and a family history of stones increases the 
likelihood of stones (Curhan et al, 1997) Renal stones are rare in black Americans, 
black Africans, native-Americans and Australian aborigines in comparison to Asians 
and Caucasians.  This high incidence of renal stones is exemplified by their 
occurrence in the United States, the British Isles, Scandinavian countries, 
Mediterranean countries and central Europe (Finlayson, 1974) and in addition are 
more common in hot climates (Prince et al, 1960). Crystalluria has been shown to be 
greater during the summer months (Hallson et al, 1977) due to increased sweating, 
during high temperatures, leading to concentrated urine and urinary crystal formation.   
 
Increased incidence of renal calculi is associated with a more ‘affluent’ diet (increased 
animal protein, refined sugar and salt and a lack of dietary fibre is also thought to 
contribute to stone formation (Robertson et al, 1978). Most importantly, a low fluid 
intake predisposes to stone formation and an increased water intake causes urinary 
dilution of the constituents that may precipitate as well as reducing the average time 
of residence of free crystal particles in the urine (Finlayson, 1974). Sedentary 
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occupations (Lonsdale, 1968) and stress (Najem, 1997) have also been associated 
with stone disease. 
 
4.1.2 Struvite stones: 
Struvite stones pose a significant clinical problem and are often found in staghorn 
calculi, which can grow rapidly. Untreated staghorn calculi can destroy the kidney 
and result in life-threatening sepsis (Griffith, 1978; Ganpule et al, 2008) and are often 
associated with pain, haematuria and infection (Singh et al, 1973). Conservative 
treatment, with a mean follow-up of 7.8 years, was used in 61 patients with staghorn 
calculi (Koga et al, 1991), with chronic renal failure developing in 22 cases and 7 
deaths from uraemia. Other complications included severe hydronephrosis, renal 
abscess and xanthogranulomatous pyelonephritis, with early stone removal being 
advised. Lechevallier et al (2008) also advocate no role for conservative treatment of 
staghorn stones. Nephrectomy was considered the treatment of choice, particularly in 
unilateral large stones in older patients (Moores et al, 1976). Extended pyelolithotomy 
was shown to be a safe and appropriate form of treatment of unilateral staghorn 
stones, without compromising the contralateral kidney and that even with incomplete 
clearance regrowth of stone within the kidney was not an inevitability (Woodhouse et 
al, 1981). More recently, the main mode of therapy for staghorn calculi has been 
percutaneous nephrolithotomy (PCNL) (Saad et al, 1993) and combination therapy 
with extracorporeal shock wave lithotripsy (ESWL) (Lam et al, 1992). The American 
Urological Association nephrolithiasis guidelines panel recommended a combination 
of percutaneous stone removal and shock wave lithotripsy (Segura et al, 1994). 
Current European Association of Urology Urolithiasis guidelines (EAU Guidelines) 
recommend PCNL, ESWL and then laparoscopic or open surgery. However, open 
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surgery is still recommended for the management of complex staghorn stone disease, 
particularly in developing countries, due to high patient load and limited resources 
(Agrawal et al, 2009). Honeck et al (2009) also suggested that open stone surgery still 
plays an important role in the management of complex stones with high stone burden 
and anatomical variations. 
 
Sepsis syndrome (McAleer et al, 2002), perinephric abscess (Tsukagoshi et al, 2006) 
and increased recurrence rates (Grenabo et al, 1985) are serious clinical 
manifestations of struvite stone formation. 
 
Renal impairment is often associated with staghorn calculi (Vargas et al, 1982; 
Kristensen et al, 1987). An accelerated rate of loss of creatinine clearance has been 
shown among stone formers in general as compared to normal subjects (Worcester et 
al, 2003; Worcester et al, 2006) with kidney loss being frequently associated with 
struvite stone cases or very large stones.  
 
Long-term catheterisation carries an increased risk of urinary tract infection and 
catheter encrustation (blockage) and can create a huge constant demand on hospital 
and community health services. Struvite and hydroxyapatite deposition have been 
identified in catheter encrustation (Cox, 1989; Morgan, 2009). Ureteric stent 
encrustation is less commonly associated with infection (Shaw et al, 2005) and is 
most commonly composed of calcium oxalate  
 
The metabolic syndrome has also been associated with stone formation (West et al, 
2008). Uric acid nephrolithiasis has particularly been associated with the metabolic 
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syndrome and a low urinary pH due to defective urinary NH4+ excretion (Sakhaee et 
al, 2008a). NH4+-selective electrodes would again provide a useful tool in monitoring 
such patients. 
 
Struvite stones are composed of magnesium ammonium phosphate, and account for 5-
20% of all urinary stones (Griffith, 1978; Sharma et al, 1989). They are thought to be 
associated with urinary tract infections caused by ‘urease’ secreting bacteria (Griffith, 
1978; Bichler et al, 2002). 
 
For struvite to form, fluid within the urinary tract must contain NH4+ and trivalent 
phosphate ions (PO43-) at the same time.  Struvite forms only under abnormal 
physiological conditions, because renal tubules only generate NH4+ when the 
organism is trying to excrete an acid load and trivalent phosphate is almost absent in 
acid urine. Non-physiological conditions, created by urease-secreting bacteria, are 
generally required for struvite to precipitate.  The alkalinisation of urine by the urease 
reaction causes the formation of NH4+, as well as carbonate ions (CO32-), and also the 
formation of PO43-. This environment in turn causes struvite and carbonate apatite 
formation (Rodman, 1999; Miano et al, 2007). However Rodman (1999) suggested 
that struvite could also form in the absence of urea-splitting bacteria, since it has been 
possible to form struvite crystals in vitro in acidic solutions (pH 6) even though the 
morphology of the resultant crystals was slightly different, suggesting that a different 
set of physico-chemical conditions was present to cause crystallisation. At present, 
very little is known about the physico-chemical conditions that result in struvite 
crystallisation. This lack of understanding has two bases: i) the particular ionised 
concentrations of the reactants (e.g. Mg2+,  NH4+, and phosphate) in the urine are 
unknown; ii) the prevailing chemical conditions that would modulate crystallisation 
are also unclear (e.g. pH, osmolality, other urinary constituents). Urinary pH is 
determined by many different factors and there is a complex buffering system, 
involving various different buffers. However it is only urinary NH4+, along with 
Mg2+, and phosphate that will eventually determine whether struvite crystals form. 
Through determining the actual urinary [NH4+], we can further understand the 
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relationship between urinary pH and  [NH4+], as well as the impact of other buffering 
systems. Recent advances in the development of ion-selective electrodes allows 
accurate determination of urinary constituents in small (<1ml) undiluted samples to 
better understand the physico-chemical basis for struvite crystallisation, as well as 
provide us with a tool for monitoring patients who are recurrent struvite stone 
formers. 
 
4.2 CHARACTERISATION OF THE NH4+ ELECTRODE: 
4.2.1  The NH4+-selective electrode: 
The NH4+-selective ligand studied previously for use in ion-selective electrodes has 
been the natural antibiotic nonactin, incorporated into plasticised poly(vinyl chloride) 
(PVC) membranes (Buhlmann et al, 1998). The main problem has been selectivity of 
the ligand for NH4+ over K+ ions. Various attempts at improving selectivity by 
varying the amount of nonactin and using different plasticisers were made in order to 
improve the conductivity of NH4+ ions through the membrane (Ghauri et al, 1994).  
 
The NH4+-ion-selective electrode used in these studies was made of Ammonium 
Ionophore I, nonactin (1% w/w; ETH 09877 – Fluka) with ≥95% purity of the 
primary agent; CAS (Chemical Abstracts Service) number 6833-84-7. 
 
Figure 4.1.  The structure of nonactin       (http://chemed.chem.wisc.edu) 
 
 161 
The agent is a ring-shaped molecule with a central region that can accommodate 
NH4+ by interacting with the eight inward-facing oxygen atoms.  
To enable the ionophore to be distributed evenly in the PVC matrix and render the 
plastic supple and therefore less prone to fracture a plasticiser is used: in this case it 
was bis(2-ethylhexyl) sebacate (CAS number 122-62-3).  
 
 
 
 
Figure 4.2.  The structure of bis(2-ethylhexyl) sebacate 
 
With this combination, the electrode behaved in a reasonably Nernstian fashion within 
an [NH4+] range, commonly seen and expected to include values found in urine (0.4–
50 mM). Calibration of the electrode in 140 mM NaCl (buffered to pH 6.0) at 37oC 
produced a mean slope of 53.8mV per decade (10-fold change of the primary ion 
concentration) between 2 mM and 20 mM NH4Cl concentrations. This increased to 
56.8mV when the range of NH4Cl concentrations was 4-40 mM. The ideal slope for a 
monovalent cation should be 61.5mV per decade at 37oC.  
 
At 25oC, the mean slope was 52.2mV per decade between 2-20 mM NH4Cl and 
51.7mV per decade between 4-40 mM NH4Cl concentrations. The ideal slope should 
be 59.1mV at 25oC. Our values obtained compared favourably with previously 
studied NH4+-selective electrodes which have been reported to have slopes between 
51.0 and 57.5 mV per decade at 25oC (Guibalt et al, 1969; Ghauri et al, 1994). 
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An important factor in the sensitivity of ion-selective electrodes is the type of 
plasticiser used and for this bis(1-butylpentyl)adipate (CAS: 77916-77-9) was also 
utilised. This molecule is similar in being a long chain hydrocarbon with several 
coordinating oxygen atoms as the plasticiser and found that there was no real 
significant difference in the way the electrodes responded. 
 
 
 
 
 
Figure 4.3.  The structure of bis(1-butylpentyl)adipate 
 
The main limitation has been that although nonactin-based ion-selective electrodes 
have reasonable NH4+/Na+ selectivity there is poorer selectivity over K+.  One study 
found mean values for 
 
logkNH4 Na
pot = -2.4 and for 
 
logkNH4 K
pot = -0.9 (Benco et al, 2003). 
This study showed comparable selectivity over Na+ and K+ (
 
logkNH4 Na
pot = -2.61;  and 
 
logkNH4 K
pot = -0.85). 
  
There have been other attempts to develop new synthetic ionophores with higher 
NH4+ selectivity. The selectivity of the ionophore has been attributed to its tetrahedral 
geometry and its ability to donate four hydrogen bonds to stabilise the cation. Benco 
et al (2003) synthesised ‘ammonium ionophore IV’ incorporating hydrogen bond 
donors in tetrahedrally symmetric complexation sites. They used nitrophenyl octyl 
ether (NPOE) and dioctyl phthalate (DOP) as the plasticisers. They also investigated 
the effect of a lipophilic ionic additive, potassium tetrakis(4-chlorophenyl)borate 
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(KtpClPB), which was added to two of the four preparations. Their study showed two 
main effects: firstly the NPOE plasticiser consistently produced slopes closest to 
Nernstian conditions as compared to DOP, and this was attributable to the higher 
polarity that NPOE imparts to the membrane, thus reducing intramolecular hydrogen 
bonding and allowing for more efficient NH4+ complexation (Gallo et al, 1993). 
Secondly the addition of KtpClPB resulted in significant deviation from Nernstian 
behaviour and reduced the selectivity, particularly over the divalent cations. The use 
of KtpClPB in the NH4+-selective electrodes used in this study was also avoided for 
the above reason.  Overall the above studies showed that optimum electrode 
characteristics were obtained with NPOE as a plasticiser and omission of KtpClPB.  
The response to NH4+ over Na+ or K+ produced somewhat inferior values of 
 
logkNH4 Na
pot  (-2.1) and 
 
logkNH4 K
pot (-0.6).  As with the electrodes used in this study 
excellent selectivity over divalent cations (Ca2+ and Mg2+) was shown.  Thus, 
although this study slightly improved on the selectivity characteristics of an NH4+-
selective electrode over common divalent cations, interference by K+, in particular, 
requires its separate determination to account for any interferent effects. 
 
Our study also showed that the NH4+-selective electrode showed equivalent Nernstian 
responses over wide range of pH variation (5.5, 6.5, and 7.5), and in effect 
interference from H+ ions was not detectable. The importance of the pH-dependence 
of [NH4+] in urinary samples will be discussed below. 
 
The osmolality and ionic strength of urine varies greatly. Therefore the sensitivity and 
selectivity of the NH4+-selective electrode was tested in solutions of varying 
osmolalities and differing ionic activities to determine if these affected the ISE 
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response. Since the values of 
 
logkNH4 Na
pot  in the different solutions were not 
significantly different from the value in base solution, it may be concluded that 
solution ionic strength and osmolality per se had no effect on the NH4+-selective 
electrode response.  
 
4.2.2  K+-selective electrode:  
In view of the interference caused by K+ ions on the NH4+-selective electrode, it was 
necessary to measure urinary [K+] to subtract the interferent contribution from the 
electrode response and thus measure accurately the urinary [NH4+]. A K+-selective 
electrode was constructed and characterised.  Valinomycin was used as a K+-selective 
ionophore and has been used previously to measure [K+] in urine and blood samples.   
 
The valinomycin K+-selective electrode showed a Nernstian response, with a mean 
slope of 54.4 mV per decade at 37oC. This value was similar to others reported in 
similar Na+-based calibration solutions; – between 57.3 and 59.7mV (Band et al, 
1978; Hill et al, 1978; Jenny et al, 1980). 
 
The K+-selective electrodes were calibrated in the presence of different potentially 
interferent ions.  Interference from Na+ ions was negligible and the interference from 
NH4+ ions was minimal (mean 
 
log kKNa
pot =-2.91;mean 
 
log kKNH4
pot = -1.63).  Despite the 
small interference from Na+, because of the potentially high [Na+] any effect was 
factored out.  The value of 
 
log kKNa
pot  means that the K+-selective electrode was 819 
times more selective for K+ ions than Na+ ions.   An upper limit of the urinary [Na+] 
150 mM was assumed and was equivalent to an apparent change of [K+] = 0.18 mM. 
This value was subtracted from the calculated values of [K+] to obtain the final quoted 
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value and that used to correct the NH4+-selective electrode estimation. This in turn led 
to a correction of the [NH4+] of 0.01 – 1.16 mM over the quoted range of values 
between 0.4 and 50 mM).  
 
These experiments also showed that there was no detectable interference from Ca2+ on 
the K+-selective electrode, nor was the electrode affected by changes to pH, ionic 
activity or osmolality of the calibrating solution. 
 
4.3 URINARY MEASUREMENT OF NH4+ 
4.3.1 Values of urinary [NH4+] at room temperature 
This study has made the first measurements of urinary [NH4+] with an ion-selective 
electrode. The study had several aims: 
• to determine any effect of pH and temperature on urinary [NH4+]  
• to determine if the urinary [NH4+] was different in control subjects and those 
with urinary tract stones. 
The method also provided a more rapid and cost-effective method than those 
previously used. 
 
From 28 normal subjects, the urinary [NH4+] and [K+] were 26.6±11.5 and 44.8±16.9 
mM respectively. The ranges of values were 8.7-55.2 and 12.4-77.6 mM respectively.  
The pH of the samples was 5.96±0.76 (range 4.97-7.33).  
 
The results showed that there was no relationship between urinary [NH4+] and [K+]. 
By comparing different methods of storage of the urine samples, it was also 
demonstrated that storing samples in a freezer did not significantly alter the urinary 
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[NH4+]. Paired t-test analysis also showed no significant difference for urinary [K+] 
however, one sample showed a very large increase after seven days, thus skewing the 
data set and a Wilcoxon rank test did show a significant difference (p=0.04) between 
the two data sets.  A larger data set will be required to determine if the seven days 
frozen storage does lead to an increase of urinary [K+], since only 7 samples were 
tested. There was no obvious cellular material in the urine samples and so the increase 
of urinary [K+] if real is unlikely to result from cell lysis as a result of storage.  
Since storage at room temperature did not significantly alter the urinary [NH4+] it was 
therefore possible to transport urine samples from distant centres and store them by 
freezing the specimens. This allowed the urinary [NH4+] and [K+] to be measured 
later without the problem of concentrations altering with storage. 
 
4.3.2 Comparison with other methods 
The above values are similar to other reported values.  Miller et al (2000) tested for 
abnormalities in acid-base regulation in hypertensive patients. They compared indices 
of urinary acid secretion, which included urinary pH and urinary [NH4+], in 
hypertensive compared to normotensive patients. The measurement of urinary [NH4+] 
was based on the Berthelot reaction, a method to detect nitrogen content of samples 
and often also used for the detection of urea by producing a blue dye formed NH3 in 
the presence of Na phenate and Na nitroprusside (Bergquist and Searcy (1963). 
Samples required dilution to 1/20 with distilled water and a standard curve of 
ammonium chloride was prepared in double-distilled water. Phenol nitroprusside 
reagent was added to sample and standard tubes. After further stirring, alkaline 
hypochlorite solution was added and the solutions placed in a water bath (37°C) for 
40 min. After adding a further 1 ml of distilled water, samples and standards were 
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measured by absorption spectrophotometry at 630 nm. The urinary NH4+ excretion 
rate was 24.6±7.7 in the normotensive group and 23.1±10.2 mmol/24h in the 
hypertensive group, concentrations were not reported. 
 
Other methods of measuring urinary ammonium are even more labour-intensive and 
more amenable to error. These include the glutamate dehydrogenase method to 
measure urinary [NH4+] (Abate et al, 2004).  
  
Gravimetric measurements have also been previously used to estimate urinary 
[NH4+]. This has involved precipitating the NH4+ out of solution using sodium 
tetraphenylborate. The solid precipitate, ammonium tetraphenylborate is then filtered 
out, washed and dried to remove any moisture. The precipitate is then weighed and 
the amount of ammonium in the original sample can then be calculated from the mass 
of the precipitate and its chemical composition or analysed by spectrophotometry 
(Kiss-Eröss et al., 1970).  However, the method is unreliable as tetraphenylborate also 
precipitates K+ which must be excluded from the final analysis. 
 
Cunarro et al (1974) compared four different methods for measuring urinary [NH4+].  
i)  The Conway microdiffusion technique involved placing urine in the outer chamber 
of a Conway microdiffusion dish, with K2CO3 on the opposite side and boric acid 
(with bromocresol green) in a central chamber. The K2CO3 and urine were mixed, 
followed by back titration with H2SO4.  The urinary [NH4+]  was calculated from the 
amount of [H+] used.  This technique is a variant used by others to detect [NH4+] by 
mixing samples with phenol and hypochlorite (Russell, 1944). 
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ii) An ammonia specific electrode is a gas detecting electrode which responds to the 
partial pressure of dissolved ammonia gas, and related to the concentration of 
ammonia using Henry's law (the amount of a given gas dissolved in a given type and 
volume of liquid is directly proportional to the partial pressure of that gas in that 
liquid). All the NH4+ in the solution is first converted to NH3, by the addition of 
NaOH to elevate the pH to 13. Measurements are conducted immediately since 
ammonia gas is lost once alkali is added. 
 
iii) A further method, formalin-titrimetric method (see Ninan et al., 1990), requires 
that a 10 ml urine sample is mixed with an equivalent volume of HCl, and all 
dissolved CO2 is removed using a vacuum. Titration to pH 7.4 is performed using 
NaOH and titratable acidity calculated. Formaldehyde solution is then added to the 
mixture and again titration to pH 7.4 is performed with NaOH, and the [NH4+] 
calculated from the amount of NaOH used. 
 
iv) Finally the Berthelot reaction, as described above was also used.  
 
Two different urine samples were analysed six times by each technique for 
comparison of the four methods of measuring urinary [NH4+]. The study concluded 
that the methods were fairly specific for urinary NH4+. However, the speed of each of 
the techniques varied greatly. It was suggested that in an eight-hour working day, a 
maximum of 50 determinations could be performed using the Conway technique and 
formalin-titration method, 100 determinations with the ammonia electrode, and 
possibly 200 determinations with the Berthelot reaction.  However, this output would 
be labour- and equipment-intensive and this represent a significant investment.  
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The advantages of the potentiometric ion-selective electrode technique used in this 
study was the ability to make immediate and accurate determinations of urinary 
[NH4+]. The apparatus took about 20 minutes to prepare, including time for baseline 
calibrations. To perform a determination on an individual urine sample required only 
two minutes, including the time for washing out the chamber before and after the 
determination, making this technique very fast to perform. Most importantly, the urine 
samples are undiluted, meaning there was less chance of errors being introduced.  
 
Szmidt-Adjide et al (2008) investigated an enzymatic method for measuring urinary 
[NH4+] using a particular ammonium reagent on an Olympus (R) AU 2700 analyzer. 
They showed a good correlation between this method and results obtained from a 
formula calculation based upon the modified urine osmolal gap (Hafen et al., 1996). 
However, a potential error introduction was again the fact that urine samples were 
diluted to 1/100. Furthermore, a brief search for the price of an Olympus AU 2700 
analyzer revealed that it cost $272,000. In contrast, ion-selective electrodes are cheap 
to produce, fairly robust and require very little maintenance. The set-up cost for ion-
selective apparatus is fairly low and many hundreds / thousands of electrodes may be 
produced at a time again at very low cost. 
 
4.4 VALIDATION OF THE NH4+-SELECTIVE ELECTRODE FOR USE IN 
URINE  
To ensure that the use of an ion-selective electrode method provided a reliable and 
accurate measurement of urinary [NH4+] it was necessary to validate it against an 
established method.  The choice of a standardised method was problematical due to 
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the fact that urinary [NH4+] is not routinely measured.  A conventional 
spectrophotometric assay was chosen (Weatherburn, 1967) as it was well-validated in 
different settings and available.  The method measures urinary [NH4+] using a phenol-
hypochlorite reaction detection method and urine samples were diluted (1/80) and 
centrifuged. The supernatant was then incubated for three hours in a solution 
containing phenol. The resulting blue colour of the solution was interpreted using 
spectrophotometric absorption against a standard curve. The whole process took about 
four to five hours to perform. 
 
A good correlation between the two methods was demonstrated, which confirmed that 
an ion-selective electrode method to measure urinary [NH4+] was accurate, but also 
demonstrated several other advantages over colour spectrophotometry:  
• ion-selective electrodes are cheap, robust, and easily produced. Their within 
batch and between batch reproducibility is very good and many electrodes can 
be produced in a single batch. The greatest cost is the ion-selective ionophore 
itself, but this is small compared to the cost of the equipment required for colour 
spectrophotometry. 
• ion-selective electrodes produce an instant reading, so that individual reading 
can be checked, whereas colour spectrophotometry requires four to five hours 
before data are available. 
• a single ion-selective electrode may be used on multiple occasions and over 
days and weeks.  The ability to carry out rapid and instant calibrations 
combined with the longevity of the electrode ensures reproducible and 
consistent responses.. 
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• ion-selective electrodes may be used with undiluted urine samples.  By contrast 
colour spectrophotometry requires that the urine is diluted.  This may not only 
introduce inaccuracies, but will also change the chemical environment of the 
measured ion i.e. dilute also other moieties that affect the value of the primary 
ion. 
• ion-selective electrodes measure the ionised fraction of the ion in solution.  
Other analytical techniques, including colour spectrophotometry, measure both 
the bound and freely ionised fraction and thus do not estimate the 
chemically/biologically active fraction.  
 
4.5 URINARY MEASUREMENT OF [NH4+] AT 37°C 
Many of the measurements of urinary [NH4+] in this thesis were carried out at room 
temperature because validation against more standardised techniques are also 
performed under this condition.  However, to understand the more physiological 
conditions under which struvite stone formation occurs, measurements were also 
carried out at 37°C. Both the NH4+- and K+-selective electrodes were therefore 
characterised at 37°C to determine the temperature-dependence of the potentiometric 
selectivity coefficients. 
 
4.5.1 Characterisation of the NH4+-selective electrode at 37°C: 
At lower NH4Cl concentrations in the calibration solution, the curve relating 
concentration to potential difference generated by the NH4+-selective electrode at 
37°C deviated more than at room temperature from an ideal Nernstian relationship. 
This indicated that interference from Na+ was greater at the elevated temperature. 
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However the true interference was still negligible as suggested by a the mean 
 
log kNH4 Na
pot   value of -2.40±0.11.  
 
K+ interference was also greater on the NH4+-selective electrode at 37°C compared to 
room temperature calibrations. The 
 
logkNH4 K
pot  was significantly smaller at -0.68±0.08 
at 37°C, compared to -0.85±0.08 at room temperature. Of interest also was that the 
extent of interference from K+ was concentration-dependent; this was less at higher 
[K+] (25 and 50 mM; 
 
logkNH4 K
pot  -0.73±0.02) compared to lower background 
concentrations (2 and 5 mM; 
 
logkNH4 K
pot , -0.65±0.06).  This makes correction for the 
interference of K+ on the NH4+-selective electrode more difficult.  In this study the 
25-50 mM kpot was used (0.195). 
 
4.5.2  Characterisation of K+-selective electrode at 37°C: 
Interference from Na+ on the K+-selective electrode at 37°C was not significantly 
different from that at room temperature (log
 
kKNa
pot  -2.76+0.10 at 37°C; log
 
kKNa
pot  
-2.91±0.33 at room temperature). 
 
Similarly, interference from NH4+ on the K+-selective electrode at 37°C was not 
significantly different from that at room temperature (log
 
kKNH 4
pot -1.59±0.04, at 37°C; 
 
log kKNH4
pot  -1.63±0.06 at room temperature). 
 
4.5.3 Urinary measurements of [NH4+] at 37°C. 
Urine samples were obtained from twenty-four patients attending the in-patient ward 
for urology operations. Since patients were nil-by-mouth from midnight the effects of 
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dietary intake on urinary [NH4+] were reduced. Diurnal variability was also 
minimised because all samples were obtained at the same time (between 7 and 8 am).  
 
Urinary [NH4+] and [K+] were 15.0±9.8 and 35.9±15.8 mM respectively. The ranges 
of values were 1.12-44.1 and 11.2-72.3 mM respectively.  The voided pH of the 
samples was 6.70±0.92 (range 5.50-8.52). There was no significant relationship 
between urinary [NH4+] and urinary [K+] at 37°C. 
 
4.5.4  pH dependence of urinary [NH4+]  
Determination of any dependence of urinary [NH4+] on pH was an important  
objective of the thesis as struvite stones forms in an alkaline environment within the 
urinary tract. At room temperature, there was a significant negative association 
between voided pH and [NH4+] - whether estimated by colour spectrophotometry 
(r2=0.792) or with ion-selective electrodes (r2=0.675). Four samples that seem to form 
a separate group and were excluded from the final analysis, figure 3.18.  However, 
these urine samples were found to be very abnormal and there was no particular 
reason, since samples of the same individuals on different occasions were normal.. In 
a small number of samples pH was artificially altered to determine if a similar 
relationship could be generated in individual samples.  However, this was not 
observed in the small sample set that was used. 
 
At 37°C, the negative relationship between voided pH and urinary [NH4+] was absent.  
The pH of individual urine samples was artificially altered and any changes in [NH4+] 
measured, as carried out in the smaller set at room temperature. In this case 
acidification of urine increased the [NH4+], similar to observed between voided pH 
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and [NH4+] at room temperature. Although a general trend is present, i.e. acidification 
of urine increases the [NH4+], the manner in which this was demonstrated at the two 
temperatures remains to be ascertained. 
 
However, the range of pH values over which the [NH4+] cannot be explained solely 
on the fact that the NH3/NH4+ pair is acting as a simple buffer.  The pK of the 
reaction 
 
NH3 + H
+ ⇔ NH4
+ 
is 9.23.  At this pH the concentration of NH3 and NH4+ would be equal. At pH 6.23 
the [NH4+] is 1000-times greater than the [NH3] and even at pH 7.23 the [NH4+] is 
100-times greater than the [NH3].  Thus if the total ammonia pool (NH4+ and NH3) in 
a urine sample remains constant, altering the pH in the range 6.0-7.0 will have only a 
trivial effect on the [NH4+] if only a change of the equilibrium was constant.  To have 
such significant changes as recorded in these experiments could only be explained by 
a non-equilibrium process whereby alkalinisation of the urine was removing H+ by 
other buffers continually forcing the equilibrium reaction above to the formation of 
NH3.  The indication is that the [NH4+] altered by about 10 mmol/l per pH unit at 
room temperature (figure 3.18) and less so at 37°C (figure 3.24) when pH was altered 
between pH 5.5-7.0.  Another urinary buffer with a pK value near this pH range 
would achieve such a non-equilibrium shift of [NH4+].  A major future objective will 
be to determine the nature of this buffer system as its manipulation will have profound 
effects on the urinary [NH4+], and potentially the ability to form struvite crystals in 
urine.  A candidate is urinary phosphate as the reaction: 
 
HPO4
2− + H+ ⇔ H2PO4
− 
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has a pK value of 7.2 (Gomori, 1959) and a concentration of about 1-30 mmol/l in 
urine (Themelis et al., 2004), i.e. similar to the change of [NH4+] documented above. 
For the formation of struvite crystals, the urine must be super-saturated with Mg2+, 
NH4+ and PO43- ions. Mg2+ will be discussed later, NH4+ is pH dependent as 
described above and H2PO4- / HPO4- ions have the above pK value. However PO43- 
ions begin to form logarithmically once the pH goes above 8-9 causing a rapid 
increase in the PO43- ion concentration. However at pH 7, the [NH4+] is less than what 
would be expected for super-saturation with this ion, hence the function of the urease-
secreting bacteria, in firstly increasing NH3 production and secondly increasing  the 
pH / alkalinising the urine, thus leading to rapid increase in PO43- ions, which 
subsequently leads to struvite deposition. Thus potentially the PO43- ions appear to be 
a driving force for struvite crystallisation. 
 
 
4.6 URINARY MEASUREMENTS FROM PATIENTS ATTENDING A 
RENAL STONE CLINIC 
 
Urine samples were obtained from patients attending a renal stone clinic at the Royal 
Free Hospital. All patients attending this clinic were recurrent stone formers or at risk 
of further stone formation. Samples were used to compare values of urinary [NH4+] 
and [K+] in this set of patients with those from other cohorts.  In addition, urine 
samples from this patient cohort underwent routine urinalysis and therefore afforded 
the opportunity to determine the effect on urine osmolality on [NH4+] and [K+].  
Finally, an algorithm used to estimate urinary [NH4+] in these patients could be 
validated against measured values using the ion-selective electrode. 
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4.6.1  Effect of temperature on urinary measurements of [NH4+] and [K+]: 
Previous experiments to characterise the NH4+-selective electrode showed that 
interference from Na+ was greater at 37°C, but still negligible. K+ interference was 
also greater and concentration dependent (i.e. less interference at higher background 
concentrations of K+). As mentioned above, the interference of Na+ and NH4+ on the 
K+-selective electrode at 37°C was not significantly different from that at room 
temperature. 
 
Comparison of urinary measurements of [NH4+] and [K+], made at 37°C and room 
temperature, for each urine sample, importantly showed that there was no significant 
difference between the [NH4+] measurements. However the [K+] measurements were 
significantly higher suggesting that the measurements made at room temperature 
underestimated the measurements made at 37°C, but this did not affect the [NH4+] 
measurements. 
 
4.6.2  The dependence of urinary [NH4+] and [K+] on urine osmolality: 
A positive association was seen between urinary osmolality and urinary [NH4+] and 
[K+].  This may be expected as when the urine becomes more concentrated the urinary 
[NH4+] and [K+] increases. 
 
4.6.3  The dependence of urinary [NH4+] and [K+] on voided pH: 
As described above, we confirmed the same significant negative association between 
urinary [NH4+] and voided pH within this cohort of patients. There was no significant 
relationship between urinary [K+] and voided pH. 
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4.6.4 Differences between stone-formers and non-stone formers 
One objective of the study was to determine if a single test for urinary [NH4+] might 
distinguish between normal control and stone-formers.  This was carried out in Table 
3.21 and showed that actually the urinary [NH4+] for non-stone formers was 
significantly greater.  The table is reproduced here for convenience. 
 
Table 3.21 Values of urinary [NH4+] and [K+] in urine samples from a non-stone 
forming and a stone-forming cohort of volunteers. * p<0.05 non-stone former vs stone 
formers at RT. 
 Non-stone 
formers 
Stone formers 
RFH patients (stone 
clinic) 
UCLH 
patients(operative) 
Room temp Room temp 37°C 37°C 
[NH4+], mM 26.1±11.5 * 13.8±8.9 13.8±10.8 15.0±9.8 
[K+], mM 44.8±16.9 30.7±13.0 39.1±17.7 35.9±15.8 
Voided pH 5.96±0.76 * 6.60±0.94 6.60±0.94 6.70±0.92 
 
However, it is clear that other variables also were different, i.e. the voided pH and the 
[K+], an increase of pH raised the [NH4+] and an increase of [K+] was consistent with 
increased osmolality and hence an increase of the [NH4+].  Therefore, a single spot-
test of the urinary [NH4+] would be insufficient to distinguish between a stone-former 
and non-stone former on the basis of the measurements.  
An approximate attempt to reduce the effect of these confounders is as follows, from 
the room temperature data: 
1. Figure 3.18 showed that the [NH4+] decreased by 11.2 mmol.l-1.pH unit-1. Voided 
pH was 0.74 units less in non-stone formers and would per se increase [NH4+] by 8.3 
mM 
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2. Figures 3.29 and 3.30 show that [NH4+] increased by 0.035 mM/mosmol and [K+] 
by 0.067 mM/mosmol if linear fits are assumed; i.e. [NH4+] increases by 1 mM per 
1.9 mM increase of [K+]., As non-stone formers [K+] was 14.1 mM greater this is per 
se is equivalent to an increased [NH4+] of 7.4 mM 
3. Subtracting these two values from the measured 26.6 mM [NH4+] yields a mean 
value of 10.9 mM for non-stone formers [NH4+] in comparison to the value of 13.8 
mM for stone-formers. 
 
A similar calculation may be carried out for the comparison of [NH4+] in urine 
samples from struvite and Ca oxalate stone formers (section 3.6.5).   
The [NH4+] in the two groups: 16.8±9.0 vs 15.0±10.0 mM (struvite vs Ca oxalate) 
The [K+] in the two groups: 26.5±7.7 vs 42.7±16.7 mM 
Normalisation around an equivalent [K+] in the two groups would increase the [NH4+] 
in the struvite group from a mean of 16.8 mM to 25.3 mM in comparison to the mean 
value of 15.0 mM in the Ca oxalate group. 
 
Although these are approximate calculations it shows the importance of matching the 
osmolality and pH when comparing measured values of [NH4+] between groups. 
However, an in vitro model found no relation between urine osmolality or ammonia 
with urease-induced crystallization (Hugosson et al., 1990) Accumulation of more 
data will determine if such a linearly independent approach is valid to correct for 
these confounders. 
 
4.6.5   Validation of the NH4+-selective electrode against a standard algorithm: 
A standard algorithm was used to calculate urinary [NH4+] (Hoge et al., 1994) 
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Urine [NH4
+] = 0.5* Measured osmolality -  2([Na] +[K]) +
urea
2
 
 
 
 
 
and these values compared to measured values.  The mean calculated urinary [NH4+] 
was 10.3±14.5 mM (range -8.5 – 49.5 mM) compared with a mean ISE urinary 
[NH4+] measurement of 13.8±8.9 mM (range 2.9 – 34.3 mM). The calculated method 
produced negative values which suggested inaccuracies with this method. There was 
however a significant association between the calculated and ISE method (r2=0.54). 
The calculated value was smaller than the measured value in most cases, but this was 
not a proportional error between the two values. As the pH rose above 6.0, there was a 
growing deviation between the two values, suggesting an in-built error in the 
calculation algorithm that is pH-dependent. On the whole, the calculated algorithm 
provides an alternative method for estimation of urinary [NH4+], despite the 
inaccuracies, however, the ion-selective electrode provides a more accurate 
measurement. Refinements of the algorithm will be possible using the ion-selective 
electrode data as a basis for empirical correction of the formula. Though we made 
preliminary attempts at refining the formula, further focused attempts will be required 
to produce an even more accurate formula. 
 
 
4.7 CHARACTERISATION OF MAGNESIUM ELECTRODE: 
 
Magnesium is the fourth most abundant cation in the human body and the second 
most common cation in the intracellular fluid (Quamme, 1986). Magnesium is an 
extremely important intracellular cation and a cofactor in essential biological systems 
(Aikawa, 1980; Flink et al, 1987).  
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Plasma [Mg2+] depends on intake and renal excretion, which is regulated mainly in 
the thick ascending limb of the loop of Henle. 25% of reabsorption occurs in the 
proximal convoluted tubule, with 60% occurring in the loop of Henle and 10-15% 
occurring in the distal convoluted tubule. The hormonal control exhibited over other 
ions (e.g. K+, Ca2+) is lacking for magnesium and therefore a negative magnesium 
balance results in a prompt decrease in plasma [Mg2+] and vice versa (de Rouffignac 
et al, 1994; Kelepouris, 1998; Quamme et al, 2000; Dai et al, 2001;).  
 
A close relationship between hypokalaemia and hypomagnesaemia has been 
identified (Whang et al, 1981), and both can induce ventricular arrhythmias (Whang, 
1987). Altura (1994a) highlighted the need for a sensitive Mg2+-selective electrode, 
for measuring the ionised free Mg2+, which is physiologically the most important 
fraction. Subsequently Mg2+-selective electrode were characterised to measure ionised 
[Mg2+] (Altura et al, 1994b; Marsoner et al, 1994) and its uses in the critical care 
setting (Altura et al, 1994c). 
 
Measurements of [Mg2+] in undiluted blood samples were also achieved by Rouilly et 
al (1990) using Mg2+-selective ionophores. The Mg2+-selective ionophore used was 
ETH 5282, and was mixed (by weight) with 33% polyvinyl chloride (Fluka),  and 
65% to 66% o-nitrophenyl octyl ether (NPOE; Fluka), plus potassium tetrakis(p-
chlorophenyl)-borate (KTpC1PB; Fluka). The main problem was selectivity over 
Ca2+, and a potMgCak log of -1.05 was obtained. International workshops have taken place 
to establish international standards for the measurement of ionised magnesium 
(Fleisher, 1994). The parameters and working mechanism to aid developing these 
electrodes have also been investigated (Eugster et al, 1991). 
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Three commercial analysers (Rehak et al, 1996) are available currently which 
measure the free [Mg2+] and [Ca2+] in blood, plasma serum. The instruments are the 
AVL 988-4 (AVL, Graz, Austria), the Microlyte 6 (KONE, Espoo, Finland), and the 
Nova CRT (Nova, Waltham, MA). They all use the [Ca2+] to subsequently correct for 
the selectivity of the Mg2+-selective electrode for Ca2+. These instruments have not 
been used in undiluted urine samples. 
  
We initially used ETH 4030 as the Mg2+-selective ionophore, but there was no 
response seen with changes in [Mg2+]. ETH 4030 had been used by Maj-Zurawska et 
al (1989), where the pot
MgCak was 1.0 and the 
pot
MgNak was 1.6 x 10
-4. Hu et al (1989) 
investigated ETH 5214, another Mg2+-selective ionophore, and found that log 
pot
MgCak ranged between 0.6 and 1.0 and the log 
pot
MgNak ranged between -2.0 and -2.3. 
 
ETH 7025 has been found to be a good Mg2+-selective ionophore (Eugster et al, 
1993). Seven ion-selective membranes were made using differing amounts of ion-
selective ionophore, PVC and plasticiser. The log pot
MgCak ranged between -0.8 and -
1.4, showing fairly good selectivity for Mg2+ over interferent ions. 
 
The Mg2+-ion-selective electrode used in the current study was made of Magnesium 
Ionophore VI, (1% w/w; ETH 5506 – Fluka) with ≥95% purity of the primary agent. 
Other constituents for the Mg2+-selective membrane included 165mg high MW PVC, 
6ml tetrahydrofuran, 330 mg of bis (2-ethylhexyl) sebacate and 3.0 mg potassium 
tetrakis(p-chlorophenyl)-borate (KTpC1PB). The response of the Mg2+-ion-selective 
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electrode was poorer at lower [Mg2+]. Calibration of the electrode in buffered NaCl 
solutions at 37°C yielded a slope of 10.4 mV per decade (n=10), between 0.2-2.0 mM 
MgCl2, and this was 16.7 mV per decade between 2.0-20 mM MgCl2(n=10). The 
ideal slope for a divalent cation should be 30.75mV per decade at 37oC. MgCl2. 
 
Selectivity for Mg2+ over Na+ was evaluated from 40 calibrations in the base solution 
(140 mM NaCl) and the log pot
MgNak was -1.59±0.15, with a mean 
pot
MgNak  value of 0.025 
(i.e. the Mg2+-ion-selective electrode was 40 times more selective for Mg2 than Na+). 
O’Donnell et al (1993) studied ETH 5506 and the ion-selective membrane 
constituents included 1% w/w ionophore, 33% w/w PVC and 66% w/w plasticiser 
(either o-NPOE (2-nitrophenyl octyl ether – Fluka) or ETH 5373). With the plasticiser 
ETH 5373, the log pot
MgNak was -4.7, whereas with o-NPOE as the plasticiser, the 
log pot
MgNak was -4.4. 
 
In the current study, the most interferent ion was Ca2+, and calibration curves of a 
Mg2+-selective electrode in the presence of 1 mm CaCl2 were performed. The mean 
value of log pot
MgCak , as determined from ten experiments, was 0.66 + 0.02, suggesting 
that since this value is less than unity, the electrode is more selective for the 
‘interferent’ ion (Mg2+). O’Donnell et al (1993), in their study, showed that with the 
plasticiser ETH 5373, the log pot
MgCak was -1.9, whereas with o-NPOE as the 
plasticiser, the log pot
MgCak was -1.7. The electrode used in the present study appeared 
more susceptible to interferent ions, than in O’Donnell’s study (1993). The reason is 
unclear but possible reasons include the different plasticiser used in the current study 
 183 
and varying ratios. Further experiments are necessary and should include using a 
different plasticiser. 
 
4.8 URINARY MEASUREMENT OF [Mg2+] AT 37°C: 
 
4.8.1 Characterisation of the Ca2+-selective electrode at 37°C: 
Separate measurement of urinary [Ca2+] was carried out using a Ca2+-ion-selective 
electrode, which was relatively unaffected by Mg2+. This allowed the interferent 
effect of varying [Ca2+] on the electrode response to be subtracted. 
 
4.8.2 Urinary measurements of [Mg2+] at 37°C: 
Reliable experiments using urine samples of 14 separate subjects were possible. After 
subtracting the interferent effect of Ca2+, the median urinary [Mg2+] was 8.9 mM, with 
the 25% and 75% interquartiles being 5.5 and 14.4 mM respectively. The urinary 
[Mg2+] was slightly increased from what might be expected, reflecting the poor 
selectivity of the Mg2+-selective electrode for Mg2+. The median voided pH was 6.89. 
 
4.8.3 pH dependence of urinary [Mg2+]: 
There was no significant association between the value of [Mg2+] and voided pH. 
However, urinary [Mg2+] values were marginally significantly greater (p=0.048) when 
the pH was titrated to 6.0. There was a significant association (r2=0.324) indicating 
that acidifying the urine increased the urinary [Mg2+], probably by increasing the 
ionized fraction of the total urinary [Mg]. This raises the possibility that as urinary pH 
changes, the urinary [Mg2+] increases and drives struvite deposition. 
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Further experiments are required to reliably obtain accurate urinary [Mg2+] and should 
include using different plasticisers, and trial of different Mg2+-selective ionophores.  
 
4.9 CONCLUSION AND FUTURE STUDIES: 
 
Struvite stones account for 10-15% of renal stones and grow rapidly forming staghorn 
calculi. An understanding of the physico-chemical conditions causing struvite 
crystallization allows development of strategies to prevent their formation. This lack 
of understanding has two bases: i) the particular ionised concentrations of the 
reactants (e.g. Mg2+, NH4+, and phosphate) in the urine are unknown; ii) the 
prevailing chemical conditions that would modulate crystallisation are also unclear 
(e.g. pH, osmolality, other urinary constituents). 
 
At present there are no current true effective treatments to prevent or treat struvite 
stones. Problems: 
• The bacteria are within the layers of the stone and matrix – since antibiotics 
are unable to penetrate deep within the stone, they are ineffective. 
• Once a patient is stone free, even a small remaining nidus can cause 
recurrence. At present there is no urinary monitoring strategy, apart from 
urinary cultures and prevention of infections, once the patient is stone free. 
• The voided urine may not be representative of the urine within the renal pelvis 
and hence voided urine cultures may therefore be an inaccurate reflection of 
the true scenario within the kidney.  
• Laboratories may be missing or ignoring organisms growing small numbers of 
colonies, and labelling them ‘not significant’, however this information may 
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be very useful and identifying all organisms regardless of count in such 
patients may be beneficial. 
 
In the present study, we have: 
• Developed and characterised an NH4+-selective electrode at room temperature 
and at 37°C. 
• Determined the selectivity coefficients of the NH4+-selective electrode against 
interferent ions. 
• Made the first measurements of urinary [NH4+] in undiluted urine from normal 
subjects at room temperature and 37°C. 
• Measured the pH-dependence of the urinary [NH4+] at room temperature and 
37°C. 
• Validated the NH4+-selective electrode data against colour spectrophotometry. 
• Validated the NH4+-selective electrode data against an empirical calculation 
method. 
• Made measurements of the urinary [NH4+] from patients with staghorn stones 
and urinary tract stone disease. 
• Developed and characterised of a Mg2+-selective electrode at room 
temperature and at 37°C as well as determining the selectivity coefficients of 
this Mg2+-selective electrode against interferent ions. 
• Made measurements of urinary [Mg2+] from normal subjects at room 
temperature and 37°C as well as from patients with urinary tract stone disease. 
 
This present study has confirmed that the NH4+-selective electrode is stable and 
responds appropriately in urine, and that along with the Mg2+-selective electrode, they 
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could realistically become useful tools for studying the behaviour of these ions and 
could become available in commercial analysers for use in routine urine analysis. 
Future uses might include: 
• Detecting urease secreting bacteria: currently it is possible to detect urease 
activity on urine samples but urine samples need to be sent to the laboratory, 
grown on specific media (can take 3-5 hours), and even so not all bacteria are 
detected. This would provide a rapid effective simple instant tool which might 
detect urease-secreting bacteria. 
• Use as an adjunct with colourimetric urine dipstick. 
• Use as a monitoring tool for patients seen in the outpatient clinic, particularly 
in those with known history of staghorn, struvite or, previous calcium stones 
(especially if associated with urinary tract infections). By monitoring the 
urinary [NH4+], a rise in the [NH4+] might alert the clinician to institute 
prophylactic treatment (e.g. antibiotics).  
 
Future studies could include: 
• Testing the [NH4+] in urine samples containing urease secreting bacteria. 
• Testing the [NH4+] in urine samples with patients with blocked catheters 
compared to unblocked catheters. 
• Testing more urine samples from patients with staghorn stones. 
• Comparing the urinary [NH4+] from voided urine samples with the urinary 
[NH4+] obtained directly from the collecting system (i.e. nephrostomy sample 
or sample obtained during PCNL). 
• Further characterisation and trial of different ionophores for the Mg2+-
selective electrode. 
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CHAPTER 5 
APPENDIX 
5.1 Consent Form 
 
            
                     
 
 
 
 
 
 
Centre Number:      UCLH Project ID number: 
Patient ID Number:      Form version:  
 
 
CONSENT FORM 
 
 
Title of project: Measuring NH4+ and Mg2+ concentrations in urine from patients with 
kidney stones. 
 
Name of Principal investigator: Professor Chris Fry 
         Please initial box 
 
1. I confirm that I have read and understood the information sheet dated …….. 
(version ……..) for the above study and have had the opportunity to ask 
questions. 
 
 
   
2.  I confirm that I have had sufficient time to consider whether or not want to 
be included in the study  
 
 
 
   
3. I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal 
rights being affected. 
 
   
4. I understand that sections of any of my medical notes may be looked at by 
responsible individuals from (company name) or from regulatory authorities 
where it is relevant to my taking part in research.  I give permission for these 
individuals to have access to my records. 
 
   
 
5. 
 
I agree to take part in the above study. 
 
 
Directorate of Urology 
Urology Department 
2B Maple House 
Ground Floor, Rosenheim Wing 
25 Grafton Way 
London WC1E 6DB 
 
Administrative Enquiries 
Telephone:  020 7380 9179   
Fax:  020 7380 9303 
www.uclh.org 
  
 
 
 
 
 
 
University College Hospitals NHS Trust NHS 
       NHS Foundation Trust 
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Centre Number:      UCLH Project ID number: 
Patient ID Number:      Form version:  
 
 
CONSENT FORM 
 
 
Title of project: Measuring NH4+ and Mg2+ concentrations in urine from patients with 
kidney stones. 
 
 
Name of Principal investigator: Professor Chris Fry 
 
 
__________________________ _________________  _________________ 
Name of patient    Date     Signature 
 
 
 
 
________________________         _____________________
 __________________ 
Name of Person taking consent  Date     Signature 
(if different from researcher) 
 
 
________________________   ____________________
 __________________ 
Researcher (to be contacted   Date     Signature 
if there are any problems)  
         
 
 
Comments or concerns during the study  
 
If you have any comments or concerns you may discuss these with the 
investigator.   If you wish to go further and complain about any aspect 
of the way you have been approached or treated during the course of 
the study, you should write or get in touch with the Complaints 
Manager, UCL hospitals.  Please quote the UCLH project number at 
the top this consent form. 
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5.2 Patient information sheet 
 
 
            
                     
 
 
 
 
 
 
Version:2 
Date: 2/01/07 
Project ID: 
 
 
 
Patient Information Sheet 
 
 
Measuring NH4+ and Mg2+ concentrations in 
urine from patients with kidney stones. 
 
 
 
You are being invited to take part in a research study.  Before you decide, it is important 
for you to understand why the research is being done and what it will involve.  Please 
take time to read the following information carefully and discuss it with others if you 
wish.  Ask us if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part.    
 
The purpose of the study: 
 
At the Institute of Urology, we are keen to understand the conditions under which large 
kidney stones form. By furthering our understanding of these conditions we aim to 
prevent these large stones from forming in the first place. 
 
With recent advances in technology it has been possible, for the first time, to accurately 
measure the concentration of certain chemicals in the urine that are the building blocks 
for large kidney stones. 
 
Why have I been chosen? 
 
You were chosen to take part because you have a large kidney stone. By providing us 
with a sample of urine, we will be able to measure the concentration of these chemicals, 
which will help our understanding of why these stones form.  
Directorate of Urology 
Urology Department 
2B Maple House 
Ground Floor, Rosenheim Wing 
25 Grafton Way 
London WC1E 6DB 
 
Administrative Enquiries 
Telephone:  020 7380 9179   
Fax:  020 7380 9303 
www.uclh.org 
  
 
 
 
 
 
 
University College Hospitals NHS Trust NHS 
       NHS Foundation Trust 
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What is involved in the study? 
 
All you will be required to do is to provide us with a sample of urine (about 30ml) and 
answer a few questions about your urological and medical history with the research 
doctor. This should take no longer than 10 minutes. 
 
If you are having an operation, your operation will not be changed in any way, by taking 
part in this study. During the operation, urine is routinely aspirated from the kidney and 
discarded. A small sample of urine will be allocated to our project. 
 
What will happen to my urine sample? 
 
The urine sample will be taken to the laboratory and kept in the freezer. It will be tested 
for urinary ammonium and magnesium concentrations. After all the experiments have 
been conducted, the sample will be destroyed and not kept for future studies by us or any 
other group. 
 
Benefits of taking part? 
 
You will not benefit directly from this study but by participating you will help to find 
treatments that prevent the condition occurring in others. Obviously, there are no risks or 
side effects from taking part in this study. Please be sure that you are entirely happy 
before you agree, and ask the doctor any questions you may wish, before signing the 
consent form. 
 
Confidentiality: 
 
Professor Christopher Fry will be the custodian for the data generated at the Institute of 
Urology (0207 679 9376) and will be pleased to help if you need further information. 
 
All information collected about you during the course of the research will be kept strictly 
confidential.  Urine samples will be coded and any identifiable information will be 
removed so that you cannot be recognised from it. The results are likely to be published 
in a scientific journal and you will not be identified in any report/publication. 
 
In the unlikely event should you wish to complain, you have a right to complain through 
the UCLH complaints procedure.   
 
Organisation and Funding: 
 
The study is being carried out in conjunction with the Institute of Urology, University 
College London. The project is funded by the Royal College of Surgeons of England.  
 
Withdrawal from the project: 
 
Your participation in the trial is entirely voluntary.  If you do decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form.  If you 
decide to take part you are still free to withdraw at any time and without giving a reason.  
If you choose not to enter the trial, or to withdraw once entered, this will in no way affect 
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your future medical care.  All information regarding your medical records will be treated 
as strictly confidential and will only be used for medical purposes.  Participation in this 
study will in no way affect your legal rights. 
 
Ethics Review: 
 
The project has been reviewed by the National Hospital for Neurology and Neurosurgery 
and Institute of Neurology Joint Research Ethics Committee. 
 
 
 
 
Contact for further information: 
 
Should you require any further information, then please do not hesitate in contacting 
Professor Chris Fry or Senthy Sellaturay at the Institute of Urology (0207 679 9376 / 
9112). 
 
We thank you for taking part in our study. 
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5.3 Parent information sheet 
 
 
            
                     
 
 
 
 
 
 
Version:2 
Date: 2/01/07 
Project ID: 
 
 
 
Patient Information Sheet - PARENT 
 
 
Measuring NH4+ and Mg2+ concentrations in 
urine from patients with kidney stones. 
 
 
 
Your child is being invited to take part in a research study.  Before you decide, it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish.  Ask us if there is anything that is not clear or if you would like more 
information.  Take time to decide whether or not you wish your child to take part.    
 
The purpose of the study: 
 
At the Institute of Urology, we are keen to understand the conditions under which large 
kidney stones form. By furthering our understanding of these conditions we aim to 
prevent these large stones from forming in the first place. 
 
With recent advances in technology it has been possible, for the first time, to accurately 
measure the concentration of certain chemicals in the urine that are the building blocks 
for large kidney stones. 
 
 
 
 
 
 
Why was my child chosen? 
Directorate of Urology 
Urology Department 
2B Maple House 
Ground Floor, Rosenheim Wing 
25 Grafton Way 
London WC1E 6DB 
 
Administrative Enquiries 
Telephone:  020 7380 9179   
Fax:  020 7380 9303 
www.uclh.org 
  
 
 
 
 
 
 
University College Hospitals NHS Trust NHS 
       NHS Foundation Trust 
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Your child was chosen to take part because they have a large kidney stone. By providing 
us with a sample of urine, we will be able to measure the concentration of these 
chemicals, which will help our understanding of why these stones form.  
 
What is involved in the study? 
 
All your child will be required to do is to provide us with a sample of urine (about 30ml) 
and for you to answer a few questions about your child’s urological and medical history 
with the research doctor. This should take no longer than 10 minutes. 
 
If your child is having an operation, the operation will not be changed in any way, by 
taking part in this study. During the operation, urine is routinely aspirated from the 
kidney and discarded. A small sample of urine will be allocated to our project. 
 
What will happen to my urine sample? 
 
The urine sample will be taken to the laboratory and kept in the freezer. It will be tested 
for urinary ammonium and magnesium concentrations. After all the experiments have 
been conducted, the sample will be destroyed and not kept for future studies by us or any 
other group. 
 
Benefits of taking part? 
 
Your child will not benefit directly from this study but by participating they will help to 
find treatments that prevent the condition occurring in others. Obviously, there are no 
risks or side effects from taking part in this study. Please be sure that you are entirely 
happy for your child to take part before you agree, and ask the doctor any questions you 
may wish, before signing the consent form. 
 
Confidentiality: 
 
Professor Christopher Fry will be the custodian for the data generated at the Institute of 
Urology (0207 679 9376) and will be pleased to help if you need further information. 
 
All information collected about your child during the course of the research will be kept 
strictly confidential.  Urine samples will be coded and any identifiable information will 
be removed so that they cannot be recognised from it. The results are likely to be 
published in a scientific journal and your child will not be identified in any 
report/publication. 
 
In the unlikely event should you wish to complain, you have a right to complain through 
the UCLH complaints procedure.   
 
Organisation and Funding: 
 
The study is being carried out in conjunction with the Institute of Urology, University 
College London. The project is funded by the Royal College of Surgeons of England.  
 
Withdrawal from the project: 
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Your child’s participation in the trial is entirely voluntary.  If you decide that your child 
may take part, then you will be given this information sheet to keep and be asked to sign 
a consent form.  If they take part you are still free to withdraw them at any time and 
without giving a reason.  If you choose not to enter your child into the trial, or to 
withdraw them once entered, this will in no way affect your child’s future medical care.  
All information regarding your child’s medical records will be treated as strictly 
confidential and will only be used for medical purposes.  Participation in this study will 
in no way affect you or your child’s legal rights. 
 
Ethics Review: 
 
The project has been reviewed by the National Hospital for Neurology and Neurosurgery 
and Institute of Neurology Joint Research Ethics Committee. 
 
 
 
 
Contact for further information: 
 
Should you require any further information, then please do not hesitate in contacting 
Professor Chris Fry or Senthy Sellaturay at the Institute of Urology (0207 679 9376 / 
9112). 
 
We thank you and your child for taking part in our study. 
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5.4 Control information sheet 
 
            
                     
 
 
 
 
 
 
Version: 
Date:  
Project ID: 
 
 
 
Patient Information Sheet - CONTROL 
 
 
Measuring NH4+ and Mg2+ concentrations in 
urine from patients with kidney stones. 
 
 
 
You are being invited to take part in a research study.  Before you decide, it is important 
for you to understand why the research is being done and what it will involve.  Please 
take time to read the following information carefully and discuss it with others if you 
wish.  Ask us if there is anything that is not clear or if you would like more information.  
Take time to decide whether or not you wish to take part.    
 
The purpose of the study: 
 
At the Institute of Urology, we are keen to understand the conditions under which large 
kidney stones form. By furthering our understanding of these conditions we aim to 
prevent these large stones from forming in the first place. 
 
With recent advances in technology it has been possible, for the first time, to accurately 
measure the concentration of certain chemicals in the urine that are the building blocks 
for large kidney stones. 
 
Why have I been chosen? 
 
You were chosen to take part to act as a control / normal volunteer because you do not 
have a large kidney stone. By providing us with a sample of urine, we will be able to 
measure the concentration of these chemicals in normal individuals and compare the 
Directorate of Urology 
Urology Department 
2B Maple House 
Ground Floor, Rosenheim Wing 
25 Grafton Way 
London WC1E 6DB 
 
Administrative Enquiries 
Telephone:  020 7380 9179   
Fax:  020 7380 9303 
www.uclh.org 
  
 
 
 
 
 
 
University College Hospitals NHS Trust NHS 
       NHS Foundation Trust 
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levels with patients who do have large kidney stones. This will help our understanding of 
why these stones form.  
 
What is involved in the study? 
All you will be required to do is to provide us with a sample of urine (about 30ml) and 
answer a few questions about your urological and medical history with the research 
doctor. This should take no longer than 10 minutes. 
 
If you are having an operation, your operation will not be changed in any way, by taking 
part in this study. During the operation, urine is routinely aspirated from the kidney and 
discarded. A small sample of urine will be allocated to our project. 
 
What will happen to my urine sample? 
 
The urine sample will be taken to the laboratory and kept in the freezer. It will be tested 
for urinary ammonium and magnesium concentrations. After all the experiments have 
been conducted, the sample will be destroyed and not kept for future studies by us or any 
other group. 
 
Benefits of taking part? 
 
You will not benefit directly from this study but by participating you will help to find 
treatments that prevent the condition occurring in others. Obviously, there are no risks or 
side effects from taking part in this study. Please be sure that you are entirely happy 
before you agree, and ask the doctor any questions you may wish, before signing the 
consent form. 
 
Confidentiality: 
 
Professor Christopher Fry will be the custodian for the data generated at the Institute of 
Urology (0207 679 9376) and will be pleased to help if you need further information. 
 
All information collected about you during the course of the research will be kept strictly 
confidential.  Urine samples will be coded and any identifiable information will be 
removed so that you cannot be recognised from it. The results are likely to be published 
in a scientific journal and you will not be identified in any report/publication. 
 
In the unlikely event should you wish to complain, you have a right to complain through 
the UCLH complaints procedure.   
 
Organisation and Funding: 
 
The study is being carried out in conjunction with the Institute of Urology, University 
College London. The project is funded by the Royal College of Surgeons of England.  
 
Withdrawal from the project: 
 
Your participation in the trial is entirely voluntary.  If you do decide to take part you will 
be given this information sheet to keep and be asked to sign a consent form.  If you 
decide to take part you are still free to withdraw at any time and without giving a reason.  
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If you choose not to enter the trial, or to withdraw once entered, this will in no way affect 
your future medical care.  All information regarding your medical records will be treated 
as strictly confidential and will only be used for medical purposes.  Participation in this 
study will in no way affect your legal rights. 
 
Ethics Review: 
 
The project has been reviewed by the National Hospital for Neurology and Neurosurgery 
and Institute of Neurology Joint Research Ethics Committee. 
Contact for further information: 
Should you require any further information, then please do not hesitate in contacting 
Professor Chris Fry or Senthy Sellaturay at the Institute of Urology (0207 679 9376 / 
9112). 
 
We thank you for taking part in our study. 
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5.5 Patient Questionnaire 
 
 
Patient Questionnaire 
 
 
 
Name:          Assigned Number: 
 
 
Address: 
 
 
 
Tel No: 
 
 
Date of Birth:        Age: 
 
 
Presenting Complaint: 
 
 
Associated symptoms and length of time: 
 
 
 
Associated urinary tract infections / how many: 
 
 
How diagnosed: 
 
 
 
Stone composition known or unknown: 
 
 
Past medical history: 
 
 
 
Drug history and allergies: 
 
 
 
Diet modification: 
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